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ABSTRACT
Polychlorinated dibenzo-p-dioxins, dibenzofurans (PCDD/Fs) and polychlorinated biphenyls 
(PCBs) are widespread environmental contaminants. Due to their lipophilicity and persistency, 
they accumulate in the food chain. The most potent of these compounds exert several toxic 
effects in experimental animals such as immunosuppression, body weight loss, enzyme 
induction, developmental defects and tumor promotion. In humans, accidental or occupational 
exposures to high doses of PCDD/Fs and/or PCBs have caused lesions of skin, chloracne, 
developmental defects, and increased the risk of cancers. Exposure to PCDD/Fs has been 
associated with mineralisation defects in the first molar teeth, and PCBs are suspected to cause 
neurobehavioural effects as well as to function as endocrine disrupters. 
PCDD/Fs have never been intentionally manufactured, but PCBs have been used in variety of 
applications e.g. dielectric fluids in transformers, hydraulic systems, and paints. There has been a 
significant reduction in the PCDD/F and PCB environmental levels due to control measures. 
Concentrations have declined by as much as 90% in the environment from those of the late 
1960s. Today the major sources of PCDD/Fs and PCBs are burning processes (waste 
incineration and backyard burning), metal industries, contaminated soil and sediments, and 
landfill sites with contaminated material. 
 Knowledge about the levels of intake and body burden of PCDD/Fs and PCBs in a population 
helps to focus efforts to diminish population exposure to these hazardous compounds. The 
effects of already applied measures to limit the population exposure to these contaminants can be 
judged by examining the temporal changes in intakes and body burdens. History and current 
occurrence of these compounds provide a way to assess future development of concentrations. 
The high PCDD/F and/or PCB exposed group of people would be the best target group to study 
hazardous effects of PCDD/Fs and PCBs and therefore finding such a group is essential for any 
epidemiological study.  
This study has evaluated the characteristics of average intake of PCDD/Fs and PCBs in Finland. 
Adipose tissue concentrations of PCDD/Fs and PCBs were measured in the general population, 
and concentrations in three geographical areas were compared. A survey of Finnish breast milk 
samples from two locations was conducted. A pilot study of professional fishermen was 
conducted. PCDD/F and PCB intake assessments, body burdens in the general population, breast 
milk concentrations, and change with time of these contaminants were compared with the 
corresponding results from Europe or around the world. 
Intake studies revealed that the average adult Finnish intake of PCDD/Fs and PCBs was 1.5 pg 
WHO-TEq/kg bw/day which is below the suggested tolerable daily intake (TDI) of 2 pg WHO-
TEq/kg bw/day according to EU SCF. When comparing to European countries, the intake of 
PCDD/Fs was similar and the intake of PCBs was slightly lower in Finland. An annual decrease 
of 6% in the PCDD/F intake during the 1990s has occured. Fish and fish products contributed 
most (60%-95%) to the intakes in Finland, this being due to the high contribution of Baltic Sea 
fish contaminated with these substances. It was proposed that in the imminent future, any 
changes in time in PCDD/F and PCB intakes would mostly be attributable to changes in 
population food habits and not to changes in the occurrence of these contaminants in foodstuffs. 
This is not surprising since changes in concentrations in fish take place very slowly and the 
results suggest that the decline of concentrations in Baltic herring has levelled off during the last 
5decade. In addition, the contribution of contaminants in other foodstuffs to the intake and 
concentrations has been small when compared to fish in Finland especially during the last years.     
Adipose tissue concentrations of PCDD/Fs (median 24 pg WHOPCDD/F-TEq/g) and PCBs 
(median 17 pg WHOPCB-TEq/g) in the general Finnish population were comparable to European 
concentrations. After age adjustment, the body burdens declined as one moves from the coastal 
areas to more inland areas. This decrease was suggested to be due to differences in the 
consumption of fish species i.e. Baltic herring were consumed more frequently in coastal than in 
inland areas. Although no numerical estimate from the available data could be made, the 
population based concentration frequency graph suggested that exposure of Finnish population 
to these contaminants have been declining during the last decades. Professional fishermen were 
shown to represent a highly exposed population. Their concentrations were 2 to 4 times higher 
than in other men of the same age. The WHOPCDD/F-TEq concentrations in serum fat of 
fishermen were at maximum 500 pg/g fat.   
A decline similar to other countries was detected in the breast milk concentrations of PCDD/F 
and PCBs, being annually 5% and 6%, respectively. A difference in concentrations in breast 
milk was found between the capital and Kuopio area until 1994 but in the most recent study from 
the year 2000, this difference had disappeared. In the year 2000, the average concentration of 
WHOPCDD/F-TEq was 9.4 pg/g fat, and WHOPCB-TEq 5.9 pg/g fat, both concentrations being 
close to European levels. 
Assessment of congener patterns of PCDD/Fs and PCBs in diet and human samples indicated that 
dioxins bioaccumulate more efficiently than furans, and lower chlorinated PCBs have a lower 
bioaccumulation property than higher chlorinated ones. The differences in bioaccumulations 
suggest that the TEF values alone are not capable in depicting differences of PCDD/F and PCB 
congeners between different matrices and trophic levels. 
Keywords: PCDD/F, dioxin, PCB, dietary intake, Baltic herring, Finnish population, body 
burden, breast milk, fishermen
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TIIVISTELMÄ 
Klooratut dibentso-p-dioksiinit, dibentsofuraanit (PCDD/F) ja klooratut bifenyylit (PCB) ovat 
kaikkialle levinneitä ympäristömyrkkyjä. Rasvaliukoisuutensa ja pysyvyytensä takia ne kertyvät 
ravintoverkossa. Kaikkein haitallisimpien niistä on todettu aiheuttavan koe-eläimissä mm. 
vastustuskyvyn heikkenemistä, painonlaskua, vierasainemetabolian aktivoitumista, 
kehityshäiriöitä ja kasvaimia. Tapaturmaisesti tai työperäisesti korkeille PCDD/F- ja/tai PCB-
pitoisuuksille altistuneilla ihmisillä on raportoitu klooriakne, kehityshäiriöitä sekä kasvanut 
syöpäriski. Ensimmäisten pysyvien poskihampaiden mineralisaatiohäiriöt on yhdistetty korkeaan 
PCDD/F altistukseen, ja PCB:eiden on epäilty vaikuttavan haitallisesti keskushermoston 
kehitykseen ja häiritsevän hormonien toimintaa.    
Dioksiineja ja furaaneja ei ole valmistettu tarkoituksellisesti, kun taas PCB:lle on ollut lukuisia 
eri käyttötarkoituksia, esim. muuntajaöljyinä, hydrauliikkanesteinä ja lisäaineina maaleissa. 
Päästörajoitukset ovat merkittävästi pienentäneet PCDD/F- ja PCB-yhdisteiden pitoisuuksia 
ympäristössä. Pitoisuudet ovat laskeneet jopa 90 % 1960-luvun lopulta alkaen. Olemassaolevia 
lähteitä ovat erilaiset polttoprosessit (jätteenpoltto ja pienpoltto), metalliteollisuus, saastuneet 
maat ja sedimentit sekä saastuneita materiaaleja sisältävät kaatopaikat. 
Tietous yhdisteiden saannista sekä ihmisissä esiintyvistä pitoisuuksista auttaa kohdentamaan 
toimenpiteitä, joilla tehkkaimmin vähennetään ihmisten altistumista näille haitallisille 
yhdisteille. Jo toteutettujen päästöjen rajoitusten tehokkuutta voidaan arvioida analysoimalla 
pitoisuuksien muutosta ajan mukana. Nykyhetken ja historian tunteminen auttaa altistumisen 
tulevaisuuden ennustamisessa. Jotta altistumisen aiheuttamia terveyshaittoja päästäisiin 
parhaiten tutkimaan, olisi tärkeätä löytää ryhmä, joka altistuu PCDD/F- ja PCB-yhdisteille 
selvästi keskimääräistä enemmän.   
Tässä tutkimuksessa selvitettiin suomalaisten: a) PCDD/F- ja PCB-saanti ja sen erityispiirteitä, 
b) keskimääräiset PCDD/F- ja PCB-kudospitoisuudet ja verrattiin pitoisuuksia alueellisesti, c) 
äidinmaitojen PCDD/F- ja PCB-pitoisuudet kahdella alueella sekä d) ammattikalastajien 
dioksiini- ja PCB-pitoisuuksia. Pitoisuustuloksia sekä niissä tapahtuneita muutoksia verrattiin 
vastaaviin tutkimuksiin Euroopassa ja muulla maailmassa. 
Suomalaisten aikuisten keskimääräiseksi PCDD/F- ja PCB-päiväsaanniksi saatiin 1,5 pg WHO-
TEq/kg rp (ruumiinpainokilo) kohti, joka on alle EU:n elintarvikealan tiedekomitean ehdottaman 
sallittavan päiväsaannin (TDI), 2 pg WHO-TEq/kg rp. Dioksiinien ja furaanien osalta saanti 
Suomessa vastaa eurooppalaista saantia, mutta PCB:lle altistutaan Suomessa hiukan vähemmän 
kuin muulla Euroopassa.  Tuloksista määritettiin vuosittainen 6 % alenema PCDD/F saannissa 
1990-luvun aikana. Kalan ja kalatuotteiden osuus saannista oli suuri (60 %-95 %), joka johtuu 
Itämeren kalan runsaasta käytöstä. Itämeren kalan osoitettiin olevan saastunut PCDD/F- ja PCB-
yhdisteillä. Tuloksista arvioitiin, että muutokset väestön ruokavaliossa vaikuttavat enemmän 
altistumiseen, kuin muutokset ravintoaineiden PCDD/F- ja PCB-pitoisuuksissa. Tämä on 
ilmeistä, sillä muutokset kalojen  haitallisten aineiden pitoisuuksissa ovat hitaita.     
Kudospitoisuuksissa (PCDD/F mediaani 24 pg WHOPCDD/F-TEq/g ja PCB mediaani 17 pg 
WHOPCB-TEq/g) suomalaisten pitoisuudet vastasivat eurooppalaisia. Kun tulokset ikävakioitiin, 
pienenivät pitoisuudet siirryttäessä rannikolta sisämaahan. Pitoisuuksien ero johtui kalalajien 
kulutuseroista eri alueilla niin, että rannikoilla käytetään enemmän silakkaa ja muita Itämeren 
7kaloja. Väestöstä mitatuista pitoisuuksista pääteltiin myös, että suomalaisten altistuminen 
PCDD/F:lle ja PCB:lle on pienentynyt viimeisten vuosikymmenten aikana. Tämä oli ilmeistä, 
sillä vakioaltistuksella ja 7-8 vuoden puoliintumisajalla odotettavissa olevaa aluksi nousevaa ja 
noin 40 ikävuoden jälkeen tasoittuvaa pitoisuuskäyrää ei löytynyt väestötasolla. 
Ammattikalastajien osoitettiin altistuvan keskimääräistä väestöä enemmän PCDD/F:lle ja 
PCB:lle. Heistä mitatut pitoisuudet olivat 2-4 kertaa korkeammat kuin samanikäisillä 
keskimääräistä väestöä edustavilla miehillä. WHOPCDD/F-TEq seerumipitoisuudet olivat 
enimmillään 500 pg/g rasvaa kohden.  
Suomalaisten äidinmaitojen vuosittaiset pitoisuuksien alenemat (PCDD/F:ssa 5 % ja PCB:ssä 6 
%) olivat samansuuruiset muiden maiden kanssa ja vastasivat saantiarvioissa määritettyä laskua. 
Vielä 1994 määritetyissä äidinmaitojen pitoisuuksissa oli pääkaupunkiseudun ja Kuopion välillä 
ero, mutta uusimmissa, vuonna 2000 määritetyissä äidinmaidoissa eroa ei enää ollut. Vuonna 
2000 keskimääräiset pitoisuudet olivat WHOPCDD/F-TEq 9,4 pg/g rasvaa kohden ja WHOPCB-TEq
5,9 pg/g, jotka vastasivat eurooppalaisia tasoja. 
Tutkituista johdosprofiileista pystyttiin päättelemään, että dioksiinit kertyvät furaaneja 
tehokkaammin ravinnosta ihmiseen. Pienemmän kloorautumisasteen omaavat PCB-yhdisteet 
taas kertyivät heikommin ihmisiin verrattuna korkeammin kloorattuihin johdoksiin. Nämä 
johdosten kertymiserot osoittavat, että nykyään käytössä olevat toksisuusekvivalenttikertoimet 
(TEF) eivät pysty kuvaamaan eri johdosten eroja eri matriiseissa ja eri ravintoketjun tasoilla. 
Avansanat: PCDD/F, dioksiinit, PCB, saanti, silakka, suomalainen, kudospitoisuus, äidinmaito, 
kalastaja
8To my family 
9ACKNOWLEDGEMENTS 
This work has been carried out in the Laboratory of Chemistry, Department of Environmental 
Health, National Public Health Institute, Kuopio, Finland. I wish to thank Professor (emeritus) 
Jouko Tuomisto and Professor Terttu Vartiainen, the former and present directors of the 
Department for providing the facilities for this study. 
I express my deepest gratitude for my principal supervisor and mentor to scientific thinking 
Professor Terttu Vartiainen for her encouraging and enthusiastic attitude and advice during this 
work. My warmest thanks also to my second supervisor Docent Pia Verkasalo for valuable 
discussions throughout writing this thesis. 
I am grateful to the two reviewers of this thesis, Professor Matti Verta and Docent Matti 
Viluksela, for their valuable and constructive comments and critics. 
This thesis is a testimony of work of a skilful and multidisciplinary group of researchers and 
technical staffs in different institutes. It has been a pleasure to work such an innovating team of 
people. My warmest thanks to colleagues Anja Hallikainen, Jaana Koistinen, Jorma 
Kumpulainen, Marja-Leena Ovaskainen, Raimo Parmanne, Raija Purkunen, Pekka Tiittanen, 
Erkki Tukiainen, and Jouni Tuomisto. 
The excellent technical assistance of the present and former personnel in the Laboratory of 
Chemistry has made this thesis possible. Especially I wish to thank Tuula Rissanen, Katri 
Mehtonen, Eija Mehtonen, and Tuomo Korhonen for their priceless work in sampling, sample 
treatment and mass analysis. All the valuable help by Seija Nyholm in organizing and taking 
care of the paper work in studies involved in this thesis and my travelling etc. is cordially 
appreciated. 
I would also like to thank all other colleagues and friends in the Department of Environmental 
Health for their support and help during this work. 
Ewen MacDonald, D.Pharm., is thanked for revising the language in this thesis. 
I thank my parents Aune and Esko, and my brother Pertti for their support during the years 
before this milestone of my scientific career. 
Finally my heartfelt thanks belong to my family, Leila, Nea, and Jenni for their love and 
unconditional support during these years. They have open my eyes to see all the other things in 
life than work.  
Kuopio, September 2005 
Hannu Kiviranta 
This study was financially supported by the Academy of Finland, and the European Commission. 
10 
ABBREVIATIONS 
AHR   aryl hydrocarbon receptor 
AMAP   Arctic Monitoring and Assessment Programme 
ANOVA  analysis of variance 
BMI   body mass index 
bw   body weight 
cf   condition factor 
COT   The UK Committee on Toxicity 
EC   European Community 
EN ISO/IEC  European Standard/International Organization for Standardization 
/International Electrotechnical Commission 
EU   European Union 
FAO   Food and Agriculture Organization 
FSA   Food Standards Agency 
fw   fresh weight 
IARC   International Agency for Research on Cancer 
ICES   International Council for the Exploration of the Sea 
I-TEF   international toxic equivalency factor according to NATO/CCMS 
I-TEQ/I-TEq  toxic equivalent quantity according to I-TEFs 
IUPAC   International Union of Pure and Applied Chemistry 
JECFA   The Joint FAO/WHO Expert Committee on Food Additives 
LOD   limit of determination 
LOQ   limit of quantitation 
MAFF   Ministry of Agriculture, Fisheries and Food 
MBM   market basket method 
N-TEQ/N-TEq Nordic toxic equivalent quantity 
OC   organochlorine compounds 
PBDE   polybrominated diphenyl ether 
PCB   polychlorinated biphenyl 
PCB-TEF  toxic equivalency factor for PCBs according to Ahlborg et al. 1994 
PCB-TEQ/-TEq toxic equivalent quantity according to PCB-TEFs 
PCDD   polychlorinated dibenzo-p-dioxin
PCDF   polychlorinated dibenzofuran 
PCDD/F  polychlorinated dibenzo-p-dioxin/ polychlorinated dibenzofuran 
SCF   Scientific Committee on Food 
SD   standard deviation 
SSIF   selective study of individual foodstuffs 
STS   soft tissue sarcoma 
TCDD   2,3,7,8-tetrachlorodibenzo-p-dioxin
TDI   tolerable daily intake 
TEF   toxic equivalency factor 
TEq/TEQ  TCDD-toxic equivalent quantity 
TWI   tolerable weekly intake 
USEPA   United States Environmental Protection Agency 
VIF   variance inflation factor 
WHO   World Health Organization 
WHOPCB-TEF  TCDD-toxic equivalency factor according to WHO for PCBs 
WHOPCB-TEQ/ -TEq toxic equivalent quantity according to WHOPCB-TEF
WHOPCDD/F-TEF TCDD-toxic equivalency factor according to WHO for PCDD/Fs 
WHOPCDD/F-TEQ/ -TEq toxic equivalent quantity according to WHOPCDD/F-TEF
NATO/CCMS North Atlantic Treaty Organization/Committee on the Challenge of Modern 
Society
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CHAPTER 1 
GENERAL INTRODUCTION 
1. LITERATURE REVIEW 
Structure and sources 
 Polychlorinated dibenzo-p-dioxins (PCDDs) and dibenzofurans (PCDFs) have a planar 
aromatic tricyclic structure with 1-8 chlorine atoms as substituents (Fig 1). It is possible to create 
75 different PCDDs and 135 PCDFs, which differ from each other in the number and positions 
for the chlorine atoms. From the human/biota point of view, 17 PCDD/Fs with lateral (2,3,7,8-) 
chlorine substitution pattern are considered to be toxicologically important (WHO/IPCS 1989). 
  Polychlorinated biphenyls (PCBs) have two benzene rings attached to each other, with 
1-10 chlorine atoms as substituents (Fig 1). Theoretically it is possible to form 209 different 
congeners of PCBs, but even the technical mixtures of PCBs have only a fraction of the total 
possible number of congeners. Some PCBs are called dioxin-like (co-planar/non-ortho-) PCBs. 
Those congeners do not have any or have only one chlorine atom (mono-ortho-PCBs) in the 
ortho-position to the carbon-carbon bond between the two benzene rings. A dozen of these 
congeners are believed to express similar toxicogical effects as PCDD/Fs to humans and biota 
(van den Berg et al. 1998).     
Fig 1. Chemical structures of polychlorinated dibenzo-p-dioxins (PCDDs), polychlorinated 
dibenzofurans (PCDFs), and polychlorinated biphenyls (PCBs). 
PCDD/Fs have never been intentionally manufactured. However they do occur as minor 
impurities in many chlorinated chemicals (e.g. in PCBs, and in chlorinated pesticides as 
fungicides and herbicides) (WHO/IPCS 1989, Vartiainen et al. 1995, Michalek et al. 1996). 
Burning processes in the presence of chlorine and with metal catalysts are sources of PCDD/Fs. 
It has been estimated that municipal solid waste incineration and accidental fires, together with 
backyard burning, contribute significantly to PCDD/F emissions to land and water in the EU 
countries (Wenborn et al. 1999). The metal-processing industries e.g. secondary Pb, Cu, and Al 
O
O
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production also contribute to PCDD/F emissions, but not to the same extent as burning processes 
(Wenborn et al. 1999). Sources of PCDD/Fs in Finland originate partly from air emissions 
coming from Central Europe, because prevailing winds in Finland are from the southwest 
direction (Shatalov et al. 2003). Some of the air emissions are domestic in origin and earlier 
emissions can be attributed to pulp and paper industries using elemental chlorine for pulp 
bleaching (Wulff et al. 1993, MacDonald et al. 1998). The production and application of a 
chlorophenol mixture called “Ky-5” which was used as a wood preservative in sawmills from the 
1940s until the mid 1980s led to soil and sediment contamination by PCDD/Fs in many sawmill, 
landfill, and disposal sites as well as in sediments of the Gulf of Finland in the Baltic Sea 
(Vartiainen et al. 1995, Kitunen and Salkinoja-Salonen 1990, Assmuth and Vartiainen 1994, 
Isosaari et al. 2002). The prohibition of usage of chlorinated pesticides and chlorophenols, and 
abandonment of elemental chlorine for pulp bleaching, together with reductions in emissions to 
air (Quaß et al. 2004) have led to a nearly 90% decrease in PCDD/F emissions since the 1980s in 
European countries and also in Finland. 
 PCBs have many useful characteristics, e.g. non-flammability, electrical insulating 
properties, and stability and they have been used globally in a great variety of applications. So-
called closed uses of PCBs included their use as dielectric fluids in transformers, capacitors, and 
as heat transfer fluids, and in hydraulic systems. Open use has involved the application as 
pesticide extenders, sealants, carbonless copy papers, industrial oils, paints, adhesives, plastics, 
flame retardants and controlling of dust on roads (http://europa.eu.int/comm/environment/ 
waste/pcbs/index.htm). At least 1.5 million tonnes of PCBs were produced between 1930s and 
1980s under different trade names such as Aroclor, Clophen, and Kanechlor (Bernes 1998). 
Nowadays PCBs can be found everywhere around the globe including the Arctic (AMAP 2004). 
The Baltic Sea sediments reveal that the maximum emissions to the area have occured during the 
late 1960s and early 1970s (Isosaari et al. 2002, Kjeller and Rappe 1995). Current surface 
sediment concentrations of PCBs are 2-5 times lower than during the periods of maximum 
concentrations (Isosaari et al. 2002, Kjeller and Rappe 1995, Konat and Kowalewska 2001). 
Persistency and toxicity 
 PCDD/Fs and PCBs are environmentally stable and (in particular 2,3,7,8-chlorine 
subsituted PCDD/F congeners) biologically persistent (Sinkkonen and Paasivirta 2000). These 
characteristics together with high lipophilicity; log Kow for PCDD/Fs ranging from 6.1 to 8.2 
(Mackay et al. 1992), and for PCBs from 4.9 to 8.2 (Mackay et al. 1991), result in accumulation 
17 
of PCDD/Fs and PCBs in food chain (AMAP 2004). The half-lives of 2,3,7,8-chlorine 
substituted PCDD/Fs in man have been estimated to be on average seven years, with values 
ranging from few months to decades (Poiger and Schlatter 1986, Flesch-Janus et al. 1996, Liem 
and Theelen 1997, Geyer et al. 2002), and with the corresponding PCB half-lives in man ranging 
from months to several years (Chen et al. 1982, Taylor and Lawrence 1992, Ryan et al. 1993). 
The toxicity of PCDD/Fs involves the cytosolic aryl hydrocarbon receptor (AHR), which 
is a ligand-activated transcription factor. Binding of PCDD/Fs to AHR initiates the expression of 
several genes in a cell (Poellinger 2000) and leads to toxic effects by mechanisms, which are still 
not fully understood. The most toxic congener of PCDD/Fs is 2,3,7,8-tetrachlorodibenzo-p-
dioxin (TCDD), which serves as a reference compound in terms of its affinity to AHR for the 
other PCDD/Fs, and also for dioxin-like PCBs. The concept of TCDD toxic equivalency factor 
(TEF) was developed to describe the total toxic equivalent quantity (TEq) of a mixture of 
PCDD/Fs and/or dioxin-like PCBs (Safe 1990). The TEF concept presupposes that the molecule 
will bioaccumulate in the food chain, will possess a structural similarity to PCDD/Fs, will bind 
to AHR, and elicit AHR-mediated responses. The most recent TEFs are based on a consensus 
statement agreed at a convention organized by the World Health Organization (WHO) in 
Stockholm in 1997 (van den Berg et al. 1998). Table 1 describes these so-called WHOPCDD/F-
TEFs and WHOPCB-TEFs together with previously used TEFs (NATO/CCMS 1988, Ahlborg et 
al. 1994). Equation 1 presents the calculation of TEq in a sample. 
(1) TEq =  ?
=
n
i 1
(Ci * TEFi) in which Ci is the concentration of a congener with a TEFi value. 
Although there are numerous toxic endpoints of PCDD/Fs and PCBs shown in 
experimental animals (Pohjanvirta and Tuomisto 1994), only a few of them have been 
demonstrated in humans. Chloracne is associated with PCDD/Fs in both occupational and 
accidental exposures to high amounts (Zober et al. 1990, Mocarelli et al. 1991, Ott et al. 1993, 
Geusau et al. 2001). Cancer is another human endpoint associated with PCDD/Fs, and the 
International Agency for Research on Cancer (IARC) has concluded, based on experimental 
animal studies, that TCDD is a human carcinogen (IARC 1997, http://www-
cie.iarc.fr/htdocs/monographs/vol69/dioxin.html). IARC has concluded that for other PCDD/F 
congeners there is inadequate evidence of carcinogenicity to humans. According to IARC, PCBs 
are probably carcinogenic to humans (http://www-cie.iarc.fr/htdocs/monographs/suppl7/ 
polychlorinatedbiphenyls.htm). 
Although epidemiological studies attempting to link PCDD/F exposure (i.e. a mixture of 
chemicals) to cancer have suffered from simultaneous exposures to other kinds of chemicals e.g. 
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chlorinated herbicides and fungicides, and limited exposure measurements, it has been estimated 
that an increased total cancer risk can be associated with high exposures to PCDD/Fs (Fingerhut 
et al. 1991, Flesch-Janus et al. 1995, Ott and Zober 1996). On the other hand, individual 
concentration measurements were used in assessing an average and usually low level diet-driven 
exposure to PCDD/Fs in a Finnish case-control study on soft tissue sarcoma (STS). In this study 
it was not possible to associate increased risk of STS to increased PCDD/F concentration 
(Tuomisto et al. 2004).
Table 1. 
Toxic equivalency factors (TEFs) according to WHO (van den Berg et al. 1998) (WHOPCDD/F-
TEFs and WHOPCB-TEFs) together with NATO (NATO/CCMS 1988) TEFs for PCDD/Fs (I-
TEF) and PCB-TEFs according to Ahlborg et al. (1994) for PCBs. 
Congener I-TEF WHOPCDD/F-TEF Congener PCB-TEF WHOPCB-TEF 
2,3,7,8-TCDD 1 1 PCB 81 - 0.0001 
1,2,3,7,8-PeCDD 0.5 1 PCB 77 0.0005 0.0001 
1,2,3,4,7,8-HxCDD 0.1 0.1 PCB 126 0.1 0.1 
1,2,3,6,7,8-HxCDD 0.1 0.1 PCB 169 0.01 0.01 
1,2,3,7,8,9-HxCDD 0.1 0.1 PCB 105 0.0001 0.0001 
1,2,3,4,6,7,8-HpCDD 0.01 0.01 PCB 114 0.0005 0.0005 
OCDD 0.001 0.0001 PCB 118 0.0001 0.0001 
2,3,7,8-TCDF 0.1 0.1 PCB 123 0.0001 0.0001 
1,2,3,7,8-PeCDF 0.05 0.05 PCB 156 0.0005 0.0005 
2,3,4,7,8-PeCDF 0.5 0.5 PCB 157 0.0005 0.0005 
1,2,3,4,7,8-HxCDF 0.1 0.1 PCB 167 0.00001 0.00001 
1,2,3,6,7,8-HxCDF 0.1 0.1 PCB 170 0.0001 - 
2,3,4,6,7,8-HxCDF 0.1 0.1 PCB 180 0.00001 - 
1,2,3,7,8,9-HxCDF 0.1 0.1 PCB 189 0.0001 0.0001 
1,2,3,4,6,7,8.HpCDF 0.01 0.01    
1,2,3,4,7,8,9-HpCDF 0.01 0.01    
OCDF 0.001 0.0001    
Developmental toxicity of PCBs (and possibly of PCDFs), have been demonstrated with 
Yusho and Yu-Cheng accidents, where people were exposed to high concentrations of these 
contaminants accidentally by consuming contaminated rice-oil (Rogan et al. 1988, Masuda 
1996). PCDD/Fs have effects on developmental processes - it was noted that mineralisation 
defects of the first molar teeth in children were assosiated with high, breast feeding derived 
exposure to PCDD/Fs, but not to PCBs (Alaluusua et al. 1996, Alaluusua et al. 1999). PCB 
exposure has been connected to neurotoxic and neurobehavioural effects as well as to alterations 
of thyroid hormone levels and lower birth weights (Feeley and Brower 2000). It has been 
claimed that fishermen’s wives in Sweden gave birth to lower birth-weight children which was 
attributed to increased PCB exposure (Rylander et al. 1995, Rylander et al. 1996). PCDD/Fs may 
also act as endocrine disrupters. A remarkably low boy to girl ratio was found in families of 
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Seveso where the father had been exposed as a prepubertal boy to high levels of TCDD during 
the well known massive release of this agent that occurred in that town (Mocarelli 2000). 
Guidelines and legislation 
 Recently a number of authorities have assessed or re-assessed risks of PCDD/Fs and 
PCBs. In many of the newer risk assessments, the focus has turned away from cancer risk 
towards developmental risks. The differences in risk assessments originate from uncertainties 
about dioxin toxicity. The risk assessment is based on animal studies and extrapolation over 
species to humans also leads to uncertainties and differences between assessments. Risk 
assessments often describe tolerable daily or tolerable weekly intakes (TDI or TWI, 
respectively).
WHO re-evaluated the risk assessment of PCDD/Fs and related compounds in a 
consultation held in 1998. Taking into account laboratory animal results on decreased sperm 
count, immune suppression, increased genital malformations, neurobehavioural effects, and 
endometriosis, the consensus meeting ultimately suggested a range of TDI intakes for humans 
(1-4 pg TEq/kg body weight (bw)) (van Leeuwen and Younes 2002). The upper bound limit 
should be considered as a maximal TDI while the lower bound limit represents an intake below 
which the intakes should ultimately decrease.  
Based on the rodent studies, The Scientific Committee on Food (EU SCF) of the 
European Commission assessed a TWI of 14 pg WHO-TEq/kg bw for PCDD/Fs and for dioxin-
like PCBs (European Commission 2001). This guideline is in line with the tolerable monthly 
intake (70 pg WHO-TEq/kg bw) established by the Joint FAO/WHO Expert Committee on Food 
Additives, JECFA (WHO/FAO 2001). The recommendation for TDI of WHO-TEq of the UK 
Committee on Toxicity of Chemicals in Food, Consumer Products and Environment (COT) is 
also in line with EU SCF and JECFA, 2 pg WHO-TEq/kg bw (COT 2001). 
The recent re-evaluation by United States Environmental Protection Agency (USEPA) 
ended up to a TDI range of 0.001 to 0.01 pg WHO-TEq/kg bw (USEPA 2000). In its risk 
assessment, USEPA has considered cancer risk as the primary risk of PCDD/Fs unlike others 
mentioned here. The recent re-evaluations of tolerable daily intake are summarized in table 2. 
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Table 2. 
Recent guidelines (in bold) on tolerable intakes (as pg WHO-TEq / kg bw) of PCDD/Fs and 
PCBs according to risk assessments by different organizations.
Organization Year Tolerable daily intake Tolerable weekly intake Tolerable monthly 
intake 
WHO 1998 1-4 7-28a 31-124 a
EU SCF 2001 2 a 14  62 a
JECFA 2001 2.3 a 16 a 70
COT 2001 2 14 a 62 a
USEPA 2000 0.001-0.01 0.007-0.07 a 0.031-0.31 a
a values calculated by dividing or multiplying by a factor of 7 or 31. 
 In addition to providing guidelines of intakes of PCDD/Fs and PCBs, in many countries 
legislative or guideline activities have been undertaken, to limit PCDD/F and PCB emissions, in 
order to protect humans and the environment from the impact of PCDD/Fs and PCBs (Basler 
1994, Farland et al. 1994, Johansson and Ahlborg 1994, Kimura 1994, Newstead and Gemmil 
1994, Gilman et al. 1995). The impact of these activities has been reflected in the declining 
emissions (Quaß et al. 2004). 
 The Council of the European Union in 2001 in a Council Directive 2001/102/EC decreed 
the maximum levels of PCDD/Fs in substances and products for animal nutrition (EC 2002) and 
there is a Council Regulation 2375/2001 setting maximum levels of PCDD/Fs in certain 
foodstuffs (EC 2001). With these legislative measures, the EU strives to protect its inhabitants 
from exposure to PCDD/Fs, since marketing of feed and foodstuffs exceeding these maximum 
levels is not allowed within the EU countries. Only PCDD/Fs were included in these regulations. 
The Commission reviewed the maximum levels by the end of 2004 and at the beginning of year 
2005 made a proposal to add dioxin-like PCBs to the set of compounds. The maximum levels in 
force for PCDD/Fs as well as the proposed maximum levels for dioxin-like PCBs in foodstuffs 
are presented in table 3. From the Finnish point of view, Finland (and also Sweden) were granted 
a derogation from the maximum limit value for fish and fish products (EC 2001). This 
derogation allows these countries to permit fish, in which the maximum level is exceeded, to be 
sold, but prohibits the export of such fish to other EU countries. This derogation states that both 
Finland and Sweden must annually report to the Commission the monitoring results of the levels 
of PCDD/Fs in fish from the Baltic region and the measures taken to reduce the human exposure 
to PCDD/Fs from fish. In the proposal given early in 2005, this derogation of Finland and 
Sweden has been proposed to become a permanent derogation, and also the new EU countries 
like Estonia, Latvia, and Lithuania would have the same permanent derogation.
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Table 3.
Maximum levels in certain foodstuffs, set by the Council of the European Union, of PCDD/Fs as 
WHOPCDD/F-TEqs, and proposed total WHO-TEq (including PCDD/Fs and PCBs) maximum 
levels.
Products WHOPCDD/F-TEqs   Proposed for total WHO-TEq    
Meat and meat products from 
- Ruminants (bovine animals, sheep) 
- Poultry and farmed game 
- Pigs 
Liver and derived products 
3 pg/g fat 
2 pg/g fat 
1 pg/g fat 
6 pg/g fat 
4.5 pg/g fat 
4 pg/g fat 
1.5 pg/g fat 
12 pg/g fat 
Muscle meat of fish and fishery products 4 pg/g fresh weight (fw) 8 pg/g fresh weight (fw) 
Milk and milk products, including butter fat 3 pg/g fat 6 pg/g fat 
Hen eggs and egg products 3 pg/g fat 6 pg/g fat 
Oils and fats 
- Animal fat 
from ruminants 
from poultry and farmed game 
from pigs 
from mixed animal fat 
- Vegetable oil 
- Fish oil intended for human consumption 
3 pg/g fat 
2 pg/g fat 
1 pg/g fat 
2 pg/g fat 
0.75 pg/g fat 
2 pg/g fat 
4.5 pg/g fat 
4 pg/g fat 
1.5 pg/g fat 
3 pg/g fat 
1.5 pg/g fat 
10 pg/g fat 
Human intake of PCDD/Fs and PCBs 
 Food intake represents the main route of human exposure to PCDD/Fs and PCBs with a 
contribution of more than 90% of the total exposure and of this dietary exposure, 80% originates 
from food of animal origin (Dougherty et al. 2000, Parzefall 2002).  
It is a challenging task to compare the dietary exposure of populations to PCDD/Fs and 
PCBs in different countries. PCDD/F and PCB dietary intake assessment studies can include 
different amounts of food items and food categories analysed for contaminants, and also 
different methods are used for assessing subjects’ food consumption habits. Usually all 
seventeen 2,3,7,8-chlorine substituted PCDD/F congeners are measured, but with PCBs, the 
situation is not so clear. In some studies, only non-ortho-PCBs have been measured, while others 
include also mono-ortho-PCBs (dioxin-like PCBs) and a set of other PCBs. Since dioxin-like 
PCBs play an important role in the total TEq in food samples, especially of animal and fish 
origin (Alcock et al. 1998), they should not be ignored when assessing total intake of these 
organic pollutants. In addition to these differences, usage of lower bound (where non-detected 
congeners are designated as nil), medium bound (where non-detected congeners are designated 
as half of LOQs) or upper bound (where non-detected congeners are designated as LOQs) 
concentrations of PCDD/Fs and PCBs may have a major impact on the final estimated exposure 
levels or on assessment of sources of PCDD/Fs and PCBs in a study population. 
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Table 4 lists the most recent average adult daily intakes of WHOPCDD/F-TEqs and 
WHOPCB-TEqs in various countries along with contributions of different food groups to the 
PCDD/F or PCB intake.  
Daily intakes of WHOPCDD/F-TEq (including lower, medium, and upper bound results) in 
Western Europe ranged between 21 and 97 pg or from 0.3 to 1.45 pg WHOPCDD/F-TEq/kg bw. 
On average in Western Europe, the daily intake was 59 pg or 0.86 pg WHOPCDD/F-TEq/kg bw. 
The difference between lower and upper bound intake estimates can range from 25% to 40% 
(Becher et al. 1998, FSA 2003). The contribution (from 24% to 44%) of dairy, meat, and egg 
products on daily intake of PCDD/Fs has been much larger than the contribution from fish (6%-
17%) in countries where the per capita consumption of fish is the lowest. Such countries in 
Europe are Germany, UK, Belgium, and the Netherlands (Welch et al. 2002, EC 2004). In 
countries, such as Sweden, France, Norway, and Spain, where fish consumption is higher, the 
contribution of fish and fish products has dominated, ranging from 30% to 43%.  
Daily intakes of WHOPCB-TEqs in Western Europe were comparable to PCDD/F intakes, 
from 35 to 145 pg or 0.4 to 2.1 pg WHOPCB-TEq/kg bw. On average, the daily intake of PCBs 
was 74 pg or 0.84 pg WHOPCB-TEq/kg bw. There is much less data on PCBs, but the 
contribution of different food groups to PCB intake seems to be rather similar in central Europe, 
but in Norway and Sweden, the contribution of fish and fish products to PCB intake was 45% 
and 51%, respectively.  
On average, the total daily intake of WHOPCDD/F-TEq and WHOPCB-TEq (1.7 pg WHO-
TEq/kg bw) is well below the upper range of WHO guideline on tolerable daily intake, which 
was the immediate goal of WHO when it set these guidelines (van Leeuwen and Younes 2002). 
The corresponding guideline by EU SCF (2 pg WHO-TEq/kg bw/day) is quite close to the 
current average intake in Western European countries (EU SCF). The Netherlands, UK, and 
Sweden have provided estimates about how large a percentage of their populations is exceeding 
the EU SCF guideline for daily intake of WHO-TEq. In the Netherlands this value is 8% of the 
whole population, in UK it is 1.1% of the adult population, whereas in Sweden as much as 12% 
of the adult population exhibit daily intakes exceeding the EU SCF guideline (Freijer et al. 2001, 
FSA report 38/03, Lind et al. 2002).     
From the USA there are two studies giving quite different, but still comparable to 
European, estimates for WHOPCDD/F-TEq medium bound daily intake, 37 and 108 pg (or 0.53 
and 1.73 pg WHOPCDD/F-TEq/kg bw) (Schecter et al. 2001, South et al. 2004). The reported daily 
intake of WHOPCB-TEq (Schecter et al. 2001) corresponded to the lower end of PCB intake in 
Western Europe. South et al. (2004) have reported daily intake estimates of WHOPCDD/F-TEq in 
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lower, medium, and upper bound concentrations and the upper bound intake was a drastic 2.7 
times higher than the lower bound intake estimate. Also the contributions of some of the foods to 
the intake changed considerably when the upper bound method instead of the lower bound 
method was used for the intake estimation. The contribution of meat and eggs was in lower 
bound method 50% and the corresponding contribution of food group “Others” was 27%. When 
moving to the intake calculated with upper bound method, the respective contributions switched 
to 27% and 58%. 
There are recent intake studies available from China, Korea, Japan, and Taiwan. Daily 
intakes of WHOPCDD/F-TEq (including lower, medium, and upper bound results) ranged from 21 
to 82 pg/day or from 0.32 to 1.64 pg WHOPCDD/F-TEq/kg bw/day. In Japan, Korea, and Taiwan, 
the consumption of fish is high and also the contribution of fish to total intake of PCDD/Fs and 
PCBs was high in these countries, although in the study from Korea the group “Others” 
contributed by 51% to the daily intake of PCDD/Fs. In China, where the consumption of fish is 
lower (EC 2004) the dominating source of PCDD/Fs was the food group “meat and eggs”. 
The lowest intake estimations have been published from New Zealand, where the lower 
bound intake of PCDD/Fs was 3.8 pg WHOPCDD/F-TEq /day (or 0.047 pg WHOPCDD/F-TEq/kg
bw/day) and the intake of PCBs 7.8 pg WHOPCB-TEq /day (or 0.098 pg WHOPCB-TEq/kg
bw/day). The medium bound intake estimates for PCDD/Fs were almost four times higher and 
for PCBs 1.5 times higher than the lower bound estimates, being 0.18 pg WHOPCDD/F-TEq/kg
bw/day and 0.15 pg WHOPCB-TEq/kg bw/day, respectively.  
Congeners contributing the most to the WHOPCDD/F-TEq intake profile have been 
reported to be  2,3,7,8-TCDD, 1,2,3,7,8-PeCDD, 2,3,4,7,8-PeCDF, and 1,2,3,6,7,8-HxCDD 
(Tsutsumi et al. 2001, Focant et al. 2002, Hsu et al. 2002, Diletti et al. 2004, Fernández et al. 
2004). The higher contribution of the group “fish” to the total intake of WHOPCDD/F-TEqs 
increases the contribution of 2,3,7,8-TCDF in the intake profile (Tsutsumi et al. 2001, Focant et 
al. 2002, Hsu et al. 2002). For WHOPCB-TEqs, the main contribution to the intake has been 
reported to come from congener PCB 126 (Tsutsumi et al. 2001, Fernández et al. 2004), but 
studies including all relevant (dioxin-like) PCBs are scarce and sometimes only non-ortho-PCBs 
have been measured. 
Due to their higher food intake in relation to the body weight, children are exposed to 
higher PCDD/F and PCB doses than adults. In this respect, crude estimations of intake of breast-
feeding infants have been performed by assuming that an infant weighing 5 kg eats 800 ml of 
breast milk with 3.5% fat. Using WHO-TEq concentrations in breast milk from the third round 
of WHO coordinated breast milk studies (Leeuwen and Malisch 2002) from figure 3, the daily 
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intake of an infant will vary from 32 to over 200 pg WHO-TEq/kg bw. This range is about 20 to 
100 times the TDI suggested by EU SCF. In the USA the intake of PCDD/Fs of breastfeeding 
infants (0-1 years) was about 20 times higher than that of general adult population (see table 4), 
(Schecter et al. 2001).  
Patandin et al. (1999) concluded that breast feeding infants were more exposed to total 
TEq by a factor of 50, compared to young adults (20-25 years). For children aged 1-5, the factor 
was 3, for 6-10 years old children the factor was 2 and for children at ages 10-20 it was 1.5; 
these factors have been verified in the following studies.  In Tarragona, Catalonia, Spain the 
daily intake of PCDD/Fs per bw of children, aged 4-9 years, was about twice (2.1 pg 
WHOPCDD/F-TEq/kg bw/day) the intake of adults (Bocio and Domingo 2005). In Germany, the 
daily intake of PCDD/Fs of children in the age range 14-47 months was on an average 1.6 pg I-
TEq/kg bw/day, ranging from 0.68 to 5.4 pg I-TEq/kg bw/day (Wittsiepe et al. 2001). In the 
USA, the intake of chilren aged 1-11 years had an intake of PCDD/Fs and PCBs that was about 
2.5-3 times higher than the intake of adult population, see table 4 (Schecter et al. 2001, South et 
al. 2004). In UK, in schoolchildren aged from 4 to 14 years the daily intakes were on average 
0.67 and 0.7 pg WHO-TEq/kg bw/day for PCDD/Fs and PCBs, respectively. This was about 1.5 
times the intake of the adult UK population. For toddlers in the age range 1.5 to 4 years, the 
intakes were about twice the adult intakes (FSA 2001). In the Netherlands the intake of 
PCDD/Fs and PCBs in two year old children was 2.5 times the corresponding intake of the 
general adult population, and intakes of 10 years old children were 1.4 times the intake of the 
adult population (Freijer et al. 2001).  
Time-trend of human intake of PCDD/Fs and PCBs 
 Figure 2 illustrates the time-trends of WHOPCDD/F-TEq and WHOPCB-TEq intake in the 
adult UK population between 1982 and 2001, and in the general population of the Netherlands 
between 1978 and 1999. In twenty years, the intakes of PCDD/Fs and  PCBs in UK declined by 
90% and 80% (4.8% and 4.3% annually), respectively (FSA 2001), and in the Netherlands by 85 
and 88% (4% and 4.2% annually), respectively (Liem and Theelen 1997, Freijer et al. 2001). 
The decrease was most dramatic in the period from the end of 1970s till the beginning of 
1990s and has been levelling off during the past 9 years in both contaminant groups in the 
Netherlands and in WHOPCB-TEq in the UK. The decrease of WHOPCDD/F-TEq has been steeper 
in the UK than the decline of WHOPCB-TEq and there has been no obvious levelling off in the 
decline. As a result of this the contribution of PCBs to the intake has risen over the reporting 
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period in the UK, representing 36% in 1982 and 55% in 2001. This indicates that restrictions 
placed on industrial emissions have worked more efficiently for PCDD/Fs than for PCBs in UK, 
which might be explained by the fact that the sources are more diffuse due to the abundant use 
of PCBs in many kinds of applications. During the same time period, from 1978 to 1999 in the 
Netherlands, marker PCB (marker PCBs include congeners PCB 28, 52, 101, 118, 138, 153, and 
180) intakes have also declined by 93%, being 83 ng/kg bw/day in 1978, 39 ng/kg bw/day in 
1984, 10 ng/kg bw/day in 1994, and 5.6 ng/kg bw/day in 1999 (Bakker et al. 2003). In 
Germany, the PCDD/F intake has declined by 68% from 1989 to 1999 (from 2.3 to 0.73 pg I-
TEq/kg bw/day) (Vieth et al. 2000), which is quite similar to the corresponding trends of 
PCDD/F intake in UK and the Netherlands. In Sweden, intakes of PCDD/Fs at the beginning of 
1990s were three times as high as those measured in 1999 and the intake of PCBs had declined 
by 75% (Lind et al. 2002). 
In Tarragona, Catalonia, Spain the adult intake of PCDD/Fs decreased from 210 pg I-
TEq/day in 1998 to 59.6 I-TEq/day (63.8 pg WHOPCDD/F-TEq/day) in 2002. This was 
attributable to a reduction of PCDD/F concentrations in most foodstuffs, because of the 
decreasing deposits from the atmosphere, and also because dietary habits of the population has 
changed towards a more healthy diet including more vegetables, fruits, and dairy products 
(Bocio and Domingo 2005). Between the years 2000 and 2002 in Catalonia, Spain, the intake of 
children aged 4 to 9 years decreased by 15% annually, from 3.2 to 2.1 pg WHOPCDD/F-TEq/kg
bw/day (Llobet et al. 2003, Bocio and Domingo 2005) An annual decrease of 11% between 
1995 and 1998 in the intake of PCDD/Fs (from 2.6 to 1.6 pg I-TEq/kg bw/day) of children was 
reported in Germany (Wittsiepe et al. 2001).
Table 4.
Average adult daily intakes of WHOPCDD/F-TEqs and WHOPCB-TEqs as pg (pg/kg bw). Contributions of different food groups to the PCDD/F 
intake (PCB intake). Bolded studies may include lower (0), medium (0.5 * LOQ) and/or upper bound (LOQ) estimations of daily intake.  
 Daily intakes, pg (pg/kg bw)  % Contribution of foods from PCDD/Fs (PCBs)  
Country, study period WHOPCDD/F-TEq WHOPCB-TEq Method Dairy Meat and eggs Fish Otherse Reference 
Norway, 1998 51 (0.73c)d 86 (1.2c)d 0 13 (20) 17 (24) 43 (48) 27 (8) Becher et al. 1998 
The Netherlands, 1999a 45 (0.60)  46 (0.61) 0 24 (30) 26 (29) 9.6 (22) 41 (19) Freijer et al. 2001 
Belgium, 2001 65 (1.00) 68 (1.04)b 0 30 (25) 31 (36) 40 (40) NA Focant et al. 2002 
United Kingdom, 2001 21 (0.3c) 28c (0.4) 0     FSA report 38/03 
USA, 2002 20 (0.29c)  0 12 50 11 27 South et al. 2004 
Japan, 2000 45 (0.89) 68 (1.36) 0 7.5 (2.1) 19 (13) 67 (83) 6.9 (1.1) Tsutsumi et al. 2001 
Taiwan, 2001 21 (0.32)  0 13 25 63 NA Hsu et al. 2002 
New Zealand, 1998 3.8 (0.047)d 7.8 (0.098)d 0 1.5 (29) 2.5 (27) 31 (37) 65 (7) Buckland et al. 1998 
        
Sweden, 1999 57 (0.79) 41 (0.56) 0.5 * LOQ 21 (12) 20 (21) 39 (51) 21 (16) Lind et al. 2002 
Germany, 1996 61 (0.88)d  Unknown 31 31 17 21 Malisch 1998 
Germany, 1999 51 (0.73) d  0.5 * LOQ 39 41 11 9 Vieth et al. 2000 
Italy, 1996 45 (0.74) d  0.5 * LOQ 26 39 35  SCOOP 2000 
Spain, 2000a 95 (1.36)  0.5 * LOQ 27 15 30 28 Llobet et al. 2003 
Spain, 2002 64 (0.91)  0.5 * LOQ 20 11 34 34 Bocio et al. 2005 
USA, 2002 37 (0.53c)  0.5 * LOQ 11 34 7 49 South et al. 2004 
USA, 1995 108 (1.73) 38 (0.61) 0.5 * LOQ 31 (24) 36 (51) 5.7 (17) 27 (7.7) Schecter et al. 2001 
China, 2000 72 (1.20)  Unknown 16 56 29 NA Wu et al. 2002 
Korea, 1999 30 (0.51)d  Unknown 1 8.7 39 51 Kim et al. 2000 
Japan, 2000 82 (1.64) 79 (1.59) 0.5 * LOQ 6.2 (2.3) 12 (12) 37 (71) 45 (15) Tsutsumi et al. 2001 
Taiwan, 2001 26 (0.40)  0.5 * LOQ 15 32 53 NA Hsu et al. 2002 
New Zealand, 1998 15 (0.18)d 12 (0.15*)d 0.5 * LOQ 16 (23) 39 (42) 12 (23) 33 (12) Buckland et al. 1998 
        
Norway, 1998 85 (1.2c)d 106 (1.5c)d LOQ 8 (17) 10 (31) 28 (45) 54 (7) Becher et al. 1998 
United Kingdom, 2001 28 (0.4 c) 35c (0.5) LOQ 44 (20) 19 (28) 6.0 (31) 31 (20) FSA report 38/03 
France, 1999 97 (1.45)d  LOQ 33 15 26 26 SCOOP 2000 
Italy, 2003  12 (0.20)  LOQ 50 50 NA NA Diletti et al. 2004 
Spain, 2000-2003 95 (1.36c) 145 (2.1) LOQ 14 (14) 58 (37) 9 (15) 18 (34) Fernández et al. 2004 
USA, 2002 53 (0.76c)  LOQ 10 27 5 58 South et al. 2004 
Taiwan, 2001 32 (0.48)  LOQ 16 36 47 NA Hsu et al. 2002 
a including children, b only non-ortho-PCBs, c average weight of 70 kg used, d I-TEqs or PCB-TEqs, e group Others may include vegetables, fruits, cereals, oils, and ready 
meals
NA, not analysed 
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Fig 2. Time-trend of intakes of WHOPCDD/F-TEqs (diamonds) and WHOPCB-TEqs
(squares) as pg/kg bw/day in the UK between 1982 and 2001 (open diamonds and 
squares) (MAFF 1984, 1994, 1998, FSA 2001), and in the Netherlands (closed 
diamonds and squares) (Liem and Theelen 1997, Freijer et al. 2001) between 1978 
and 1999. 
PCDD/Fs and PCBs in breast milk 
Breast milk is a useful bioindicator for assessing and comparing of the exposure of 
populations to PCDD/Fs and PCBs since its collection is easy and non-invasive. In addition, 
breast milk has a high content of fat, which makes the analysis easy to perform. It is assumed 
that the levels of PCDD/Fs and PCBs in breast milk are similar to those in plasma (from fasting 
blood), serum lipid (from fasting blood), and the adipose tissue of the mother (Norén 1988). 
Since 1987, WHO has coordinated esposure studies on levels of PCDD/Fs and PCBs in 
breast milk. By adhering to the WHO sampling protocol, the target groups should be 
homogenous between studies. Selection of breast milk donors in WHO studies has been based 
on the following criteria: the mother should be primipara, both mother and child should be 
healthy, the pregnancy should have been normal, the mother should breastfeed only one child 
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during the sampling, the mother should have lived in the area for at least 5 years, and the mother 
who is exclusively breastfeeding should be included. In the third round of WHO breast milk 
studies, the analysis of pooled breast milk samples was also performed in a single laboratory in 
order to avoid between laboratory variability of the results. Figure 3 depicts the most recent 
(2000-2002) median WHOPCDD/F-TEq and WHOPCB-TEq fat based concentrations in primiparae 
mothers all over the world measured in the third round of WHO breast milk study and other 
subsequent studies. 
The WHOPCDD/F-TEq median concentrations in Western Europe were on average 11.1 
pg/g fat and ranged between 6.9 pg/g fat in Ireland and 31.5 pg/g fat in Belgium, but it must be 
kept in mind that concentrations in Belgium originated from breast milk samples from an area 
known to be contaminated with PCDD/Fs (Focant et al. 2002).
Fig 3. Median WHOPCDD/F-TEq and WHOPCB-TEq fat based concentrations in 
primiparae mothers in different countries measured in the third round of WHO 
breast milk study (Leeuwen and Malisch 2002) and studies (*) after that from 
Taiwan (Chao et al. 2004) and from Belgium (Focant et al. 2002). 
This PCDD/F contamination of breast milk samples in Belgium was confirmed by WHOPCB-
TEq concentrations, which were in Belgium 10 pg/g fat corresponding to an average of 
WHOPCB-TEq median concentrations in Western Europe, 10.3 pg/g fat (range 4.7 – 16.3 pg/g 
fat). The contribution of WHOPCB-TEq to the total WHO-TEq in Western Europe was on 
average 45%. 
 Median WHOPCDD/F-TEq and WHOPCB-TEq in breast milk
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 In Eastern Europe, the WHOPCDD/F-TEq median concentrations were lower than those 
found in Western Europe and ranged from 6.1 pg/g fat in Bulgaria to 10 pg/g fat in Ukraine 
being on average 8.0 pg/g fat. The contribution of WHOPCB-TEq to the total WHO-TEq was 
about 10% higher in Eastern than in Western Europe (53%) and was the highest in the Czech 
Republic, Russia, and Ukraine (65%). This might be due to longer lasting duration of use of 
PCB in the Eastern European countries. 
 In Taiwan, Australia, and New Zealand, the median concentrations of both WHOPCDD/F-
TEq and WHOPCB-TEq were comparable with each other, being on average 6.7 and 4.0 pg/g fat, 
respectively. The smallest median concentrations of both WHOPCDD/F-TEq and WHOPCB-TEq in 
the third round of WHO breast milk study were measured in Brazil, 3.9 and 1.8 pg/g fat, 
respectively. The high median concentration of WHOPCDD/F-TEq (22.8 pg/g fat) in Egypt may 
be due to breast milk samples from PCDD/F contaminated locations, since the WHOPCB-TEq
concentration was quite comparable to that in other countries, being 6.0 pg/g fat. 
 The six marker PCB median concentrations in the third round of WHO breast milk study 
ranged from 16 ng/g fat in Brazil to 502 ng/g fat in the Czech Republic. Between Eastern and 
Western Europe there was no difference in the marker PCB median concentrations, these being 
200 and 195 ng/g fat, respectively.  
When comparing breast milk concentrations between studies other than the WHO 
studies, it must be kept in mind that there might be deviations from WHO protocols in sample 
collection, for example variation in the time of sampling of the milk and perhaps not all studied 
mothers have been primiparae. A woman’s body burden of lipophilic chemicals, including 
PCDD/Fs and PCBs, in adipose tissue and breast milk becomes depleted over the duration of 
lactation. Fürst et al. (1989) reported that concentrations of PCDD/Fs in mothers breast-feeding 
their second child were 20-30% lower than in primiparae mothers (Fürst et al. 1989). Similar to 
Fürst et al. percentages of PCDD/F decrease during one breast-feeding period have been 
reported by Beck et al. (1994). A monthly decrease of 12% for bioaccumulating PCBs and 
PCDD/Fs was reported in a Swedish study (Dahl et al. 1995). One extreme example of the 
decrease in concentrations of PCDD/Fs and PCBs in breast milk comes from a case study, in 
which a mother had breast-fed her twins for 30 months. During this time period, her breast milk 
concentrations of I-TEQs decreased by 69% and PCB concentrations by 78% on average 
(Schecter et al. 1998). In addition, the age of studied mothers can vary between studies, and 
results may not be representative for the whole country in question. A recent example of local 
differences in concentrations of PCDD/F and PCB TEq is illustrated with results from the Czech 
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Republic. In the third round of WHO breast milk studies, the median sum of WHOPCDD/F-TEq
and WHOPCB-TEq was 23 pg/g fat (range 21.8 to 39.2 pg/g fat), but in a more recent study the 
median TEqs ranged from 28 to 65 pg/g fat depending on the origin of the breast milk samples 
(Bencko et al. 2004).  
In table 5 there are the most recent concentrations of WHOPCDD/F-TEq or I-TEq of breast 
milk from countries, which did not provide samples to the third round of WHO breast milk 
study. Five of those concentrations originate from the second round of WHO coordinated breast 
milk studies, and those concentrations ranged from 4.3 pg I-TEq/g fat in Albania to 27.4 pg I-
TEq/g fat in Belgium (Liem et al. 1996). In other studies in table 5 the WHOPCDD/F-TEq
concentration ranged from 3.1 in China to 26.4 pp/g fat in the UK (Schecter et al. 1994, Wearne 
et al. 1996).  
Congeners contributing the most to the WHOPCDD/F-TEq in breast milk have been 
reported to be  2,3,4,7,8-PeCDF, 1,2,3,7,8-PeCDD, 2,3,7,8-TCDD, and 1,2,3,6,7,8-HxCDD, 
while OCDD contributes the most to the PCDD/F sum concentrations. PCB 126, PCB 156, and 
PCB 118 are the congeners dominating in the WHOPCB-TEq, while contribution to the sum of 
PCB congeners are dominated by PCB 153, PCB 138, PCB 180, and PCB 170 (Norén and 
Meironyté 2000, Focant et al. 2002, Chao et al. 2004, Bencko et al. 2004). These contributions 
of PCDD/F and PCB congeners are similar to those reported in intake studies for those food 
groups which contribute most to the intakes. Due to local contamination patterns or due to 
differences in dietary habits, the contributions might change to some extent.
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Fig 4. Time-trend of WHOPCDD/F-TEqs (open diamonds) and WHOPCB-TEqs 
(open squares) as pg/g in Swedish breast milk samples (Norén and Meironyté 
2000, Leeuwen and Malisch 2002), and of I-TEqs in German (closed diamonds) 
breast milk samples. (WHO 1989, Jensen and Slorach 1991, Liem et al. 1996 
,EC 1999) between 1976 and 2002. 
Time-trend of PCDD/Fs and PCBs in breast milk  
 Collecting longitudinally breast milk samples, as recommended by WHO, provides a 
way of assessing, whether control on sources of PCDD/Fs and PCBs has been effective. 
Similarly to the dietary intake time-trend, the levels of PCDD/Fs and PCBs have been 
decreasing in breast milk. Figure 4 illustrates the time-trends of WHOPCDD/F-TEqs and 
WHOPCB-TEqs in breast milk samples from Sweden between 1972 and 2002 (Norén and 
Meironyté 2000, Leeuwen and Malisch 2002), and of I-TEqs from Germany between 1984 and 
1997 (WHO 1989, Jensen and Slorach 1991, Liem et al. 1996 ,EC 1999). The decrease of 
WHOPCDD/F-TEq and WHOPCB-TEq concentrations during the last 30 years in Sweden has been 
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about 80%, being annually 2.7% (Norén and Meironyté 2000). In Germany the total decrease in 
the given period of I-TEq was 62%, i.e. about 4.8% decline per year. 
Table 5 lists the annual declines of I-TEq or WHOPCDD/F-TEq from different countries. 
On average, the annual decline was 4.0% (median 4.1%) ranging from 1% in Ukraine to 6.6% in 
Brazil. No regional or sampling period differences were observed from those annual declines in 
table 5. 
In Swedish breast milk samples from 1967 to 1997 the concentrations of PCBs initially 
increased, peaking in 1972 and have been decreasing since that time. The total decrease of PCBs 
from 1972 was about 70% which was annually 2.8% corresponding to the annual decrease of 
WHOPCDD/F-TEq in the same breast milk samples (Norén and Meironyté 2000). Between the 
second and third WHO coordinated breast milk studies the concentrations of marker PCBs 
decreased on average by 3.9% ranging from 0.9% in Russia to 6.4% in Norway (countries 
participating in both studies were: Croatia, Czech Republic, Hungary, Norway, Russia, Slovakia 
Republic, Spain, The Netherlands, and Ukraine) (WHO 1996, Leeuwen and Malisch 2002).
Table 5.
Annual decline (%) of concentration of I-TEq or WHOPCDD/F-TEq from different countries along 
with the most recent estimations of concentrations of I-TEq or WHOPCDD/F-TEq (pg/g fat) in 
breast milk in those countries, which did not provide samples to the third round of WHO 
coordinated breast milk studies. 
Country I-TEq or WHOPCDD/F-TEq (year) Annual decline % Reference 
Albania 4.3a (1992) - Liem et al. 1996 
Austria 11.9a (1992) 6 (1986-1992) WHO 1989, Liem et al. 1996 
Belgium 27.4a (1992) 4.8 (1986-1992) WHO 1989, Liem et al. 1996 
Brazil  6.6 (1992-2001) Paumgartten et al. 2000, Leeuwen and Malisch 2002 
Canada 16.2a (1992) 3 (1981-1992) Ryan et al. 1993, Liem et al. 1996 
China 3.1b (1994) - Schecter et al. 1994a 
Croatia  4.7 (1992-2001) Liem et al. 1996, Leeuwen and Malisch 2002 
Czech Republic  5.9 (1992-2001) Liem et al. 1996, Leeuwen and Malisch 2002 
Denmark 15.2a (1992) 2.3 (1986-1992) Jensen and Slorach 1991, Liem et al. 1996 
Hungary  2.8 (1986-2001) WHO 1989, Leeuwen and Malisch 2002 
Japan 18.8b (1995) 4.5 (1980-1995) Jensen and Slorach 1991, Iida et al. 1999 
Kazahkstan 22.6b (1996) - Petreas et al. 1996 
Lithuania 16.7b (1993) - Becher et al. 1995 
The Netherlands  5.1 (1985-2001) Jensen and Slorach 1991, Leeuwen and Malisch 2002 
New Zealand  4.1 (1986-2001) WHO 1989, Leeuwen and Malisch 2002 
Norway  4.1 (1986-2001) WHO 1989, Leeuwen and Malisch 2002 
Russia  3.5 (1992-2001) Liem et al. 1996, Leeuwen and Malisch 2002 
Slovakia  1.2 (1992-2001) Liem et al. 1996, Leeuwen and Malisch 2002 
Spain  2.9 (1990-2001) Gonzalez et al. 1996, Leeuwen and Malisch 2002 
UK 26.4b (1993) 5.5 (1987-1993) Wearne et al. 1996 
Ukraine  1 (1992-2001) Liem et al. 1996, Leeuwen and Malisch 2002 
USA 18.8b (1990) - Schecter et al. 1990 
a I-TEq, b WHOPCDD/F-TEq 
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PCDD/Fs and PCBs in adipose tissue and serum 
 Table 6 lists recent average human adipose tissue and serum fat concentrations of sum of 
PCDD/Fs, WHOPCDD/F-TEq, PCB 126, PCB 153, marker PCBs, and WHOPCB-TEq from 
different countries. These studies do not include occupationally or accidentally exposed subjects 
but are based on random sampling of the general population. The high correlation of 2,3,7,8-
TCDD and other PCDD/F congeners between serum and adipose tissue of the same individual 
makes it possible to use both matrices if one wishes to assess the human body burden of 
PCDD/Fs (Patterson et al. 1988, Schecter et al. 1991). PCBs are included in table 6 irrespective 
of the claim by Whitcomp et al. (2005) who stated that using serum concentrations of OCs for 
exposure assessment of young women may result in divergence from the use of adipose tissue 
concentrations, at least if linear dependency between matrixes is assumed. These workers 
reported linear correlation coefficient (r > 0.6) between lipid adjusted serum and fat 
concentrations of PCB congeners: 138, 153, 180, 188, 194, and 206. 
Human exposure to PCDD/Fs and PCBs starts already before birth during pregnancy, since 
PCDD/Fs and PCBs are transferred from mother to fetus via the placenta. Placenta PCDD/F 
concentrations corresponded in the study of Abraham et al. (1998) with the concentrations in 
breast milk, but concentrations of PCBs in placenta were on average only 30% of the 
corresponding breast milk concentrations. In a study from Åland, Finland, the concentrations of 
PCB congeners PCB 118, PCB 138, PCB 153, and PCB 180 were two to three fold lower in cord 
blood than in venous blood of delivering mothers (Hagmar et al. 1998). A similar result was 
reported in a Swedish study where the sum concentration of 15 PCB congeners in cord blood 
plasma was 41% lower than the corresponding concentration in maternal blood plasma (Meironyt?
Guvenius et al. 2003). Analysis of PCDD/Fs and PCBs from infants and children have rarely been 
performed due to obvious ethical reasons. From Germany there exist two studies of adipose tissue 
levels of PCDD/Fs in infants; in the first one, infants aged 3.8-23 months exhibited a concentration 
range from 2.1 to 22 pg I-TEq/g fat (Beck et al. 1994), and in the second study of 3 stillborns and 
17 infants (0.43-44 weeks of age) had PCDD/F concentrations from 1.55 to 29.6 pg I-TEq/g fat, in 
their adipose tissues (Kreuzer et al. 1997). In Dallas, Texas, the concentrations of WHOPCDD/F-TEq 
in the whole blood in children from 0-14 years ranged between 4.12 and 5.58 pg/g fat and this was 
about 20% of the concentration measured in the whole blood of adults in the same area (22.3 pg/g 
fat) (Schecter et al. 2003). 
Many studies have reported that concentrations of PCDD/Fs and PCBs increase with the 
age of the subject (Päpke 1998, Sjödin et al. 2000,  Covaci et al. 2002, Costabeber and 
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Emanuelli 2003, Wicklund Glynn et al. 2003, Harden et al. 2004, Kim et al. 2005). Therefore 
the concentrations listed in table 6 must be interpreted with caution since the mean age of the 
subjects has varied between studies. The mean concentration of WHOPCDD/F-TEq in Europe was 
29.5 pg/g fat in the study populations with a mean age of 52 years. There were three studies 
from Spain in which the mean age was 50 years and the mean WHOPCDD/F-TEq concentration 
was 20.6 pg/g fat (Wingfors et al. 2000, Bocio et al. 2004). This was a very similar 
concentration to that measured in Germany (18.8 pg WHOPCDD/F-TEq/g fat) five years earlier in 
a population with a mean age of only 37 years (Päpke 1998). In older populations from Sweden, 
Belgium, and France (mean age 59.6 years) the WHOPCDD/F-TEq concentration was 42 pg/g fat. 
Concentrations of the sum of PCDD/Fs are available only from five studies in Europe – they 
have reported a mean concentration of 777 pg/g fat (mean age 53 years). 
PCB 153 is one of the most commonly measured PCB congeners in all studies due to its 
abundance in all kinds of matrices. In recent human adipose and serum fat samples from 
Europe, the average concentration of PCB 153 was 232 ng/g fat (mean age of the study 
populations was 53 years) (Table 6). The marker PCB concentrations ranged from 389 to 855 
ng/g fat with a mean value of 606 ng/g fat. The WHOPCB-TEq mean concentration is based only 
on three reported concentrations from Sweden, Belgium, and Spain, and the average 
concentration was 37.8 pg/g fat (Wingfors et al. 2000, Koppen et al. 2002). 
From the USA, there are recent reports of PCDD/F concentrations from the year 2002 
with the WHOPCDD/F-TEq concentration of 19.3 pg/g fat, and the sum of PCDD/F concentrations 
of 505 pg/g fat (Schecter et al. 2003). 
The mean concentrations in the Far-East, in India, Korea, and Japan, were lower than the 
concentrations found in Europe, 13.0 pg WHOPCDD/F-TEq/g fat, sum of PCDD/Fs 511 pg/g fat, 
and 13.1 pg WHOPCB-TEq/g fat, but the study populations were also younger than the 
populations examined in Europe, table 6 (Kumar et al. 2001, Choi et al. 2002, Kim et al. 2005).  
The lowest human adipose or serum fat concentrations of PCDD/Fs and PCBs so far 
reported originate from Australia in 2002 (Harden et al. 2002). The WHOPCDD/F-TEq and 
WHOPCB-TEq concentrations were 6.9 and 4.0 pg/g fat, respectively.  
The highly PCB contaminated human adipose or serum fat tissues in Uelen, Russia and 
Greenland Inuit populations were due to consumption of meat and blubber of marine mammals 
which themselves had a high PCB body burden (Sandanger et al. 2003, Dewailly et al. 1999).  
 The main exposure of the general population comes from food, especially food of animal 
origin, but still no relation of adipose tissue PCDD/F concentrations and daily dietary dioxin 
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intake or tissue PCB concentrations and alimentary habits have been found in France and Spain, 
respectively. (Arfi et al. 2001, Costabeber and Emanuelli 2003). On the other hand, it has been 
shown that consumption of Baltic Sea fish leads to a high contribution of the dioxin congener 
2,3,4,7,8-PeCDF (Svensson et al. 1991), and also PCB concentrations in serum have been 
reported to correlate positively with consumption of fatty fish in the Baltic Sea region (Grimvall 
et al. 1997, Sjödin et al. 2000, Wicklund Glynn et al. 2003).  
 As the majority of human exposure to PCDD/Fs originates from fat of animal origin, 
Welge et al. (1993) postulated that vegetarians should have lower body burdens of PCDD/Fs 
compared to non-vegetarians. This presumption was not confirmed, since I-TEq concentrations 
in the blood of both groups were very similar, around 33 pg/g fat. The similarities of PCDD/F 
concentrations in vegetarians and non-vegetarians were explained by the higher consumption of 
dairy products by vegetarians, which would compensate for part of the PCDD/F intake 
originating from meat and fish in non-vegetarians (Welge et al. 1993).  
The congeners contributing the most to the sum of PCDD/Fs and WHOPCDD/F-TEqs in 
adipose tissue or serum fat are depicted in figure 5. The contribution of congeners OCDD, 
1,2,3,4,6,7,8-HpCDD, 1,2,3,6,7,8-HxCDD, and 2,3,4,7,8-PeCDF to the sum of PCDD/Fs was 
on an average 92%. There were little differences between depicted areas in these contributions 
to the sum of PCDD/Fs. Four congeners, 2,3,4,7,8-PeCDF, 1,2,3,7,8-PeCDD, and 1,2,3,6,7,8-
HxCDD, and 2,3,7,8-TCDD accounted for on average 87% of the WHOPCDD/F-TEq profile in 
adipose tissue or serum fat samples in the depicted areas in figure 5. The contribution of these 
four congeners was largest in Sweden and lowest in the USA, 92% and 83%, respectively. The 
consumption of Baltic fatty fish might explain why congener 2,3,4,7,8-PeCDF contributed more 
to the WHOPCDD/F-TEq profile in the average Swedish population compared to other areas, as it 
does in Swedish fishermen (Svensson et al. 1991). In Europe, the congener 1,2,3,7,8-PeCDD 
was the most prevalent congener in WHOPCDD/F-TEq profile followed by 2,3,4,7,8-PeCDF, 
which originates also from milk products in addition to fish products. A quite different profile 
has been reported from the USA, where the contribution of 2,3,4,7,8-PeCDF to WHOPCDD/F-TEq
profile was only 15% instead of about 30% in the Europe and Far-East and 40% in Sweden.
Table 6.
Recent adipose tissue and serum fat concentrations of sum of PCDD/Fs, WHOPCDD/F-TEq, PCB 126, PCB 153, marker PCBs, and WHOPCDD/F-
TEq from different countries. 
Country, study period Age of subjects, 
mean and range 
Sum of PCDD/Fs 
pg/g fat 
WHOPCDD/F-
TEq 
pg/g fat 
PCB 126 
pg/g fat 
PCB 153 
ng/g fat 
Marker PCB 
ng/g fat 
WHOPCB-TEq 
Pg/g fat 
Reference 
Finland, mid 1990s 30 (19-40)a - - - 56 - - Hagmar et al. 1998 
Sweden, unknown 68 804 32.8 180 300 778 44.3 Wingfors et al. 2000 
Sweden, late 1990s 63b(40-75) - - - 296 675  Wicklund Glynn et al. 2000 
Sweden, 1996-1997 63a (54-75) - - - 223 - - Wicklund Glynn et al. 2003 
Sweden, 2001 52b (33-79) - - - 241 - - Wallin et al. 2003 
Latvia, 1993 48b (24-79) - - - 403 - - Sjödin et al. 2000 
Germany, 1996* 37 (18-71) 403 18.8     Päpke 1998 
Belgium, 1999 58a (50-65) 999 48 102 168 389 23.7 Koppen et al. 2002 
Belgium, 2000 47 (19-77) - - - 211 504 - Covaci et al. 2002 
France, 1999* 53 (30-94) 497 45.1 - - - - Arfi et al. 2001 
Spain, unknown 51 1180 33.0 220 300 855 45.5 Wingfors et al. 2000 
Spain, 1996-1997 51 (15-87) - - - 121 432 - Costabeber and Emanuelli 2003 
Spain, 2002 58 (19-94) - 11.1 - - - - Bocio et al. 2004 
Spain, 2003 41 (19-62) - 17.8 - - - - Bocio et al. 2004 
Uelen/Russia, 2001 37 (20-70) - - 1200 744 1410 - Sandanger et al. 2003 
Greenland, 1992-1994 60 - - - 1689 4242 - Dewailly et al. 1999 
USA, 2002 Adults 505 19.3 - - - - Schecter et al. 2003 
India, 2000 (20-69) 550 14.4 125 - - 14.4 Kumar et al. 2001 
Korea, 2001* 43 (21-63) 813 12.8 - 64 - 9.6 Kim et al. 2005 
Japan, 2000 (40-50) 171 11.9 72 - - 15.3 Choi et al. 2002 
Australia, 2002 (<16->60) - 6.9 18.6 - - 4 Harden et al. 2004 
a only women, b only men, * results originally as I-TEqs and here re-calculated as WHOPCDD/F-TEqs 
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In the USA congeners, originating mostly from meat, 1,2,3,7,8-PeCDD, 2,3,7,8-TCDD, and 
1,2,3,6,7,8-HxCDD contributed more to the WHOPCDD/F-TEq profile than 2,3,4,7,8-PeCDF 
(Wingfors et al. 2000, Päpke 1998, Koppen et al. 2002, Arfi et al. 2001, Schecter et al. 2003, 
Kumar et al. 2001, Choi et al. 2002, Kim et al. 2005). Similar patterns to the WHOPCDD/F-TEq
profile as that found in USA have been reported also from Canada (Schecter et al. 1994b). 
Figure 6 depicts the relative contribution of selected PCB congeners to the sum of these 
particular PCBs and to the WHOPCB-TEq. There were minor differences between the Swedish 
and the average European profiles of PCBs. Congener PCB 153 was the main contributor in the 
adipose tissue or serum samples in all areas followed by PCB 138 and PCB 180. The 
contribution of PCB 153 was clearly more dominant in samples from the Inuit population when 
compared to other areas (see Fig 6, A, Uelen/Russia). On the other hand, the contributions of 
PCB 180 and PCB 170 were lower in Inuit population than in Swedish or European populations. 
These differences in PCB contributions between northern and southern populations might be 
due to different occurrence of various PCB congeners in the foodstuffs consumed by these 
populations. Eighty percent or more of the WHOPCB-TEq concentration has been reported to be 
due to a contribution of congeners PCB 126, PCB 156, and PCB 118 (Fig 6, B). Again the 
difference between Sweden and Southern Europe was not so evident, but in the Far East, the 
contribution of PCB 126 dominated the WHOPCB-TEq profile. 
Time-trend of PCDD/Fs and PCBs in adipose tissue and serum 
Similar declining trends in human adipose and serum fat concentrations as those found 
in breast milk have been reported from several countries. Figure 7 illustrates the time-trends of 
PCDD/F-TEqs between 1980 and 2002 from Germany, USA, and Japan (Päpke 1998, Schecter 
et al. 2003, Choi et al. 2002). The annual decline of PCDD/F- TEq in Germany and Japan has 
been about 4%, which is very close to the decline in breast milk in these countries. In the USA, 
the decline of WHOPCDD/F-TEq is not so clear with increasing concentrations reported in studies 
from the years 1996 and 2002. Nevertheless between mid 1990s and the early 2000s the decline 
of WHOPCDD/F-TEq has been about 15% (Schecter et al. 2003). 
Declining time-trends of PCB concentrations in adipose tissue or in serum fat in the 
USA are more clear than the corresponding PCDD/F trends. The concentrations of congener 
PCB 153 declined from 1985-1989 to 2000-2002 by 61% (about 4% annually) from 90 ng/g 
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serum fat to 35 ng/g (Sjödin et al. 2004). Another study from the USA has indicated that the 
concentration of PCB congener 126 declined by about 88% between 1985 and 1995 (Aylward et 
al. 2002). Also in a study of Swedish men, the decline of serum PCB 153 concentration was on 
average 34% (3% annually) during the time period 1991-2001 (Wallin et al. 2003), which is 
similar to WHOPCDD/F-TEq decline reported in Swedish breast milk (Norén and Meironyté 
2000). In Tarragona, Spain, there was an average 41% reduction of WHOPCDD/F-TEq in human 
plasma samples (10% annually); in the adipose tissue samples the reduction was 70% (18% 
annually), both of which follow the decline of PCDD/F daily intake in the same district (Bocio 
et al. 2004).
Fig 7. Time-trend in 1980-2002 of human adipose tissue or serum fat PCDD/F-
TEq concentrations in Germany (striped bars) (Päpke 1998), in the USA (white 
bars) (Schecter et al. 2003), and in Japan (black bars) (Choi et al. 2002). 
19
80
19
82
19
84
19
86
19
88
19
90
19
92
19
94
19
96
19
98
20
00
20
02
0
5
10
15
20
25
30
35
40
45
50
55
60
T
E
Q
 p
g/
g 
fa
t
Year
Fig 5. Adipose tissue or serum fat congener profile of (A) PCDD/Fs and (B) WHOPCDD/F-TEqs in Sweden, Europe, USA, and Far-East. 
Calculated from the data by: Wingfors et al. 2000, Päpke 1998, Koppen et al. 2002, Arfi et al. 2001, Schecter et al. 2003, Kumar et al. 
2001, Choi et al. 2002, Kim et al. 2005. 
0
10
20
30
40
50
60
70
80
2
3
7
8
-
T
C
D
D
1
2
3
7
8
-
P
D
1
2
3
4
7
8
-
H
D
1
2
3
6
7
8
-
H
D
1
2
3
7
8
9
-
H
D
1
2
3
4
6
7
8
-
D
O
C
D
D
2
3
7
8
-
T
C
D
F
1
2
3
7
8
-
P
F
2
3
4
7
8
-
P
F
1
2
3
4
7
8
-
H
F
1
2
3
6
7
8
-
H
F
2
3
4
6
7
8
-
H
F
1
2
3
7
8
9
-
H
F
1
2
3
4
6
7
8
-
F
1
2
3
4
7
8
9
-
F
O
C
D
F
Congeners
P
e
r
c
e
n
t
a
g
e
Sweden
average Europe
USA
average Far-East
0
5
10
15
20
25
30
35
40
2
3
7
8
-
T
C
D
D
1
2
3
7
8
-
P
D
1
2
3
4
7
8
-
H
D
1
2
3
6
7
8
-
H
D
1
2
3
7
8
9
-
H
D
1
2
3
4
6
7
8
-
D
O
C
D
D
2
3
7
8
-
T
C
D
F
1
2
3
7
8
-
P
F
2
3
4
7
8
-
P
F
1
2
3
4
7
8
-
H
F
1
2
3
6
7
8
-
H
F
2
3
4
6
7
8
-
H
F
1
2
3
7
8
9
-
H
F
1
2
3
4
6
7
8
-
F
1
2
3
4
7
8
9
-
F
O
C
D
F
Congeners
P
e
r
c
e
n
t
a
g
e
BA
39
Fig 6. Adipose tissue or serum fat congener profile of  (A) certain PCBs and (B) WHOPCB-TEqs in Uelen/Russia, Sweden, Europe, 
and Far-East. Calculated from the data by: Wingfors et al. 2000, Wicklund Glynn et al. 2000, Wicklund Glynn et al. 2003, Sjödin et 
al. 2000, Grimvall et al. 1997, Covaci et al. 2002, Koppen et al. 2002, Costabeber and Emanuelli 2003, Sandanger et al. 2003, Kumar 
et al. 2001, Choi et al. 2002. 
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2. AIMS OF THE STUDY 
 The aims of this study were to: 
1. Assess the average intake of PCDD/Fs and PCBs of the general population in Finland, with 
the emphasis on estimating the contribution of different foods to the intake. 
2. Analyse the average adipose tissue concentrations of PCDD/Fs and PCBs in the general 
population in Finland and to determine whether differences in concentrations occur in three 
geographical areas. 
3. Determine the concentrations of PCDD/Fs and PCBs in breast milk in two areas in Finland 
and to evaluate temporal changes in the concentrations in breast milk. 
4. Compare the intake of PCDD/Fs and PCBs and occurrence of these contaminants in human 
tissues to EU and other countries. 
5. Study, if there is a population in Finland, which experience high exposure to PCDD/Fs and 
PCBs.
6. Study the differences in the PCDD/F and PCB congener profiles between the exposure (diet) 
and human tissues in order to evaluate the bioaccumulation efficiencies of different 
congeners.   
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1. ABSTRACT 
Samples of cow milk, pork, beef, eggs, rainbow trout, flours and vegetables were 
analyzed for 17 polychlorinated dibenzo-p-dioxins and dibenzofurans (PCDD/F) and 36 
polychlorinated biphenyls (PCB). Daily dietary intake of PCDD/Fs as toxic equivalent (I-TEq) 
and PCBs (PCB-TEq) was assessed using food consumption data from a 24-hour dietary recall 
study for 2862 Finnish adults. The calculated intake of PCDD/F was 46 pg I-TEq day-1. The 
current level was about half of the earlier estimation of intake in Finland made in 1992. The 
assessed PCB intake was 53 pg PCB-TEq day-1. Thus, the total intake of PCDD/Fs and PCBs 
was 100 pg TEq day-1 (1.3 pg TEq kg-1 b.w. day-1), which is within the range of tolerable daily 
intake (TDI) proposed by the WHO (1-4 pg TEq kg-1 b.w. day-1).
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2. INTRODUCTION
In spring 1999, polychlorinated dibenzo-p-dioxins and dibenzofurans (PCDD/Fs) were 
discovered in Belgian chicken and eggs. Subsequently this contamination event was expanded to 
cover all foods of animal origin in Belgium. It was subsequently reported that the point 
introduction of a polychlorinated biphenyl (PCB) containing oil into the production of animal 
feed in Belgium led to a contamination of part of the food chain of animal origin (Bernard et al. 
1999). Public alarm at this incident in Belgium launched or accelerated the pace of national 
studies into the dioxin content in foods and the intake of dioxins via the food chain in different 
European countries. 
In Finland, the intake of PCDD/Fs was first estimated in 1992 (Hallikainen et al. 1995) 
using measured concentrations of PCDD/Fs in cow milk, egg, meat, Baltic herring and rainbow 
trout samples and a 3-day food consumption questionnaire for adults (aged from 25-64 years) in 
1992 (Vartiainen et al. 1993). The authors estimated the total PCDD/F daily intake to be 95 pg 
Nordic toxic-equivalents (N-TEq) or 1.6 pg N-TEq kg-1 body weight using 60 kg as average 
weight of adult population. Fish and fish products accounted for 60% of the daily intake 
followed by milk and dairy products (31%), eggs (3%) and meat and meat products (1.4%) 
(Hallikainen and Vartiainen 1997). 
This study reports the results of current PCDD/F and PCB concentrations in 1998-2000 
for cow milk, pork, beef, eggs, rainbow trout, flours and vegetables, which combined with new 
food consumption data in 1997 for average adults (National Public Health Institute 1997), 
allowed estimation of the intake of PCDD/Fs of average adult Finnish population. In addition, 
for the first time, PCB-TEq intake in Finland was assessed. The contribution of each food and 
food group was also revised. 
3. MATERIALS AND METHODS
Concentrations of PCDD/Fs and PCBs in foods
Representative samples of cow milk, pork, beef, eggs, rainbow trout, flour and vegetables 
were collected encompassing the Finnish food supply and analysed for PCDD/F and PCB 
content. Five pooled cow milk samples (three individual samples in each pool) were collected 
from five dairies around Finland. These dairies represented  ~50% of all cow milk production in 
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Finland. Six pork tenderloin and five beef tenderloin samples were collected from two of the 
largest slaughterhouse chains in Finland covering all the major production areas and representing 
~80% of the total production in Finland. The samples were pooled by production areas (5-24 
individual samples in each pool) by weighing equally sized samples from each subsample. 
Pooled egg samples were collected from five henhouses in South-Western Finland. Each egg 
pool consisted of eight to nine individual eggs. Two years old rainbow trouts were collected 
from eight different fish farms in southern Finland. Altogether 40 individual rainbow trout 
samples were analysed in eight pools (five individual samples in each pool). Domestic leafy 
vegetables (three different kinds of lettuces and cabbage), fruit vegetables (cucumber, tomato, 
onion and sweet pepper) and potatoes, 200g of each individual item, were purchased from a 
supermarket in the province of Kuopio. Also flours (rye and wheat) in 1 kg packages were 
bought from a supermarket but the origin of the flour remained undetermined. All the samples 
were collected between 1998 and 2000. 
The concentrations of 17 toxic PCDD/Fs (10 PCDF, seven PCDD) congeners of three 
non-ortho (IUPAC 77, 126, 169), eight mono-ortho (IUPAC 105, 114, 118, 123, 156, 157, 167, 
189), and of 25 other (IUPAC 18, 28, 33, 47, 49, 51, 52, 60, 66, 74, 99, 101, 110, 122, 128, 138, 
141, 153, 170, 180, 183, 187, 194, 206, 209) PCB congeners, the total sum of PCDD/Fs 
(ΣPCDD/F) and PCBs (ΣPCB), and toxic equivalents, I-TEqs (PCB-TEqs, for PCBs) were 
determined (NATO/CCMS 1988, Ahlborg et al. 1994). 
All homogenized samples were spiked with 115 pg 13C-labelled PCDD/F standards 
(seventeen 2,3,7,8-chlorinated PCDD/F congeners), with 100 pg 13C-labelled non-ortho PCB 
standards (PCB 77, 126, 169), and with 960 pg 13C-labelled PCB standards (PCB 30 [12C-
labelled], 80, 101, 105, 138, 153, 156, 180 and 194 Cambridge Isotope Laboratories). Cow 
milk's fat was extracted with diethyl ether-hexane, fat from eggs with diethyl ether and hexane, 
and fat from pork, beef and rainbow trout with toluene for 24 h using Soxhlet apparatus. The fat 
content was determined gravimetrically. All the samples were defatted in a silica gel column and 
initially purified on activated carbon column (Carbopack C, 60/80 mesh) containing Celite 
(Merck 2693) to separate PCDD/Fs from PCBs. Both fractions were further cleaned with an 
activated alumina column (Merck 1097, standardized, activity level II-III). The separated PCB 
fraction was further fractionated, after having been analyzed for mono- and di-ortho PCB 
congeners on another activated carbon column (without Celite) in order to separate the non-ortho
PCBs. The quantitation was performed by selective ion recording using a VG 70-250 SE (VG 
Analytical, UK) mass spectrometer (resolution 10 000) equipped with a HP 6890 gas 
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chromatograph with fused silica capillary column (DB-DIOXIN, 60 m, 0.25 mm, 0.15 μm). The 
laboratory reagent and equipment blank samples were treated and analyzed by the same method as 
the actual samples, one blank for every five samples. In cow milk, pork and beef samples, the limits 
of determination (LOD) for PCDD/Fs, non-ortho PCBs, and other PCBs were 0.1-1, 0.1, and 10 pg 
g-1, respectively, and in rainbow trout samples 0.01-0.1, 0.01, and 1 pg g-1, respectively. In 
vegetable and flour samples, LODs were 0.005-0.05, 0.005, and 0.05 pg g-1, respectively. PCDD/F, 
non-ortho PCB, and other PCB LODs for eggs were 0.5-5, 1, and 10 pg g-1, respectively. In the 
calculations of TEqs, results below the LOD were considered as zero. Concentrations in cow milk, 
eggs, pork and beef samples were calculated on a fat basis, in other samples on a wet weight (w.w.) 
basis. Recoveries for internal standards were >60% for all congeners. 
The laboratory has participated in several international quality control studies for the 
analysis of PCDD/Fs, and PCBs. The matrixes in these studies have included cow milk, human milk, 
human serum and fish. (Yrjänheikki 1991, Rymen 1994, Liem et al. 1996, WHO/EHEC 1996). The 
laboratory is also an accredited testing laboratory (No T77) in Finland (EN 17025). The scope of 
accreditation includes PCDD/Fs, PCBs, and non-ortho PCBs from milk and tissue samples. 
Food consumption data
The food and food group consumption data used in the intake calculations consist of the 
average consumption figures taken from the 1997 Dietary Survey of Finnish Adults (National 
Public Health Institute 1998). The method of 24-h dietary recall was applied in this national 
survey of the adult population from five selected areas, aged 25-64 (n=2862). In the dietary 
survey, the average consumption (g day-1) of each food item was calculated. The food items 
which were relevant for intake estimations of PCDD/F and PCB were aggregated into food 
groups (table 4). The number of individual food items was 54 for milk and milk products, three 
for eggs, 28 for fish, 45 for meat, 29 for flour, and 43 for potatoes and vegetables. 
Estimation of average daily intakes of PCDD/Fs and PCBs
Average daily intakes of PCDD/Fs and PCBs were estimated by multiplying the 
measured concentrations of PCDD/F and PCB toxic equivalents by the average daily 
consumption of the respective food. Intakes for PCDD/Fs and PCBs were calculated separately. 
For Baltic herring, data were used that included 1200 herring samples from the Baltic Sea (data 
partly published, Vartiainen et al. 1997). The PCB-TEq data for Baltic herring were incomplete 
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because a major part of the concentrations for congeners IUPAC 114, 123, 157, 167, 170 and 
189 was not available. The I-TEq and PCB-TEq used for other fish were estimations based on 
the unpublished data from Finland. 
The intake results were reported as pg toxic equivalents per day (pg TEq day-1) or as pg 
toxic equivalents kg-1 body weight per day (pg TEq kg-1 b.w. day-1). The body weight used in these 
calculations was 76 kg, which was the average body weight of the adult population participating in 
the 1997 Dietary Survey of Finnish Adults (National Public Health Institute 1998). 
4. RESULTS
The mean concentrations of seven toxic PCDDs and 10 PCDFs for foods are presented in 
table 1 including ? PCDD/F and I-TEq results. The results for non-ortho (three congeners), 
mono-ortho (eight) and other PCBs (25) are presented in table 2 along with ? PCB and PCB-
TEq results. The fat contents in the cows' milk, eggs, pork, beef and rainbow trout were 3.2, 9.7, 
5.9, 6.6 and 8.3%, respectively. 
Table 3 lists the congeners that contributed to TEqs by >5 % and their contribution is 
presented for the most relevant foods. Although samples of Baltic herring were not analysed 
here, the contribution of congeners to TEqs in Baltic herrings are added to table 3. The I-TEq 
contribution pattern in different foods varied extensively for the different foods. In Baltic 
herrings, rainbow trouts, eggs and cow's milk 2,3,4,7,8-pentachloro dibenzofuran (2,3,4,7,8-PF) 
was the most dominant congener, while in beef and pork samples 1,2,3,6,7,8-hexachloro 
dibenzo-p-dioxin (1,2,3,6,7,8-HD) was the most dominant congener. The secondary congener 
contributing most significantly to I-TEq varied greatly for the different foods. It was 2,3,7,8- 
tetrachloro dibenzofuran (2,3,7,8-TCDF) in rainbow trout samples, 1,2,3,7,8-pentachloro 
dibenzo-p-dioxin (1,2,3,7,8-PD) in Baltic herring, beef and pork samples and 1,2,3,6,7,8-HD in 
egg and cow milk samples. In PCB-TEq, the situation was different. In all samples, excluding 
eggs, IUPAC126 was the most dominating congener followed by IUPAC118, which was the 
most dominating congener in egg samples. 
In rainbow trout and egg samples, PCDFs contributed most extensively to ? PCDD/F 
(table 1) and from the individual congeners 2,3,7,8-TCDF and 2,3,4,7,8-PF were dominating in 
rainbow trout and 1,2,3,4,6,7,8-heptachloro dibenzofuran (1,2,3,4,6,7,8-F) in egg samples. In all 
other food samples, PCDDs dominated the ? PCDD/F and the higher chlorinated PCDDs, 
1,2,3,4,6,7,8-heptachloro dibenzo-p-dioxin (1,2,3,4,6,7,8-D) and octachloro dibenzo-p-dioxin 
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(OCDD), were the most abundant. In PCBs, the group "other-PCBs" was the most dominating 
group accounting for >84 % of ? PCB in all food groups. With respect to the individual 
congeners IUPAC 101, 110, 118, 153, 138 and 180 had the strongest impact on ? PCBs. In beef 
and pork samples, congeners IUPAC 51 and 47 also contributed significantly to ? PCB.
The daily consumption of different food and food groups, and the concentrations and 
intakes of PCDD/Fs and PCBs as TEqs in Finland are presented in table 4. In all other food 
groups excluding eggs, and meat and meat products PCB-TEqs contributed more strongly to 
total TEq intake than to I-TEq. In herring samples, PCB-TEq was underestimated because in part 
of the samples all of the PCB congeners were not measured. Therefore the daily intake of PCB-
TEq was clearly an underestimation with respect to Baltic herrings. 
 Table 1. Polychlorinated dibenzo-p-dioxins (seven PCDD congeners), dibenzofurans (10 PCDF congeners), sum of PCDD/Fs (? PCDD/Fs) and 
toxic equivalents (I-TEqs) as pg g-1 in food samples in Finland, 1998-2000. 
Food item 
n
Analytes 
Rainbow trout 
8
Meana (SD)
Eggs 
5
Meanb (SD) 
Beef
5
Meanb (SD) 
Cow milk 
5
Meanb (SD)
Pork 
6
Meanb (SD) 
Leafy vegetablesc
4
Meana (SD)
Flourd
2
Meana (SD) 
Potatoa
1
Meana
Fruit vegetablese
4
Meana (SD)
PCDD 0.41 (0.16) 6.6 (8.4) 13 (14) 1.6 (1.0) 4.4 (1.6) 0.2 (0.18) 0.5 (0.36) 0. 083 0.003 (0.006) 
PCDF 2.7 (0.96) 19 (42) 0.72 (0.52) 0.88 (0.42) 1.0 (1.4) 0.047 (0.088) 0.008 (0.011) nd nd 
Σ PCDD/F 3.1 (1.1) 26 (40) 14 (14) 2.5 (1.0) 5.4 (1.8) 0.24 (0.25) 0.51 (0.37) 0. 083 0.003 (0.006) 
I-TEq 0.74 (0.29) 0.52 (0.44) 0.29 (0.24) 0.12 (0.02) 0.051 (0.023) 0.01 (0.02) 0.00094 (0.00065) 0.00025  0.00003 (0.00006) 
nd, <Limit of determination (LOD) 
a Wet weight (w.w.) basis. 
b Fat basis. 
c Three different kinds of lettuces and cabbage. 
d Rye and wheat. 
e Cucumber, tomato, onion and sweet pepper. 
Table 2. Polychlorinated biphenyls (three non-ortho-PCB, eight mono-ortho-PCB, and 25 other PCB congeners), sum of PCBs (? PCBs) and toxic 
equivalents (PCB-TEqs) as pg g-1 in food samples in Finland, 1998-2000. 
Food item 
N
Analytes 
Rainbow trout 
8
Meana (SD)
Eggs 
5
Meanb (SD)
Beef
5
Meanb (SD) 
Cow milk 
5
Meanb (SD)
Pork 
6
Meanb (SD) 
Leafy vegetablesc
4
Meana (SD)
Flourd
2
Meana (SD)
Potato 
1
Meana
Fruit vegetablese
4
Meana (SD)
Non-ortho-PCBs 45 (14) 3.2 (6.3) 4.2 (1.9) 2.1 (1.1) 1.9 (0.78) 1.3 (2.2) 0.17 (0.021) nd 0.0037 (0.0043) 
Mono-ortho-PCBs 3 100 (1 100) 730 (430) 530 (250) 410 (110) 60 (27) 34 (50) 1.4 (1.9) 1.6 0.33 (0.28) 
Other-PCBs 17 000 (6 200) 5 100 (2 300) 5 400 (2 700) 2 200 (740) 1 800 (230) 390 (550) 38 (14) 23 3.7 (2.5) 
Σ PCB 21 000 (7 400) 5 800 (2 300) 5 900 (3 000) 2 600 (840) 1 800 (220) 420 (600) 39 (16) 24 4.1 (2.8) 
PCB-TEq 1.5 (0.48) 0.12 (0.12) 0.31 (0.15) 0.22 (0.078) 0.024 (0.012) 0.038 (0.058) 0.00022 (0.00018) 0.00016 0.000036 (0.000031) 
nd, <Limit of determination (LOD) 
a Wet weight (w.w.) basis. 
b Fat basis. 
c Three different kinds of lettuces and cabbage. 
d Rye and wheat. 
e Cucumber, tomato, onion and sweet pepper. 
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Table 3. Contibution (%) of single congeners to I-TEqs and PCB-TEqs in different food 
samples. Only congeners contributing at least 5% to TEqs are shown. The two most 
dominating congeners are shaded. 
Dioxin Baltic herring Rainbow trout Eggs Beef Cow milk Pork 
2,3,7,8-TCDF  22     
2,3,4,7,8-PF 68 50 51 12 70  
1,2,3,4,6,7,8-F   16   14 
       
2,3,7,8-TCDD 7 12     
1,2,3,7,8-PD 13 11  19 23 
1,2,3,6,7,8-HD   20 47 7 39 
1,2,3,4,6,7,8-D    10 5 11 
OCDD      9 
% of I-TEq 88 96 87 87 82 96 
PCB       
IUPAC126 42 67 9 63 68 45 
IUPAC169      7 
IUPAC105 8  15    
IUPAC118 17 13 49 13 12 22 
IUPAC156 18 7 18 8 9 15 
IUPAC170    11  5 
% of PCB-TEq 85 87 91 95 89 95 
5. DISCUSSION
PCDD/F and PCB occurrence data
I-TEq and PCB-TEq concentrations for rainbow trouts, 0.74 pg g-1 w.w. and 1.5 pg g-1,
respectively, were moderate when one considers that rainbow trout is a fatty fish. Two explanations 
can be provided for the low concentrations (1) all rainbow trouts were very young (2 years of age) 
and (2) they were all farmed trouts and they had been fed with artificial fodder. Two-year-old 
trouts were chosen for the study because this is the age farmed trouts are normally harvested. 
A decline of 50% was observed from 1.8 in 1993 (Hallikainen et al. 1995) to 0.74, in the 
I-TEq concentration of rainbow trout samples in Finland. This current value is now in the same 
range as the concentration of rainbow trout in Germany (Malisch 1998). 
In cows' milk from 1991 (Vartiainen and Hallikainen 1994) to 1998 the decline in 
concentration of I-TEq was from 0.99 to 0.12 pg I-TEq g-1 fat. In Germany and The Netherlands, 
the concentrations in cow's milk were six to 10 times higher than in Finland, respectively (Liem 
and Theelen 1997, Malisch 1998). The concentrations may have declined in cows' milk in 
Finland due to the decrease in deposition of PCDD/Fs onto grassland from the atmosphere. 
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Similarly to cows' milk, concentration of I-TEq also in eggs has declined during the 
1990s from 1.6 to 0.52 pg I-TEq g-1 fat. In Germany and The Netherlands, the concentrations in 
eggs were three to four times higher than in Finland (Liem and Theelen 1997, Malisch 1998).
Table 4. Daily consumption of food and food groups, and concentrations and intakes of 
polychlorinated dibenzo-p-dioxins and furans (PCDD/Fs) and polychlorinated biphenyls (PCBs) 
as toxic equivalents (TEqs) in Finland. 
Food group Consumption,  
g day-1
(g fat day-1)
PCDD/F 
(pg I-TEq g-1)
PCB
(pg PCB-TEq g-1)
Daily intake, 
PCDD/F
(pg I-TEq) 
Daily intake, 
PCB 
(pg PCB-TEq) 
Daily intake, 
total 
(pg TEq) 
Milk, high fat 40 (1.3) 0.12 b 0.22 b 0.16 0.29 0.45 
Milk, fat <1.6% 170 (2.6) 0.12 b 0.22 b 0.32 0.58 0.91 
Milk products 51 (16) 0.12 b 0.22 b 2.0 3.6 5.6 
Butter 8 (6.4) 0.12 b 0.22 b 0.79 1.4 2.2 
Butter based 
mixtures 
4 (2.6) 0.12 b 0.22 b 0.32 0.58 0.91 
Milk and dairy 
products 
270 (29)   3.6 6.5 10 
Eggs 19 (1.7) 0.52 b 0.12 b 0.89 0.21 1.1 
Herring 3 8.0 a 7.9 a 24 24 48 
Rainbow trout 6.5 0.74 a 1.5 a 4.8 9.6 14 
Other fish 19 0.5 a 0.5 a 9.5 9.5 19 
Fish and fish 
products 
29   38 43 81 
Beef 23 (2.1) 0.29 b 0.31 b 0.62 0.65 1.3 
Pork 33 (5.0) 0.051 b 0.024 b 0.26 0.12 0.38 
Other meat, 
sausages
62 (14) 0.17 b 0.17 b 2.4 2.3 4.8 
Meat and meat 
products 
120 (21)   3.3 3.1 6.4 
Flour 160 0.00094 a 0.00022 a 0.15 0.035 0.19 
Potato 110 0.00025 a 0.00016 a 0.028 0.017 0.045 
Leafy 
vegetables 
17 0.01 a 0.038 a 0.18 0.65 0.82 
Fruit vegetables 82 0.00003 a 0.000036 a 0.0025 0.0029 0.0054 
Others 370   0.36 0.70 1.1 
Total intake 
pg TEq day-1
   46 53 100 
a TEqs as pg g-1 w.w. 
b TEqs as pg g-1 fat. 
I-TEq concentrations in pork have decreased from the 1991 value of 0.29 (Vartiainen and 
Hallikainen 1994) to 0.051 pg I-TEq g-1 fat. The opposite situation was discovered with beef, 
where the values increased from 0.018 to 0.29 pg I-TEq g-1 fat. In Germany and The 
Netherlands, the concentrations in pork and beef were two to 10 times higher than those found in 
Finland (Liem and Theelen 1997, Malisch 1998). It was very difficult to detect any time trend in 
these figures in Finland. Both values are low probably because pigs as well as beef cattle are 
slaughtered when they are still very young. 
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The concentrations of I-TEqs and PCB-TEqs in flour, potato and vegetable samples were 
both virtually negligible and their impact on intake was very small. It is very difficult to compare 
the concentrations of vegetables between different countries because of the heterogenity of the 
measured items in each country. The measured concentrations in Finland were very low when 
compared to Spain or Germany (Malisch 1998, Domingo et al. 1999). Only the I-TEq 
concentration of leafy vegetables, 0.01 pg g-1 w.w., was in the same range as reported in the 
study from Germany (Malisch 1998). 
Intake of PCDD/Fs and PCBs
The intake of PCDD/Fs declined from 95 pg N-TEq (Hallikainen et al. 1995) to 46 pg I-
TEq between 1992 and 1999 (N-TEq and I-TEq toxic equivalency factors are almost identical). 
Two obvious reasons for this decline were found. First, the lower concentrations of I-TEqs in 
cows' milk and eggs. Second, the consumption of eggs, fish and milk has also diminished 
compared to the previous dietary survey. 
To estimate the impact of new occurrence and new consumption data to the intake of 
PCDD/Fs, the intake of PCDD/Fs was calculated with new concentrations of PCDD/Fs 
combined with the old food consumption data. With this kind of procedure, the intake was 
calculated to be 70 pg I-TEq day-1. It is concluded that the changes in consumption data and 
concentrations have both affected almost equally the intake of PCDD/Fs. 
The intake of PCB-TEqs, 53 pg PCB-TEq day-1, was clearly underestimated in this study 
because PCB-TEq concentration data for Baltic herring were incomplete. The total intake of 
TEqs was 100 pg TEq day-1 (1.3 pg TEq kg-1 b.w. day-1), which is in the range of the tolerable 
daily intake (TDI), 1-4 pg TEq kg-1 b.w. day-1, given by WHO (van den Berg et al. 1998). 
The average intake of PCDD/Fs in Europe has been reported to be between 42 and 210 
pg I-TEq day-1 (Liem and Theelen 1997, Becher et al. 1998, Harrison et al. 1998, Malisch 1998, 
Domingo et al. 1999, Zanotto et al. 1999). Both the lowest and the highest intakes have been 
measured in the Mediterranean around Venice, Italy (42 pg I-TEq day-1) and in Spain (210 pg I-
TEq day-1) (Domingo et al. 1999, Zanotto et al. 1999). In Western Europe (The Netherlands, 
Germany, UK), the intake has been calculated to vary between 61 and 90 pg I-TEq day-1 (Liem 
and Theelen 1997, Harrison et al. 1998, Malisch 1998). In the northern parts of Europe in 
addition to Finland, there is a current estimation available for the daily intake of PCDD/Fs for 
Norway where it varied between 50.6 and 84.6 pg I-TEq day-1 (Becher et al. 1998). The PCDD/F 
intake in the USA was estimated to be 41 pg TEq day-1 (US EPA 2000). In Japan, the estimated 
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intake of PCDD/Fs was equivalent to European intakes, ~70 pg I-TEq day-1 (Yoshida et al. 
2000). The lowest intake of PCDD/Fs has been reported from New Zealand, 14.5 pg I-TEq day-1
for the average population (Buckland et al. 1998). 
The recent PCB-TEq intake estimations are available from UK, USA, Norway and New 
Zealand. The lowest intake for PCB-TEqs was also found in New Zealand, 12.2 PCB-TEqs day-
1, followed by the USA (24 PCB-TEqs), UK (54 PCB-TEqs) and Norway, where the intake was 
estimated to be between 137 and 190 pg PCB-TEq day-1.
Time trends of PCDD/F intake have been studied in the UK, The Netherlands and 
Germany (Liem and Theelen 1997, Harrison et al. 1998, Malisch 1998). The trends for the 
intakes have been declining in all of these studies. In the UK, the intake of PCDD/Fs between 
1982 and 1992 decreased from 4.1 to 1.5 pg I-TEq kg-1 b.w. day-1. Simultaneously, the daily 
intake of PCB-TEq also declined from 2.7 to 0.9 pg PCB-TEq kg-1 b.w. (Harrison et al. 1998). A 
decline of almost 40% in the intake of PCDD/Fs was observed in The Netherlands between 1991 
and 1997, when the daily intake decreased from 115 to 73 pg I-TEq (Liem and Theelen 1997). In 
Germany, the time trend results showed that the intake in 1993-96 was about one-half of the 
intake calculated between 1986 and 1991, from 127 to 61 pg I-TEq day-1 (1.82-0.88 pg I-TEq kg-
1 b.w. day-1) (Malisch 1998). 
The contribution of fish in Finland increased from 60 to 82%, indicating that fish is 
clearly the most important contributor to PCDD/F intake in Finland. In the dietary method used 
in the FINDIET 1997 survey, the fish consumption can be estimated lower than by other dietary 
methods and this further emphasizes the impact of fish to the intake. The contribution of milk 
and dairy products had clearly diminished, from 31 to 8% because of the decreased I-TEq 
concentration and reduced consumption. 
In the Venetian and Norwegian studies, fish and fish products contributed to the PCDD/F 
intakes as much as in the Finnish study. In Venice, the proportion varied from 42 to 50% and in 
Norway from 28 to 43% (Becher et al. 1998, Zanotto et al. 1999). In the UK, Germany, The 
Netherlands, the USA and New Zealand the main source of PCDD/Fs are meat and meat 
products and milk and dairy products, the proportion of both groups being ~30% (Liem and 
Theelen 1997, Buckland et al. 1998, Harrison et al. 1998, Malisch 1998, US EPA 2000). The 
proportion of fish and fish products in these countries varied between 1 and 20%. The impact of 
vegetables on the intakes of PCDD/Fs have been considered as negligible or insignificant in 
many studies, but recently in Spain the contribution of vegetables has been estimated as being 
noteworthy (Domingo et al. 1999). Taking the impact of vegetables into consideration in the 
intake calculations, Domingo et al. concluded the intake in Catalonia to be 210 pg I-TEq day-1. If 
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one excluded vegetables from the calculations, then the intake would have been 117 pg I-TEq 
day-1. Lovett et al. (1997) concluded that the increase in intake of PCBs and PCDD/Fs resulting 
from eating fruits and vegetables was unlikely to >3% for PCBs and 8% for PCDD/Fs, of the 
average daily intakes of these contaminants from all food sources. 
Table 5 shows the percentage exposure for PCDD/F from the most important food 
sources, and daily intake of PCDD/Fs in different countries. It reveals that geographically the 
countries nearest to Finland i.e. Germany and Norway, have the most similar intakes as Finland, 
61.3 and 51 pg TEq day-1, respectively. The Western European countries, The Netherlands and 
UK can be grouped with each other with 73 and 90 pg TEq day-1 intakes. The daily intake of 
PCDD/Fs in Finland was ~3 times higher than the intakes in New Zealand (14.5 pg I-TEq). 
In this study, the TEq intakes have been calculated with the concentration results where the 
non-detected results were considered as zeros. If the intakes of PCDD/Fs and PCBs were 
calculated with these results replaced by LODs, the PCDD/F intake would be 65 pg I-TEq day-1
and PCB intake 54 pg PCB-TEq day-1. This shows the crucial effect of handling the non-detected 
values when the concentrations of studied substances are very near to the limit of determination 
(LOD). 
6.CONCLUSIONS
In this study, the updated PCDD/F intake calculations revealed ~50% decrease in daily I-
TEq intake in the average Finnish population. The main reason for this decrease was the lower 
concentrations of PCDD/Fs in cows' milk and eggs and also the lower consumption of milk, eggs 
and fish. This study shows that the contribution of fish to the intake of PCDD/F has become 
more dominant compared to the previous study in Finland. 
The estimated daily intake of PCB-TEq was close to I-TEq intake, but the data for PCBs 
was not totally comprehensive, thus in the future the PCB occurrence data in foods must be 
completed in order to obtain a better estimate for PCB-TEq intake. The intake and trend for I-
TEq in Finland is very consistent with other European countries. The total intake of PCDD/Fs 
and PCBs, 1.3 pg TEq kg-1 b.w. day-1, is within the range of tolerable daily intake (TDI) 
provided by the WHO. 
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Table 5. Percentage exposure of PCDD/F from the most important food sources, and daily 
intake of PCDD/Fs in different countries.
Country 
Milk and 
dairy
products 
Meat and 
meat 
products 
Fish and 
fish 
products 
Eggs Others 
PCDD/F 
daily intake 
(pg I-TEq) 
Reference 
Spain 16 10 15 2 57 210 Domingo et al. (1999) 
USA 29 39 20 3 9 41 US EPA (2000) 
Italy (Venice) 29-53 3-11 42-50 2-10 - 15-130 Zanotto et al. (1999) 
UK 25 31 8 5 31 90* Harrison et al. (1998) 
Norway 8-13 6-10 28-43 4-7 27-54 51-85 Becher et al. (1998) 
The Netherlands 46 23 3 4 24 73 Liem and Theelen (1997) 
Germany 31 23 17 8 21 61.3 Malisch (1998) 
New Zealand 16 36 12 3 33 15 Buckland et al. (1998) 
Finland 1992 31 1.4 60 3 - 95 Hallikainen et al. (1995) 
Finland 1999 8 7 82 2 1 46 present study 
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1. ABSTRACT
We have measured the concentrations of polychlorinated dibenzo-p-dioxins (PCDD/F), 
polychlorinated biphenyls (PCBs), and polybrominated diphenyl ethers (PBDE) in 10 market 
baskets consisting of almost 4000 individual food samples representing 228 different food items, 
and also in the total diet basket. Lower bound concentrations of PCDD/Fs ranged between 0.0057 
and 5.6 pg/g fresh weight in the market baskets and the corresponding values for PCBs from 39 to 
25,000 pg/g. The fish basket contributed most to the concentrations of dioxins and PCBs, and also 
to concentrations of PBDEs in which the lower bound range was from 0.82 to 850 pg/g. We also 
assessed the average daily intakes of these substances by the Finnish adult population. The average 
daily intake of sum of PCDD/Fs and PCBs as WHO toxic equivalents was assessed to be 115 pg 
which was 1.5 pg WHO-TEq/kg body weight using an average mean weight of 76 kg for the 
general population in Finland. The contribution of fish to the intake of PCDD/Fs was between 94% 
and 72%, depending on whether lower or upper bound concentrations were used. With respect to 
PCBs, the contribution of fish was 80%. The calculated intake of PBDEs of 44 ng/day was 
comparable to intake assessments from other countries. Fish also contributed most to the PBDE 
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intake, but there was some other source of PBDEs that distinguishes the exposure to PBDEs from 
exposure to PCDD/Fs and PCBs. This additional source seemed to be found in the market basket 
that included beverages, spices, and sweets. 
2. INTRODUCTION
More than 90% of the average human intake of polychlorinated dibenzo-p-dioxins and 
polychlorinated dibenzofurans (PCDD/F, dioxins) and polychlorinated biphenyls (PCBs) 
originates from food, especially food of animal origin (Liem et al., 2000). In a risk assessment of 
dioxins and dioxin-like PCBs in the diet, the Scientific Committee for Food (SCF) of the 
European Commission assessed a tolerable weekly intake (TWI) of 14 pg/kg body weight (bw) 
for these chemicals as toxic equivalents (WHO-TEq), according to the WHO toxic equivalency 
factor (TEF) scheme (European Commission, 2001; Van den Berg et al., 1998). Exposure 
estimates, made by SCF, indicated that a proportion of the European population has a dietary 
intake of dioxins and dioxin-like PCBs which is in excess of the TWI. 
In our previous study we concluded that at the end of the 1990s the exposure of the 
Finnish population to dioxins was only about 50% of their exposure at the beginning of the 
decade (Kiviranta et al., 2001). In that survey we used the Selective Study of Individual 
Foodstuffs (SSIF) approach combined with food consumption data from a 24-h dietary recall 
study for 2862 Finnish adults (National Public Health Institute,1998). The average dioxin intake, 
using former Ahlborg and NATO TEFs (Ahlborg et al., 1994; NATO/CCMS, 1988), was 
calculated to be 46 pg TEq/day, and the assessed PCB intake was 53 pg PCB-TEq/day. Thus the 
total intake of dioxins and dioxin-like PCBs was 100 pg TEq/day. On average, weekly intake of 
these chemicals in Finland was then assessed to be 9.2 pg TEq/kg bw and this was below the 
Commission's recommendation. 
In this study, the Agricultural Research Centre of Finland composed an average Finnish 
market basket diet and the National Public Health Institute, Laboratory of Chemistry, analyzed 
the diet for dioxins and PCBs, and also for polybrominated diphenyl ethers (PBDEs). The 
compositions and consumption of the market baskets were based on the same Dietary Survey of 
Finnish Adults (National Public Health Institute,1998) as used in our previous study. Thus we 
were able to compare intake assessments of dioxins and dioxin-like PCBs between these two 
methods; Market Basket Method  (MBM) and SIFF-method. The intake assessment of PBDEs 
was conducted for the first time in Finland, with our main interest focussed on the origin and 
level of adult population exposure to PBDEs. 
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3. MATERIALS AND METHODS 
Food consumption data and composition of the market baskets
The food and food group consumption data used in the composition of the market baskets 
and in the intake calculations consist of the average consumption figures taken from the 1997 
Dietary Survey of Finnish Adults (National Public Health Institute, 1998). In this 24-h recall 
study the whole adult population, sampled from five major Finnish provinces and cities, aged 25-
64, was included (n=2862). 
Ten individual market baskets were created: (1) liquid milk products; (2) solid milk 
products; (3) fish; (4) meat and eggs; (5) fats; (6) cereal products; (7) potato products; (8) 
vegetables; (9) fruits and berries; (10) beverages, spices, sweets etc. In addition, a total diet 
basket was created by mixing individual market baskets based on the consumption proportion of 
each individual market basket in the total average diet. Alcoholic beverages were omitted from 
the market baskets and also from the total diet basket. Table 1 shows the average daily 
consumption of market baskets, and the main items within the basket. Market baskets included 
all food items whose average daily consumption exceeded 0.5 g. A total of 228 different food 
items was included, with 3,988 individual samples (177 kg in total weight) being combined. In 
the market basket, the amount of each food item was obtained from the consumption data and the 
amount of each sample within a food item from market share data obtained from A.C.Nielsen 
Finland. Sample collection was carried out during a period of April 1997 and June 1999 in order 
to collect each product at its peak season. Of the samples 39.9% were collected from 
supermarkets, 38.7% directly from manufacturers, 11.2% from wholesalers, 6.3% from 
producers, and 3.9% from farmer markets. 
Preparation of food samples for analysis of PCDD/Fs, PCBs, and PBDEs
Pooling of food samples into 10 market baskets and to the total diet basket was undertaken 
in the Agricultural Research Centre of Finland, where measurements of the fat content of market 
baskets were conducted. Due to the lengthy collection period, the purchased food samples were 
stored mainly frozen at - 25°C before pooling into their respective market basket. 
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Table 1.
Market baskets, their average daily consumption, g/d (percentage of total daily consumption), 
and their main items (percentage in a basket).
Market basket Consumption g/d (%) Main items (%) 
(1) Liquid milk products 427 (21) Milk (71) 
Sour milk (15) 
Yogurt (11) 
(2) Solid milk products 32.5 (1.6) Cheese (94) 
(3) Fish 27.4 (1.4) Salmon and rainbow trout (29) 
Tuna and saithe (19) 
Baltic herring (11) 
Vendace (8) 
(4) Meat and eggs 132 (6.5) Processed meat products (31) 
Beef (20) 
Pork (19) 
Poultry (13) 
Eggs (13) 
(5) Fats 35.7 (1.8) Margarines (43) 
Butter (22) 
Butter-oil mixtures (16) 
Vegetable oils (13) 
(6) Cereal products 181 (9.0) Bread (48) 
Flour and other cereals (43) 
(7) Potato products 121 (6.0) Potato (97) 
(8) Vegetables 117 (5.8) Tomato (20) 
Carrot (15) 
Cucumber (12) 
Onion (9) 
(9) Fruits and berries 221 (11) Citrus fruits (32) 
Other fresh fruits (28) 
Whole juices (24) 
Berries (12) 
(10) Beverages, spices, sweets 725 (36) Coffee and tea (80) 
Beverages and juices (14) 
Sugars and honey (3) 
Total 2020 (100)  
The fat content of all market baskets, except basket 10, and the total diet basket was determined 
by diethyl ether extraction after acid hydrolysis. The fat content was determined gravimetrically. 
All market baskets, with the exception of basket 10 were freeze dried before transporting to the 
laboratory of chemistry in the National Public Health Institute.
Analysis of PCDD/Fs, PCBs, and PBDEs
The occurrence of 17 PCDD/F (toxic) congeners, of three non-ortho (PCB 77, 126, and 
169), eight mono-ortho (PCB 105, 114, 118, 123, 156, 157, 167, and 189), of 23 (PCB 18, 28, 
33, 49, 52, 60, 66, 74, 99, 101, 110, 122, 128, 138, 141, 153, 170, 180, 183, 187, 194, 206, and 
209) other PCB congeners, and of five PBDE congeners (PBDE 47, 99, 100, 153, and 154) were 
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measured. For PCDD/Fs, toxic equivalents (TEq) were calculated with two different sets of toxic 
equivalency factors (TEF), the NATO factors (NATO/CCMS, 1988) gave I-TEqs, and the 
factors recommended by WHO in 1998 (Van den Berg et al., 1998) gave WHOPCDD/F-TEqs. For 
PCBs, TEqs were also calculated with two sets of TEFs, factors by Ahlborg et al. (1994) gave 
PCB-TEqs and factors by WHO gave WHOPCB-TEqs.
Samples were spiked with 16 13C-labeled PCDD/F standards (2,3,7,8-chlorinated 
PCDD/F congeners), with three 13C-labeled non-ortho PCB standards (PCB 77, 126, and 169), 
13 13C-labeled other PCB standards (PCB 30 [12C-labeled], 80, 101, 105, 118, 138, 153, 156, 
157, 170, 180, 194 and 209), and with two 13C-labeled PBDE standards (PBDE 77 and 126). 
Samples of market baskets 1 to 9 and the total diet basket were extracted with toluene for 24 h 
using the Soxhlet apparatus. Sample of market basket 10, beverages, spices, sweets etc., was first 
filtered and the filtrate was then extracted with toluene in a separation funnel. The same toluene 
was used for extraction of the precipitate of the filtration in a Soxhlet apparatus. All the samples 
were defatted in a silica gel column containing acidic and neutral layers of silica, and all analytes 
were eluted with dichloromethane (DCM)/cyclohexane (c-hexane) (1:1). PCDD/Fs were 
separated from PCBs and PBDEs on activated carbon column (Carbopack C, 60/80 mesh) 
containing Celite (Merck 2693). The first fraction including PCBs and PBDEs was eluted with 
DCM:c-hexane (1:1) following a back elution of the second fraction (PCDD/Fs) with toluene. 
Eluents from both of the fractions were evaporated using nonane as a keeper and then fractions 
were further cleaned by passing through an activated alumina column (Merck 1097). The 
PCDD/F fraction was eluted from the alumina column with 20% DCM in n-hexane and recovery 
standards (13C 1,2,3,4-TCDD and 13C 1,2,3,7,8,9-HxCDD) were added to the fraction before 
DCM and n-hexane were replaced by 10-15 μl of nonane. The PCB-PBDE fraction was eluted 
from the alumina column with 2% DCM in n-hexane, and the fraction was further fractionated, 
after changing the eluent to n-hexane and transferring to another activated carbon column 
(without Celite) in order to separate the non-ortho PCBs from other PCBs and PBDEs. DCM 
(50%) in n-hexane was used to elute other PCBs and PBDEs, and non-ortho PCBs were back 
eluted with toluene. Recovery standards, PCB 159 for other PCBs and PBDEs, and 13C PCB 60 
for non-ortho PCBs were added prior to analysis; for non-ortho PCBs toluene was replaced by 
10-15 μl of nonane. The quantitation was performed by selective ion recording using a VG 70-
250 SE (VG Analytical, UK) mass spectrometer (resolution 10,000) equipped with a HP 6890 
gas chromatograph with a fused silica capillary column (DB-DIOXIN, 60 m, 0.25 mm, 0.15 
μm). Two microliters were injected into a split-splitless injector at 270°C.  The temperature 
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programs for PCDD/Fs, non-ortho-PCBs, mono-ortho- and other PCBs , and PBDEs were: start, 
140°C (4 min), rate 20°C/min to 180°C (0 min), rate 2°C/min to 270°C (36 min); start, 140°C (4 
min), rate 20°C/min to 200°C (0 min), rate 10°C/min to 270°C (12 min); start, 60°C (3 min), rate 
20°C/min to 200°C (0 min), rate 4°C/min to 270°C (14 min); start, 100°C (2 min), rate 25°C/min 
to 240°C (0 min), rate 4°C/min to 300°C (25 min), respectively. Limits of quantitation (LOQ) 
for PCDD/Fs, non-ortho PCBs, mono-ortho- and other PCBs, and PBDEs varied between 0.0007 
and 0.63, 0.0007 and 0.13, 0.048 and 3.2, 0.035 and 13 pg/g fw, respectively, depending on each 
individual congener and on the individual market basket. Recoveries for internal standards were 
more than 50% for all congeners. Fresh weight concentrations were calculated with both lower 
bound and upper bound methods. In the lower bound method, the results of congeners with 
concentrations below LOQ were designated as nil, while in the upper bound method they were 
denoted as the LOQ. 
Quality control and assurance
The laboratory reagent and equipment blank samples were treated and analyzed with the 
same method as the actual samples, one blank for every five samples. Fish oil is used as an 
internal quality control sample in the laboratory, and the random errors within the laboratory for 
WHOPCDD/F-TEq, WHOPCB-TEq, and sum of PBDEs are 5.7%, 4.6%, and 4.3%, respectively. 
The laboratory has participated in several international quality control studies for the analysis of 
PCDD/Fs, and PCBs. The matrices in these studies have included milk, meat, fat and fish 
samples. (IUPAC, 1995, 1998, 2000; Lindström et al., 2000; Becher et al., 2001; Småstuen Haug 
et al., 2002). When taking the systematic error obtained from these studies into account, the 
uncertainty of  WHOPCDD/F-TEq and WHOPCB-TEq results were 9.2% and 13.1%, respectively. 
The laboratory of chemistry in the National Public Health Institute is an accredited testing 
laboratory (No T077) in Finland (current standard: EN ISO/IEC 17025). The scope of 
accreditation includes PCDD/Fs, non-ortho PCBs, mono-ortho- and other PCBs, and PBDEs 
from environmental samples. 
Intake calculations
In the intake calculations, the average daily consumption of the food baskets was 
multiplied with the corresponding concentrations. Daily intakes (pg/day) for PCDD/Fs, PCBs, 
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and PBDEs were calculated on a fresh weight basis as a sum of the individual baskets and from 
the total diet basket. Intakes were calculated with both lower bound and upper bound 
concentrations. When calculating daily intakes per kg body weight (pg/kg bw), the average 
weight of 76 kg, which represents the average weight of the population participating in the 1997 
Dietary Survey (National Public Health Institute, 1998), was used. In that kind of study it can be 
assumed that even as many as every third subject has underreported the daily food intake, which 
is a common phenomenon in national dietary surveys (Hirvonen et al., 1997). The underreporters 
tend to claim a higher consumption of recommended food items, like vegetables, but lower 
consumption of less favourable food items such as spread fats. Thus, the average food intake 
estimated by individual dietary recalls is lower than the actual habitual intake.
4. RESULTS
The concentrations, as pg/g fresh weight (fw), of selected sets of PCDD/Fs and PCBs, 
corresponding toxic equivalents, and concentrations of PBDEs in 10 market baskets and in the total 
diet basket are presented in Table 2. Both, lower and upper bound concentrations were calculated.  
The maximum concentration of the sum of PCDD/Fs was detected in the fish basket 5.6 
pg/g fw followed by fats (3.0), and meat and eggs basket (0.55). The lowest concentration 
occurred in liquid milk products 0.0057 pg/g fw. Also in TEqs, the fish basket (1.8 pg/g of I-TEq 
or 2.0 pg/g WHOPCDD/F-TEq) dominated since its concentration was over 150 or 200 times 
higher than in the next biggest basket, fats (0.011 pg/g of I-TEq or 0.0088 pg/g WHOPCDD/F-
TEq). In the baskets, meat and eggs, fats, cereal products, potato products, vegetables, fruit and 
berries, the most abundant congeners were octachloro dibenzo-p-dioxin (OCDD), 1,2,3,4,6,7,8-
heptachloro dibenzofuran (1,2,3,4,6,7,8-HpCDF), and 1,2,3,4,6,7,8-heptachloro dibenzo-p-
dioxin (1,2,3,4,6,7,8-HpCDD). In the two milk product baskets, the most abundant congeners 
were 1,2,3,6,7,8-hexachloro dibenzo-p-dioxin (1,2,3,6,7,8-HxCDD) and 1,2,3,4,6,7,8-HpCDD. 
In the fish basket, the majority of the PCDD/F congeners could be quantified, with 2,3,4,7,8-
pentachloro dibenzofuran (2,3,4,7,8-PeCDF) and 2,3,7,8-tetrachloro dibenzofuran (2,3,7,8-
TCDF) being the most abundant congeners. Since the quantified congeners in most of the market 
baskets were highly chlorinated compounds with low TEF-values, the difference in TEqs 
between fish and other baskets was larger than the difference in the sum of PCDD/Fs. It also 
meant that the upper bound TEqs in baskets were from 3 to as much as 1250 times higher than 
the lower bound TEqs. The congener profiles in the total diet basket in Fig. 1 illustrates the 
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average Finnish exposure pattern to dioxins. The profile of the sum of PCDD/Fs was dominated 
by OCDD (60%) and the next abundant congeners were: 2,3,4,7,8-PeCDF, 2,3,7,8-TCDF, 
1,2,3,4,6,7,8-HpCDD, and 1,2,3,6,7,8-HxCDD. In the TEq profiles, 2,3,4,7,8-PeCDF accounted 
for 65% with congeners 2,3,7,8-tetrachloro dibenzo-p-dioxin (2,3,7,8-TCDD) and 1,2,3,7,8-
pentachloro dibenzo-p-dioxin (1,2,3,7,8-PeCDD) being the next abundant congeners. 
The fish basket also showed the highest concentrations of PCBs in every subset of 
congeners. The maximum concentration of the sum of PCBs was 25,000 pg/g fw followed by fats 
(750), and solid milk products basket (740). The lowest concentration was measured in the potato 
products basket 39 pg/g. The TEqs in the fish basket (1.6 pg/g of PCB-TEq or 1.5 pg/g WHOPCB-
TEq) were 35 times higher than concentrations in the next highest basket, fats (0.046 pg/g of PCB-
TEq or 0.043 pg/g WHOPCB-TEq). The majority of PCB congeners exceeded the LOQ values in all 
baskets. The three and four chlorine substituted PCBs were more abundant than the higher 
chlorinated congeners in the following baskets; liquid milk products, fats, cereal products, potato 
products, fruits and berries, and beverages, spices, sweets, but the most abundant PCBs in baskets; 
solid milk products, fish, meat and eggs, and also in vegetables were penta, hexa and hepta 
chlorinated congeners: PCB 101, 110, 118, 138, 153, 170, and 180. For the PCBs the TEqs 
calculated either with upper or lower bound concentrations did not differ from each other. The 
lower bound TEqs of PCBs were higher than respective PCDD/F TEqs by a factor ranging from 
1.5 to 220 in all other baskets except in the fish and the total diet basket. When comparing upper 
bound TEqs between dioxins and PCBs, only in the baskets with liquid milk products and 
vegetables did the PCB TEqs exceed the dioxin TEqs. The congener profiles in the total diet basket 
describe the average Finnish exposure pattern to PCBs, Fig. 2. Congeners PCB 153, 138, 110, 118, 
99, 180, 101 dominated the sum of PCBs profile with coverage of 65%. In the TEq profiles, three 
congeners; PCB 126, 118, and 156 accounted for 82-89% of the profile.
Table 2. 
Concentrations of PCDDs, PCDFs, dioxin toxic equivalents, non-ortho-PCBs, mono-ortho-PCBs, other PCBs, PCB toxic equivalents, PBDEs, 
and fat percentages of 10 market baskets and total diet basket as pg/g fresh weight.
Analyte group, pg/g Market baskets Total diet  
(1)
Liquid 
milk 
products 
(2)  
Solid milk 
products 
(3)
Fish 
(4)
Meat and 
eggs 
(5)  
Fats
(6)
Cereal 
products 
(7)
Potato
products 
(8)
Vegetables 
(9)
Fruits and 
berries 
(10)  
Beverages, 
spices, sweets 
basket 
Fat% 2.0 21 6.4 11 79 2.1 0.34 0.90 1.3  3.5 
PCDD [7] 0.0043 (2) 
0.018 
0.056 (2) 
0.25 
0.91 (7) 
0.91 
0.50 (2) 
0.54 
3.0 (3) 
3.3 
0.28 (2) 
0.30 
0.031 (1) 
0.038 
0.051 (2) 
0.057 
0.12 (2) 
0.13 
0.00076 (1) 
0.011 
0.19 (6) 
0.19 
PCDF [10] 0.0014 (1) 
0.019 
ND (0) 
0.27 
4.7 (7) 
4.7 
0.049 (3) 
0.17 
ND (0) 
1.2 
0.032 (4) 
0.091 
ND (0) 
0.022 
0.15 (4) 
0.16 
0.014 (3) 
0.041 
0.0096 (1) 
0.022 
0.058 (3) 
0.10 
Sum of PCDD/Fs 0.0057 
0.037 
0.056 
0.52 
5.6 
5.6 
0.55 
0.71 
3.0 
4.5 
0.31 
0.39 
0.031 
0.059 
0.21 
0.22 
0.14 
0.17 
0.010 
0.033 
0.25 
0.29 
I-TEq 0.00093 
0.0031 
0.0027 
0.042 
1.8 
1.8 
0.0082 
0.026 
0.011 
0.19 
0.0043 
0.013 
0.000031 
0.0033 
0.0012 
0.0042 
0.00083 
0.0052 
0.00017 
0.0021 
0.027 
0.029 
WHOPCDD/F-TEq 0.00093 
0.0036 
0.0027 
0.049 
2.0 
2.0 
0.0078 
0.029 
0.0088 
0.22 
0.0041 
0.015 
0.0000031 
0.0039 
0.0010 
0.0047 
0.00073 
0.0059 
0.00017 
0.0025 
0.029 
0.030 
Non-ortho-PCB [3] 0.11 (3) 
0.11 
1.1 (3) 
1.1 
34 (3) 
34 
0.59 (3) 
0.59 
0.76 (2) 
0.88 
0.80 (2) 
0.81 
0.080 (2) 
0.082 
0.52 (3) 
0.52 
0.39 (2) 
0.39 
0.0024 (1) 
0.0038 
0.76 (3) 
0.76 
Mono-ortho-PCB [8] 7.2 (8) 
7.2 
89 (8) 
89
3600 (8) 
3600 
52 (8) 
52 
110 (5) 
120 
24 (6) 
24
1.3 (4) 
1.5 
14 (8) 
14 
4.0 (4) 
4.3 
1.1 (2) 
1.6 
69 (8) 
69 
Other PCB [23] 64 (20) 
64 
650 (20) 
650 
22,000 (23) 
22,000 
410 (22) 
410 
640 (13) 
680 
380 (20) 
380 
38 (20) 
38 
250 (23) 
250 
51 (19) 
51 
78 (19) 
79 
540 (22) 
540 
Sum of PCBs 71 
71 
740 
740 
25,000 
25,000 
470 
470 
750 
790 
400 
400 
39 
40 
260 
260 
55 
56 
79 
80 
610 
610 
PCB-TEq 0.0043 
0.0043 
0.043 
0.043 
1.6 
1.6 
0.024 
0.024 
0.046 
0.049 
0.0071 
0.0073 
0.00076 
0.00085 
0.0092 
0.0092 
0.0021 
0.0022 
0.00046 
0.00056 
0.030 
0.030 
WHOPCB-TEq 0.0040 
0.0040 
0.039 
0.039 
1.5 
1.5 
0.021 
0.021 
0.043 
0.046 
0.0062 
0.0064 
0.00067 
0.00076 
0.0068 
0.0068 
0.0018 
0.0019 
0.00041 
0.00051 
0.028 
0.028 
Sum of PBDEs [5] 0.82 (1) 
2.0 
34 (3) 
40
850 (5) 
850 
13 (4) 
15 
180 (2) 
220 
15 (5) 
15
1.3 (4) 
1.4 
17 (5) 
17 
3.8 (3) 
4.2 
5.4 (3) 
5.5 
43 (5) 
43 
Lower bound concentrations shown in bold and non-bold font represents the corresponding upper bound concentrations. The number of analysed congeners in brackets and 
the number of congeners exceeding the LOQ concentrations in parenthesis for each analyte group. 
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Fig 1. Percentages of PCDD/F congeners in the total diet basket. (A) Percentages from the sum 
of PCDD/Fs (B) Percentages from toxic equivalents (I-TEq: black bars; WHOPCDD/F-TEq: white 
bars). Congeners: 1D: 2,3,7,8-TCDD; 2D: 1,2,3,7,8-PeCDD; 3D: 1,2,3,4,7,8-HxCDD; 4D: 
1,2,3,6,7,8-HxCDD; 5D: 1,2,3,7,8,9-HxCDD; 6D: 1,2,3,4,6,7,8-HpCDD; 7D: OCDD; 1F: 
2,3,7,8-TCDF; 2F: 1,2,3,7,8-PeCDF; 3F: 2,3,4,7,8-PeCDF; 4F: 1,2,3,4,7,8-HxCDF; 5F: 
1,2,3,6,7,8-HxCDF; 6F: 2,3,4,6,7,8-HxCDF; 7F: 1,2,3,7,8,9-HxCDF; 8F: 1,2,3,4,6,7,8-HpCDF; 
9F: 1,2,3,4,7,8,9-HpCDF; 10F: OCDF. 
Fig. 2. Percentages of PCB congeners in the total diet basket. (A) Percentages from the sum of 
PCBs. (B) Percentages from toxic equivalents (PCB-TEq: black bars; WHOPCB-TEq: white 
bars).
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The concentration of the sum of PBDEs ranged from 0.82 to 850 pg/g fw, and similarly 
to PCDD/Fs and PCBs, the fish basket had the highest concentration of PBDEs. The congener 
profile of PBDEs in the total diet basket is illustrated in Fig. 3. The main contributor to the 
profile was PBDE 47, followed by congeners PBDE 99 and 100, which was also the case in the 
following baskets; fish, potato products, fruits and berries, and beverages, spices, sweets. In all 
other baskets, the main contributor to the profile was PBDE 99. 
Fig. 3. Percentages of PBDE congeners in the total diet basket. 
The average daily intakes of the sum of PCDD/Fs and PCBs, the corresponding toxic 
equivalents, and of the sum of PBDEs are presented in Table 3. Intakes calculated with lower 
bound concentrations were higher in the total diet basket than in the sum of the individual 
baskets. The sum of PCDD/Fs intake was 500 pg/day in the total diet basket this being 9% 
higher than the intake calculated from the sum of individual baskets (460 pg). In dioxin TEqs, 
the difference was not so evident in I-TEqs 55 versus 53 pg/day and in WHOPCDD/F-TEqs 58 
versus 57 pg/day, respectively. The difference in lower bound intakes between the total diet 
basket and the sum of individual baskets was the largest, 19%, in the sum of PCBs, i.e. either 
1200 or 1010 ng/day, respectively. In PCB-TEq and WHOPCB-TEq, the difference was about 9% 
(60 versus 55 and 56 versus 51 pg/day, respectively). Upper bound sum of PCBs, PCB-TEq, and 
WHOPCB-TEq intakes in the total diet basket and in the sum of the individual baskets were 
similar to lower bound intakes. For dioxins, upper bound intakes calculated from the sum of 
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individual baskets were higher than the corresponding intake from the total diet basket. The 
difference in the sum of PCDD/Fs was 5%, in I-TEq 17%, and in WHOPCDD/F-TEq 25%. The 
lower and upper bound intakes of the sum of PBDEs were similar, around 44 ng/day.  
The contribution of fish to daily intake was overwhelming. In the lower bound intake of 
WHOPCDD/F-TEq, the fish basket accounted for 95% of the daily intake and with WHOPCB-TEq
the intake was 80%. When calculating shares in the upper bound intakes, fish accounted for 71% 
of the dioxin TEq intake while the contribution to the PCB TEqs remained at 80%. In the sum of 
PCDD/Fs the major contributors to daily intake were fish (30%), fats (24%), meat and eggs 
(16%), and cereal products (12%). In addition to fish, three other major contributors to the sum 
of PCBs were cereal products (7%), meat and eggs (6%), and beverages, spices, sweets (6%). 
Over half (53%) of the sum of PBDEs intake came from the fish basket, followed by fats (17%), 
beverages, spices, sweets (9%), and cereal products (6%). 
5. DISCUSSION
Lower bound I-TEq intake in the sum of individual baskets in this study (53 pg/day) was 
15% higher than the corresponding intake in our previous study with the SSIF-method (46 
pg/day) (Kiviranta et al. 2001). The corresponding upper bound intake in these two studies were 
more comparable (68 pg I-TEq/day  versus 65 pg/day, respectively). In PCB-TEqs lower and 
upper bound intakes were comparable between both studies (55 and 53, and 56 and 54 pg PCB-
TEq/day, respectively).
In this study, the main contributor, i.e. fish, accounted for 94% of the lower bound dioxin I-
TEq intake while in the previous study the contribution of fish was 82%. The contribution of milk 
products and meat and eggs to the lower bound intake of I-TEqs was 0.93 and 2.0% in this study 
compared to 8 and 9% in the previous study. Using the upper bound I-TEq values, the 
contributions of different kind of foodstuffs were alike between the studies (73, 4%, 5%, and 18% 
for fish, milk products, meat and eggs, and others, respectively in this study versus 59%, 15%, 
13%, and 9%, respectively, in the previous study). The contribution of the different kinds of 
foodstuffs to lower or upper bound PCB-TEq intake between the studies were rather similar and 
comparable (80%, 6%, 6%, and 8% for fish, milk products, meat and eggs, and others, respectively 
in this study versus 81%, 12%, 6%, and 1%, respectively in the previous study). The differences in 
lower bound I-TEq and in percentages of fish, dairy, and meat products of dioxin intake between 
our two studies are mainly due to the contribution of fish. In this study, the fish basket I-TEq 
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concentration was 1.8 pg/g, while the corresponding concentration (weighed by fish species 
consumption) in our previous study would be 1.3 pg/g. In addition, in the dairy and meat products 
baskets, the pooling of a large amount of different food items into the basket seemed to cause a 
critical dilution of low chlorinated dioxin analytes (1,2,3,7,8-PeCDD and 2,3,4,7,8-PeCDF) leading 
to lower I-TEq concentrations in these baskets compared to the corresponding food groups in our 
previous study. The PCB concentrations were much higher compared to the dioxin concentrations, 
and therefore there were only minor differences in the concentrations of PCB TEqs and the 
contributions of different food groups to the daily intake between our two studies. 
The total diet basket seems to be the most reliable choice to assess the daily intake of 
these contaminants. Especially with respect to dioxin intakes, the numerous congeners with 
concentrations below LOQ in the individual baskets result in an underestimation of the lower 
bound intakes and an overestimation of the upper bound intakes. 
Table 4 provides an overview of the average daily dietary intakes of dioxin- and PCB 
TEqs of adult populations from a number of countries. In addition, the food groups that 
contribute most to the intake of dioxins are presented. It is a difficult task to compare the results 
of intake estimations between countries because there are notable differences in the analytical 
methods e.g. upper bound versus lower bound concentrations used and set of TEFs utilized. 
There are differences between studies in collection methods and number of foods analysed, and 
differences in the means to study food consumpion. The daily intake of dioxins ranged between 
29 pg I-TEq in Norway (SCOOP, 2000) and 104 pg WHOPCDD/F-TEq in the USA (Schecter et al., 
2001), and of PCBs from 31 pg WHOPCB-TEq in Sweden (Lind et al., 2002) to 110 PCB-TEq in 
Norway. The recent Finnish TEq estimates of daily intakes (46-61 pg in dioxins and 51-60 in 
PCBs) were within these ranges reported from other countries. The Finnish daily intake of 
WHOPCDD/F-TEq together with WHOPCB-TEq per body weight (bw) was 1.5 pg/kg bw in this 
study which is at the lower end of the tolerable daily intake (TDI) range set by WHO, 1-4 pg 
TEq/kg bw (Van Leeuwen and Younes, 2000). None of the reported daily intakes in Table 4 
exceeded the WHO TDI upper range value. The TWI of TEqs in Finland was 10.5 pg WHO-
TEq/kg bw which is also below the highest recommended TWI value of 14 pg WHO-TEq/kg bw 
given by EU (EC/SCF 2001). In the future, analyses using distributional information for 
consumption data are needed in order to assess the percentage of Finns exceeding the TWI.  
Depending on the method used in the calculations, in Finland fish accounted for from 
63% up to 94 % of the daily intake of dioxins. A rather similar food contribution profile exists in 
Japan where 71% of the intake comes from fish (Tsutsumi et al., 2001). Fish are also the major 
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source of dioxin intake in Norway, Sweden, and Italy, but there exist a common trend in central 
and southern Europe for the dairy and meat/poultry food groups to be the most significant food 
groups in the intake of dioxins. That was also the case with the USA. The contribution of the 
food group “other” is very difficult to compare between the countries because of the large 
differences in food groups analysed in individual studies. 
Intake estimations of PBDEs have been reported from Canada (Ryan and Patry, 2001), 
Sweden (Lind et al., 2002), the United Kingdom (Wijesekera et al., 2002), and the Netherlands 
(Winter-Sorkina et al., 2003). In Canada, the daily intake was estimated to be 44 ng, which is 
similar to the results of this study. The food group which contributed most to the daily intake 
was different in Canada, 70% came from meat products, 6% from dairy products, and only 3% 
from fish. The corresponding contributions in this study were 4%, 3% and 55%, respectively. In 
Sweden the daily intake of PBDEs has been assessed to be 31 ng. The contribution of fish to the 
intake in Sweden was similar to that reported in this study about 58%, and dairy and meat 
products accounted for about 10% in Sweden. If we exclude cereals, potato products, fruits and 
vegetables, and beverages from the intake calculations of PBDEs from our study, the daily intake 
would be 33 ng, which is quite close to the value in the Swedish study, which did not evaluate 
these food groups. The contribution (9%) of the food group beverages, spices and sweets 
suggests that in PBDE intake there might be relevant exposure sources other than animal 
products. In the UK, the average daily lower bound intake was assessed to be 90.5 ng, and it was 
estimated that this would contribute 73% of the overall daily exposure. The lower bound daily 
intake of PBDEs in the Netherlands was estimated to be 13 ng, while the medium bound was 
assessed to be 185 ng (Winter-Sorkina et al., 2003). The difference between the intake estimates 
in the Netherlands was due to large number of congeners below the detection limits and the 
relatively high detection limits of some samples. 
6. CONCLUSIONS
Two different methods to assess dioxin and PCB intakes, i.e. either by analyzing food baskets 
(MBM-method) or by analyzing separate food items (SIFF-method), gave quite similar results. 
This implies that on average, the exposure in Finland is rather stable. 
The assessed average daily TEq intake, 1.5 pg/kg bw, was at the lower end of the 
tolerable daily intake (TDI) range for PCDD/Fs and PCBs set by WHO (1-4 pg WHO-TEq/kg 
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bw), and the assessed weekly intake, 10.5 pg WHO-TEq/kg bw was below the highest 
recommended weekly intake value of 14 pg WHO-TEq/kg bw given by EU.  
The intake of PBDEs were assessed for the first time in Finland and these were comparable 
to intakes in Canada and Sweden. The contribution profile of PBDEs suggested that there might be 
a difference in human exposure sources of PBDEs when compared to dioxins and PCBs.
Table 3.
Average intakes of PCDD/Fs, dioxin toxic equivalents, PCBs, PCB toxic equivalents, and PBDEs from 10 market baskets and total diet
basket as pg/day.
Market baskets Intake, pg/day Intake, pg/day Intake, pg/day 
 Sum of PCDD/Fs I-TEq WHOPCDD/F-TEq Sum of PCBs x 103 PCB-TEq WHOPCB-TEq Sum of PBDEs  x 103
(1) Liquid milk 
products 
2.4 (0.53) 
16 (2.6) 
0.40 (0.76) 
1.3 (2.0) 
0.40 (0.7)
1.5 (2.0) 
30 (3.0)
30 (3.0) 
1.8 (3.3)
1.8 (3.3) 
1.7 (3.4)
1.7 (3.4) 
0.35 (0.8)
0.86 (1.9) 
(2) Solid milk 
products 
1.8 (0.40) 
17 (2.8) 
0.089 (0.17)
1.4 (2.0) 
0.089 (0.16)
1.6 (2.1) 
24 (2.4)
24 (2.4) 
1.4 (2.5)
1.4 (2.5) 
1.3 (2.5)
1.3 (2.5) 
1.1 (2.6)
1.3 (2.9) 
(3) Fish 150 (33)
150 (25) 
50 (94)
50 (73) 
54 (95)
54 (71) 
690 (68)
690 (68) 
44 (80)
44 (79) 
41 (80)
41 (80) 
23 (55)
23 (52) 
(4) Meat and eggs 72 (16)
94 (16) 
1.1 (2.0)
3.4 (5.0) 
1.0 (1.8)
3.9 (5.2) 
62 (6.1)
62 (6.1) 
3.1 (5.7)
3.1 (5.6) 
2.8 (5.6)
2.8 (5.5) 
1.8 (4.2)
2.0 (4.5) 
(5) Fats 110 (23)
160 (26) 
0.41 (0.77)
6.7 (9.8) 
0.31 (0.55)
7.7 (10) 
27 (2.6)
28 (2.8) 
1.6 (3.0)
1.8 (3.2) 
1.5 (3.0)
1.6 (3.2) 
6.5 (15)
7.9 (18) 
(6) Cereal 
products 
56 (12) 
70 (12) 
0.78 (1.5)
2.3 (3.4) 
0.74 (1.3)
2.6 (3.5) 
73 (7.2)
73 (7.2) 
1.3 (2.3)
1.3 (2.4) 
1.1 (2.2)
1.2 (2.3) 
2.8 (6.6)
2.8 (6.2) 
(7) Potato 
products 
3.7 (0.81)
7.2 (1.2) 
0.0037 (0.0071)
0.40 (0.59) 
0.00037 (0.00066)
0.47 (0.62) 
4.8 (0.47)
4.8 (0.47) 
0.092 (0.17)
0.10 (0.19) 
0.081 (0.16)
0.092 (0.18) 
0.16 (0.4)
0.17 (0.4) 
(8) Vegetables 24 (5.3)
26 (4.2) 
0.14 (0.26)
0.50 (0.73) 
0.12 (0.21)
0.55 (0.73) 
31 (3.1)
31 (3.0) 
1.1 (1.9)
1.1 (1.9) 
0.80 (1.6)
0.80 (1.6) 
1.9 (4.5) 
1.9 (4.3) 
(9) Fruits and 
berries 
31 (6.7) 
38 (6.3) 
0.18 (0.35)
1.15 (1.7) 
0.16 (0.29)
1.3 (1.7) 
12 (1.2)
12 (1.2) 
0.53 (0.82)
0.48 (0.87) 
0.39 (0.77) 
0.42 (0.82) 
0.85 (2.0)
0.93 (2.1) 
(10) Beverages, 
spices, sweets 
7.5 (1.6)
24 (4.0) 
0.12 (0.24)
1.5 (2.3) 
0.12 (0.22)
1.8 (2.4) 
58 (5.7)
58 (5.7) 
0.33 (0.6)
0.40 (0.73) 
0.30 (0.59)
0.37 (0.73) 
3.9 (9.2)
4.0 (8.8) 
Sum of baskets 460
610 
53
68 
57
75 
1010
1010 
55
56 
51
51 
43
45
Total diet basket 500
580 
55
58 
58
60 
1200
1200 
60
60 
56
56 
44
44
Intakes with lower bound concentrations are shown in bold and non-bold fonts represent the corresponding upper bound intakes. Percentage of a basket of the intake in 
parenthesis. 
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Table 4. 
Average daily intakes of dioxin TEqs, PCB TEqs as pg and (pg/kg bw), and contributions of different food groups to the dioxin exposure.
Country, study period Daily intakes, pg,  (pg/kg bw) % contribution of foods from dioxins  Ref. 
 I-TEq WHOPCDD/F-TEq PCB-TEq WHOPCB-TEq Methoda Dairy Meat, poultry Eggs Fish Otherb
Finland, 1999 55 (0.72) 58 (0.76) 60 (0.79) 56 (0.74) 0 2 2c  94 2 This study 
Finland, 1999 58 (0.76) 60 (0.79) 60 (0.79) 56 (0.74) LOQ 14 5c  72 9 This study 
Finland, 1999 46 (0.61)  53 (0.70)  0 8 7 2 82 1 Kiviranta et al., 2001 
Finland, 1999 61 (1.01)  51 (0.84)  LOQ 16 6 4 63 11 SCOOP, 2000 
Japan, 2000  82 (1.64)  79  (1.59) 0.5*LOQ 2 12c  71 15 Tsutsumi et al., 2001 
Norway, 1997 29  110  LOQ 22 14 12 46 6 SCOOP, 2000 
Korea, 1999 30 (0.51)    unknown 1 4 5 39 51 Kim et al., 2000 
Belgium, 2001  65   0 30 31  39  Focant et al., 2002 
Sweden, 1999  44 (0.62)  31 (0.43) 0.5*LOQ 19 15 1 36 29 Lind et al., 2002 
Sweden, 1999 68 (1.06)  63 (0.85)  LOQ 19 31 2 34 14 SCOOP, 2000 
Italy, 1996 45 (0.74)    0.5*LOQ 26 32 7 35  SCOOP, 2000 
Spain, 2000 78 95   0.5*LOQ 27 13 2 30 28 Llobet et al., 2003 
China, 2000  72   unknown 16 35 21 28  Wu et al., 2002 
France, 1999 97 (1.45)    LOQ 33 13 2 26 26 SCOOP, 2000 
Germany, 1998 51 (0.73)    0.5* LOQ 39 30 11 11 9 SCOOP, 2000 
The Netherlands, 1999  45 (0.65)  46 (0.58) 0 24 21 5 10 40 Freijer et al., 2001 
The Netherlands, 1991 82  81  LOQ 39 20 4 2 35 SCOOP, 2000 
The United Kingdom, 2001  (0.4)  (0.5) LOQ 44 18 1 6 31 FSA report 38/03 
The United Kingdom, 1992 88 (1.26)  57 (0.81)  LOQ 25 20 4 6 45 SCOOP, 2000 
USA, 1995 29 104 (1.66)  42 (0.67) 0.5*LOQ 29 30 7 6 28 Schecter et al., 2001 
amethod of denoting concentrations of unquantified congeners in intake calculations: 0=lower bound, 0.5*LOQ=medium bound, LOQ=upper bound 
bother  = e.g. cereals and cereal products, vegetables, fruit, vegetable fats and oils 
cincludes meat, poultry, and eggs 7
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1. ABSTRACT
Baltic herring samples caught from the Baltic Sea during the spring periods of 1993-94 
and 1999 were analysed for polychlorinated dibenzo-p-dioxins (PCDD), polychlorinated 
dibenzofurans (PCDF), and polychlorinated biphenyls (PCB). For analyses, 1570 individual 
herring were combined to 120 pools. Correlations between concentrations of congeners 
1,2,3,7,8-PeCDD, 1,2,3,7,8-PeCDF, 2,3,4,7,8-PeCDF, and 2,3,4,6,7,8-HxCDF, and age of 
herring were the strongest (r > 0.8) followed by correlations between PCB congeners PCB 105, 
118, 126, 156, 169 and 180 (r > 0.7), and age of herring. Due to higher fat percentage in herring 
in the Gulf of Bothnia the concentrations of PCDD/Fs and PCBs on fresh weight (fw) basis were 
higher than in herring in the Gulf of Finland. The concentrations of WHOPCDD/F-TEQs ranged 
from 1 to 27 pg/g fw, depending on the age and catchment area of herring, and concentrations of 
WHOPCB-TEQs reached 32 pg/g fw. Between the two studied time points no clear downward 
trend in concentrations was observed. 
2. INTRODUCTION
Fish and fish products play a significant role in the Finnish dietary intake of 
polychlorinated dibenzo-p-dioxins, polychlorinated dibenzofurans (PCDD/F; dioxins), and 
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polychlorinated biphenyls (PCB). If one considers the PCDD/F intake, then fish and fish 
products accounted for 82%, and Baltic herring (Clupea harengus L.) alone 52% of the total 
intake. For PCBs, the contributions were similar although the data were not fully consistent 
(Kiviranta et al., 2001). In November 2001, the EU Council set maximum levels for PCDD/Fs in 
foodstuffs (EU, 2001), which will come into force on 1 July 2002. For fish and fishery products, 
the limit was set at 4 pg toxic equivalents (WHOPCDD/F-TEQ) per gram of fresh weight (fw). 
Finland and Sweden were granted an exception to this value until 2006. 
The total catch of Baltic herring by professional fishermen in Finland during the 1990s 
ranged from 51 000 to 98 000 tonnes of which about 25% was processed for human 
consumption, with the rest being used as feed for fur animals. The main catchment area was the 
southern part of the Gulf of Bothnia, the Bothnian Sea, which accounted for about 70% of the 
catch. About one third of the total catch was caught during the main spawning season in May-
June (Finnish Game and Fisheries Research Institute, 2000, 2001). 
Baltic herring populations in the Gulf of Finland and in the Gulf of Bothnia have 
distinctive characteristics which might affect the prevailing levels of PCDD/Fs and PCBs. Fat 
percentage varies substantially in populations throughout the year being highest in the autumn, 
and at its minimum in the spring during the main spawning season (Plorinja et al., 1975). The 
behaviour of the herring population in the Gulf of Finland differs from that of the shoals in the 
Gulf of Bothnia with respect to migration. Herring in the Gulf of Bothnia have a low migratory 
behaviour and can therefore be considered to be stationary fish. In the Gulf of Finland, young 
herring move within a limited area, whereas some of the sexually mature herring migrate over 
considerable distances as far as the southern Baltic Sea (Parmanne, 1990). The stock of cod 
(Gadus morhua L.), which is the main predator of sprat (Sprattus sprattus L.) and herring, has 
decreased in the Baltic Sea since the 1980's (ICES, 2001). This has led to an increase in numbers 
of sprat. Sprat compete with herring for food supplies and thus, the growth of herring has been 
retarded in the Gulf of Finland. This decline is evident when mean weight of herring in age 
groups is plotted as a function of time (Fig. 1). Another explanation for diminished growth of 
herring in the Gulf of Finland might be the temporal decline in the water salinity which may 
affect the amount, composition and availability of zooplankton suitable for herring (Lankov and 
Raid, 1997). No such major decline in growth of herring has taken place in the Gulf of Bothnia 
(ICES, 2001), where changes in salinity, zooplankton and in the abundance of cod and sprat have 
been less extensive than in the Gulf of Finland.
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Fig 1. Mean weight of Baltic herring at age groups in Baltic Sea proper and the Gulf 
of Finland, and in the Bothnian Sea, southern part of the Gulf of Bothnia, from 1980 
to 2000. (Data from ICES, 2001) 
Prevailing levels of organochlorine pesticides and PCBs in Baltic Sea have been 
monitored intensively since the late 1960s, and a continuous decline of several organochlorines, 
including PCBs, in Baltic herring from 1978 to 1995 has been reported (Bignert et al., 1998). 
Consistent data for PCDD/Fs in Baltic herring is currently missing, but some clues can be 
derived from studies in which eggs of herring-consuming sea-birds have been studied (Odsjö et 
al., 1997; Schramm et al., 1997). In these studies, a downward trend in PCDD/F concentrations 
has been detected in guillemot (Uria aalge) eggs from the beginning of the 1970s to 1994, and a 
similar trend has been reported in herring gull (Larus argentatus) eggs from 1988 to 1993. The 
declining trends in all of the above studies were most intensive during the late 1970s and during 
the 1980s, but have started to level off at the beginning of the 1990s. 
In this study of PCDD/Fs and PCBs in herring, the following main tasks were 
undertaken: (a) to determine the age correlation of concentrations; (b) to assess possible 
differences in concentrations between the Gulf of Finland and the Gulf of Bothnia; (c) to 
evaluate the time trend of concentrations during the 1990s. 
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3. MATERIALS AND METHODS 
Herring sampling and pooling
Altogether 1573 Baltic herring were collected from 11 locations of the Baltic Sea during 
most vigorous spawning season of the fish (beginning of May to mid-June) in 1993-94 and 1999 
(Fig. 2). In 1993-94 herring were caught mainly from the Gulf of Finland and only one 
catchment area was located in the Gulf of Bothnia. Weight (w) and length (l) of individual fish 
were measured and a condition factor (Cf) was calculated according to the equation: 
 Cf = w  l-3 * 100 (g cm-3)
Otoliths of herring were taken for age determination, n = 1194, in 1993-94 (ICES, 1998). 
Age was not determined in 1999 from otoliths, instead data (herring weight as function of age) 
from ICES (Fig. 1) were used for estimation of herring age. 
Herring from 1993 to 1994 were pooled into 100 pools. The main determinants for 
pooling were age (2, 3, 4, 5, 6, 7, 8, 10, 12, 14, and over 15 years old), gender, catchment area 
(six areas, Fig. 2). Herring caught from the Gulf of Bothnia consisted of older herring (over 8 
years), whereas the Gulf of Finland herring represented all age groups. Selective sampling on 
large herring in age groups 8 to >15 years resulted in non-randomized samples. These samples 
were collected in order to assess the maximum concentrations of PCDD/Fs and PCBs in Baltic 
herring and to compare concentrations in the Gulf of Finland and the Gulf of Bothnia. Pooling of 
herring (20 pools) caught in 1999 was based on two determinants: catchment area (nine areas, 
Fig. 2) and herring length (below 18.5 cm were "small" and over that "large"). Herring pools 
from catchment areas 8, 10, and 11 contained small and large herring from the Gulf of Finland 
(there was double sampling in area 10) and pools from areas 1, 2, 3, 5, and 6 consisted of small 
and large herring from the Gulf of Bothnia. In one area, Korsnäs, pooling was not done and the 
results are presented as an average of small and large herring. Numbers of individual herring in 
all pools varied from 1 to 34.
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Fig 2. Catchment areas of Baltic herring in two sampling periods 1993-94 and 1999. 
Analysis of PCDD/Fs and PCBs
Fats from cleaned (head, fins and gut removed), pooled, freeze-dried, and homogenized 
herring were Soxhlet extracted using toluene and the fat contents were determined gravimetrically. 
A previously described method was used for purification of samples and fractionation of PCDD/Fs, 
PCBs and non-ortho PCBs (co-PCB, co-planar PCB) (Kiviranta et al., 1999). 
13C-labeled internal PCDD/F standards (16 2,3,7,8-chlorinated PCDD/F congeners) were 
used for determination of the concentrations of 17 toxic PCDD/Fs. Toxic equivalents (TEQ) for 
PCDD/Fs were calculated with two different sets of toxic equivalency factors (TEF), the NATO 
factors (NATO/CCMS, 1988) gave I-TEQs, and the factors recommended by WHO in 1998 (van 
der Berg et al., 1998) for the WHOPCDD/F-TEQ. Limits of determination (LOD) for PCDD/Fs 
were isomer dependent, and varied between 0.1 and 1 pg/g fat, and between 0.005 and 0.05 pg/g 
fw. In the calculations of TEQs, concentrations below LODs were considered as zero. 
In 1993 co-PCBs (PCB 77, 126, and 169) were determined with corresponding 13C-
labeled internal standards. Other 13C-labeled PCBs (PCB 80, 101, 153, 180), and PCB 30 were 
used to determine 13 other congeners (PCB 8, 18, 28/31, 52, 80, 101, 105, 118, 138, 153, 156, 
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180 and 181). In 1994 one additional co-PCB (PCB 81) and 21 additional other PCBs (PCB 33, 49, 
51, 60, 66, 74, 99, 110, 114, 122, 123, 128, 141, 157, 167, 170, 183, 187, 189, 194, 206) were 
determined. Two PCBs were excluded from the set of 1993, (PCB 8 and 181). For herring caught 
in 1999, four additional 13C-labeled internal standards (PCB 105, 138, 156, 194) were used in the 
analysis of other PCBs. Congeners measured were the same as in 1994, except that PCB 81 was 
excluded, and two other congeners (PCB 47 and 209) were included in the set of PCBs analysed. 
TEQs for PCBs were calculated with two different sets of TEFs, factors by Ahlborg et al. (1994) 
gave PCB-TEQs and factors by WHO gave WHOPCB-TEQs (van der Berg et al., 1998). LODs for 
co-PCBs and other PCBs were 3 pg/g, and 0.2 ng/g fat, respectively, and 0.15 pg/g, and 0.01 ng/g 
fw. In the calculations of TEQs results below LODs were considered as zero. 
The laboratory reagent and equipment blank samples were treated and analyzed by the 
same method as the actual samples, one blank for every five samples. Recoveries for internal 
standards ranged between 60 and 110%. 
The laboratory of chemistry in the National Public Health Institute has participated in 
several international quality control studies for the analysis of PCDD/Fs, and PCBs in fish 
samples (IUPAC, 1995; IUPAC, 1998; IUPAC, 2000; Lindström et al., 2000; Becher et al., 
2001). Since 1996, the laboratory has been an accredited testing laboratory (No. T077) in 
Finland (current standard: EN ISO/IEC 17025). The scope of accreditation includes PCDD/Fs, 
PCBs, and co-PCBs from tissue samples. 
Statistical Analysis
Statistical analyses were carried out by means of SPSS software (for Windows, release 
9.0.1). Before the statistical tests, all results were transformed to a natural logarithm (ln) scale in 
order to ensure that the concentrations are as normally distributed as possible. Two tailed 
Pearson's correlation analysis was used to determine if the studied correlations were statistically 
significant. For comparisons of two groups, the Mann-Whitney U nonparametric test was used to 
test the statistical significances of the differences of concentrations between groups. One way 
analysis of variance (ANOVA) or Kruskal-Wallis H test were used to compare the differences of 
concentrations between multiple groups. 
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4. RESULTS AND DISCUSSION
No significant sex-related differences in PCDD/F or PCB concentrations were found 
(either calculated per fresh weight or fat) in herring. Similarly, there were no significant 
differences in the concentrations between the catchment areas in the Gulf of Finland, or in the 
Gulf of Bothnia. 
PCDD/F and PCB concentrations in 1993-94
Concentrations of PCDD/Fs, marker-, and PCB-congeners with dioxin-like toxicity along 
with fat percentages, weights, lengths, and Cfs of herring caught in 1993-94 are presented 
according to age groups in Tables 1 and 2. In age groups 2-7, the fat percentage varied between 
0.41 and 4.8, and the differences between ages were not statistically significant. Therefore the 
proportional differences between age groups in concentrations on a fresh weight and on fat basis 
were negligible. Weight and length increased significantly in age groups 2-4 years, but in groups 
older than 4 years no significant differences existed. This implies that the assessment of a 
herring's age based on its size is very difficult. 
All PCDD congeners, and penta-, and hexachlorinated PCDFs (except for 1,2,3,7,8,9-
HxCDF) were bioaccumulating in herring in age groups 2-7 (Table 1). Correlations for fresh 
weight were linear and the strongest correlations (r > 0.8) were measured for 1,2,3,7,8-PeCDD, 
1,2,3,7,8-PeCDF, 2,3,4,7,8-PeCDF, and 2,3,4,6,7,8-HxCDF. For these congeners, concentration 
differences between age groups were most evident. Although significant, the correlations 
between concentrations of 1,2,3,7,8,9-HxCDD, 1,2,3,4,6,7,8-HpCDD, and OCDD and age were 
poor (r < 0.5). The strongest correlation with age was noted for 2,3,4,7,8-PeCDF (r = 0.92) 
followed by both I-TEQ and WHOPCDD/F-TEQ (r = 0.90). To evaluate herring TEQ in fresh 
weight according to age, the first-degree equation for the linear line fit was calculated (y = 0.962 
x - 0.77 for I-TEQ, and y = 1.08 x - 0.845 for WHOPCDD/F-TEQ). A rule of thumb was created: 
every year of a herring's life led a rise of one TEQ unit on fresh weight basis. 
All PCB congeners (except for PCB 28/31 and 77) showed bioaccumulation, although to 
a lesser extent than dioxins (Table 2). The strongest correlations with age had congeners PCB 
105, 118, 126, 156, 169 and 180 (r > 0.7), whereas the marker congeners (PCB 52, 101, 138, and 
153) that do not contribute to TEQs had lower correlations (r < 0.6). PCB 169 showed the 
strongest correlation with age (r = 0.89) followed by PCB 180 (r = 0.88). No rule of thumb for 
Table 1.
Medians (range) of fat percentages, weights, lengths, condition factors (Cf), concentrations (pg/g fw and pg/g fat ) of PCDD/Fs and toxic 
equivalents of PCDD/Fs in different age groups of Baltic herring, caught in 1993-94 in the Gulf of Finland and in the Gulf of Bothnia.
 Gulf of Finland Gulf of Bothnia 
Age 2 3 4 5 6 7 8-> 15 8-> 15 
Amount pools 10 17 17 10 10 10 9 9 
Fat% 2.6 (1.3-3.7)a 1.8 (0.41-3.3) a 1.9 (0.61-4.8) a 1.9 (1.1-3.2) a 1.7 (0.99-3.5) a 1.9 (0.49-3.4) a 5.6 (1.8-9.2)* 11 (7.7-14) 
Weight 16 (13-16) a 19 (14-29)b 26 (22-34)c 28 (23-29)c 30 (23-35) c 31 (23-35) c 150 (96-250) 160 (58-360) 
Length 13.7 (13.2-14.1) a 14.6 (13.6-17.3) b 16.9 (16.5-17.7) c 16.9 (16.7-17.4) c 17.5 (16.8-18.3) c 17.4 (16.8-18.1) c 28.0 (23.7-32.4) 29.0 (20.7-36.4) 
Cf 0.58 (0.56-0.69) a 0.58 (0.52-0.7) a 0.57 (0.48-0.65) a 0.55 (0.49-0.61) a 0.56 (0.48-0.63) a 0.56 (0.46-0.68) a 0.71 (0.62-0.77) 0.7 (0.62-0.74) 
2378-TCDD 0.11 (ND-0.15)a
4.1 (ND-7.0) a
0.14 (0.051-0.31) a, b
8.2 (4.0-20)b
0.19 (0.11-0.52)b, c
10 (4.5-32) b, c
0.29 (0.15-0.44)c, d
15 (8.0-24) b, c
0.33 (0.25-0.76) d
17 (11-55) c
0.31 (0.087-0.51)c,d
18 (7.2-21)c
0.88 (0.59-1.2)* 
17 (9.6-32) 
1.7 (0.81-3.5) 
17 (9.1-29) 
12378-PeCDD 0.26 (0.19-0.45) a
13 (7.0-17)a
0.45 (0.28-0.79) b 
24 (13-68)b
0.65 (0.47-1.4)c
38 (16-84) b, c
1.2 (0.71-1.5) d
64 (28-110) c, d
1.4 (1.2-2.5) d
84 (38-180) d
1.4 (0.77-2.8)d
82 (41-160) d
4.0 (2.3-6.2) 
74 (35-190) 
4.9 (1.4-7.5) 
59 (15-61) 
123478-HxCDD 0.013 (ND-0.042) a
0.57 (ND-1.8) a
0.022 (ND-0.067) a
1.7 (ND-7.7) a, b
0.013 (ND-0.083) a, b
0.53 (ND-4.4) a, b, c
0.07 (0.013-0.14)b
3.9 (0.54-8.1)b, c
0.095 (0.031-0.14)b
4.4 (0.88-10) c
0.075 (0.049-0.12) b
4.7 (2.0-12)c
0.18 (ND-0.35) 
3.2 (ND-6.7) 
0.36 (0.078-0.75) 
3.4 (0.87-6.0) 
123678-HxCDD 0.35 (0.24-0.68) a
15 (6.9-25) a
0.51 (0.27-1.1) a
30 (11-75)b
0.65 (0.38-1.8) a, b
42 (14-110)b
1.5 (0.53-2.3) b, c
71 (24-170) b, c
1.3 (0.47-3.8)c
65 (31-270) b, c
1.5 (0.61-2.9) c
93 (28-150) c
3.1 (1.4-8.2) 
60 (18-230) 
3.4 (ND-6.7) 
43 (ND-54) 
123789-HxCDD 0.036 (0.019-0.1)a,b
1.6 (0.59-2.1) a
0.028 (0.006-0.1)b
1.7 (0.2-7.3) a
0.064 (0.02-0.11)a, b
2.9 (0.76-6.9) a
0.099 (0.024-0.14) a
5.7 (1.2-9.6) a
0.10 (ND-0.25) a
5.9 (ND-18) a
0.065 (0.03-0.13)a,b
4.3 (1.4-21) a
0.029 (ND-0.18) 
0.62 (ND-3.2) 
0.17 (ND-0.69) 
1.5 (ND-5.6) 
1234678-
HpCDD 
0.12 (0.052-0.23) a
4.8 (1.8-9.4) a
0.15 (0.05-0.88) a, b
11 (1.9-53) a, b
0.17 (0.089-2.8) a, b
13 (2.4-140) a, b
0.28 (0.11-1.2) a, b
13 (4.0-74) a, b
0.25 (0.13-1.2) a, b
16 (5.6-87) a, b
0.48 (0.11-1.2)b
22 (11-140) b ND
0.20 (ND-0.92) 
1.7 (ND-11) 
OCDD 0.29 (ND-0.98) a
17 (ND-31) a
0.60 (ND-3.6) a
34 (ND-230) a, b
0.62 (0.18-13) a
41 (5.8-640) a, b
0.81 (0.25-7.2) a
37 (10-470) a, b
0.78 (0.29-6.5) a
38 (14-450) a, b
1.8 (0.25-6.5) a
80 (27-450)b
0.62 (0.35-1.1)* 
9.3 (3.8-50) 
2.0 (0.50-7.5) 
16 (3.9-97) 
Dioxins 1.4 (0.66-2.2) a
60 (24-84) a
2.6 (0.72-5.7) a,  b
150 (36-420)b
2.3 (1.6-18)b, c
170 (45-860) b, c
4.6 (1.9-12) b, c
210 (78-800) b, c
4.7 (3.1-11) c
280 (120-810) b, c
5.4 (1.9-12)c
320 (120-920)c
8.9 (5.2-16) 
170 (78-500) 
18 (4.8-24) 
160 (54-240) 
2378-TCDF 1.8 (0.90-2.4) a
69 (37-85) a
1.3 (0.32-2.5) a
75 (38-110) a
1.5 (0.27-3.1) a
72 (31-100) a
1.4 (0.59-2.9) a
80 (43-95) a
1.3 (0.59-3.1) a
74 (40-87) a
0.64 (0.26-2.6) a
56 (21-95) a
4.1 (1.1-6.2)* 
72 (54-93) 
9.6 (6.5-14) 
84 (71-130) 
12378-PeCDF 0.23 (0.18-0.38) a
10 (6.4-18) a
0.35 (0.24-0.55)a
22 (12-57) b
0.62 (0.36-1.0) b
32 (19-59)c
0.83 (0.62-1.3) b, c
46 (33-81) c, d
1.1 (0.90-1.9) c
68 (37-110) d
0.91 (0.063-1.9)b, c
59 (13-97) c, d
1.6 (0.99-4.0)* 
27 (18-75) 
4.9 (0.54-38) 
47 (6.0-340) 
23478-PeCDF 1.5 (1.2-2.0) a
63 (42-94) a
2.5 (1.6-3.3) b
120 (81-380) b
3.7 (2.0-5.1) c
200 (100-330) b, c
5.5 (4.4-8.1) d
320 (190-480) c, d
8.2 (7.3-9.7) e
440 (220-850) d
8.0 (4.9-15)e
490 (260-1010) d
25 (12-30)* 
460 (190-1400) 
36 (12-55) 
280 (130-440) 
123478-HxCDF 0.12 (0.043-0.79) a, b
4.7 (1.8-29) a
0.11 (0.045-0.19) a
5.9 (2.2-21) a
0.25 (0.073-0.62) a,b
12 (3.7-44) a, b
0.28 (0.17-0.53) a, b
17 (7.6-25) a, b
0.41 (0.24-2.0) a, b
23 (6.6-68) b
0.37 (0.16-1.2) a, b
23 (8.9-60) b
0.36 (ND-0.84)* 
5.4 (ND-18) 
0.99 (ND-3.1) 
9.4 (ND-25) 
123678-HxCDF 0.09 (0.057-0.46) a
4.0 (1.8-13) a
0.17 (0.08-0.27) a, b
9.6 (4.4-27) a, b
0.22 (0.07-0.35)a,b,c
12 (4.9-20) a, b
0.40 (0.095-1.1)a,b,c
20 (7.6-51) b
0.50 (0.075-2.6) c
33 (3.5-88) b
0.48 (0.034-0.96)c
34 (2.0-80) b
1.1 (0.35-2.3) 
16 (5.9-130) 
2.0 (0.25-5.0) 
23 (2.8-40) 
234678-HxCDF 0.17 (0.09-0.25) a
6.3 (3.3-12) a
0.28 (0.13-0.42)b
16 (6.4-38) b
0.40 (0.17-0.66)c
19 (12-41) b, c
0.65 (0.35-0.98) d
35 (19-50) c, d
0.86 (0.69-1.3) d
44 (24-94) d
0.66 (0.41-1.5) d
43 (21-96) d
1.3 (0.80-2.5)* 
23 (12-93) 
3.0 (ND-5.8) 
34 (ND-47) 
1234678-HpCDF 0.21 (0.12-0.45) a
9.7 (3.6-17) a
0.24 (0.11-0.60) a
19 (4.8-52) a
0.24 (0.12-0.65) a
11 (3.5-48) a
0.31 (0.11-0.63) a
15 (6.2-30) a
0.27 (0.14-0.78) a
17 (5.9-57) a
0.28 (0.13-0.59) a
17 (7.3-93) a ND ND 
OCDF 0.07 (ND-0.36) a
2.6 (ND-11) a
0.091 (ND-0.36) a
5.0 (ND-39) a
0.055 (ND-0.35) a
3.0 (ND-20) a
0.057 (ND-0.27) a
2.9 (ND-17) a
0.082 (ND-0.23) a
4.6 (ND-15) a
0.15 (ND-0.41) a
5.7 (ND-82) a ND ND 
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Table 1 (continued) 
Gulf of Finland Gulf of Bothnia
Furans 4.7 (2.8-5.4) a
170 (110-220) a
5.1 (2.7-7.2) a
280 (160-660) b
7.0 (3.3-11) b
380 (220-570) b, c
9.9 (6.6-14) b, c
560 (340-700) c, d
13 (11-20) c
700 (390-1300) d
12 (7.1-20) c
740 (430-1500) d
33 (19-40)* 
600 (340-1800) 
57 (21-110) 
440 (230-970) 
Sum of PCDD/Fs 6.0 (3.7-7.3) a
240 (130-280) a
7.8 (3.5-11) a, b
400 (191-950) b
10 (4.9-25) b, c
570 (270-1200) b, c
15 (8.6-22) c, d
790 (440-1500)c, d
18 (15-26) d
940 (510-1900)d
19 (9.0-31)d
1030 (550-2400) d
43 (24-55)* 
780 (430-2300) 
67 (26-130) 
680 (290-1100) 
I-TEQ 1.4 (0.93-1.5) a
50 (34-72) a
1.9 (1.1-2.5) b
110 (59-270) b
2.7 (1.5-3.7) c
150 (77-240) b, c
4.3 (3.0-5.7) d
240 (130-350) c, d
5.6 (5.0-7.7) e
310 (160-570) d
5.5 (3.2-10)d, e
330 (180-650) d
16 (8.6-21)* 
310 (140-880) 
24 (8.3-39) 
190 (92-310) 
WHOPCDD/F-TEQ 1.5 (1.0-1.7) a
57 (38-79) a
2.2 (1.3-2.8) b
120 (65-300) b
3.0 (1.7-4.2) c
170 (86-280) b, c
4.8 (3.3-6.4) d
270 (150-400) c, d
6.3 (5.6-8.9) e
350 (180-650) d
6.2 (3. 6-11)d, e
370 (200-740) d
18 (9.8-24)* 
340 (160-970) 
27 (9.0-42) 
220 (100-340) 
Statistical significance of concentration differences between age groups 2-7 (tested with one-way ANOVA, significant level p < 0.05) are distinguished by different letter as 
superscript. Differences between concentrations of age groups 8-> 15 were tested separately from age groups 2-7, and statistically significant differences (tested with 
Mann-Whitney U test, significant level p < 0.05) are denoted here with an asterisk. 
ND = concentration below LOD 
Concentrations of 1,2,3,7,8,9-HxCDF and 1,2,3,4,7,8,9-HpCDF were all below LOD 
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Table 2
Medians (range) of concentrations as ng/g fw and as ng/g fat of PCBs and as pg/g fw and as pg/g fat of co-PCBs and toxic equivalents of PCBs in 
different age groups of Baltic herring, caught in 1993-1994 in the Gulf of Finland and in the Gulf of Bothnia.
 Gulf of Finland       Gulf of Bothnia 
Age 2 3 4 5 6 7 8-> 15 8-> 15
Amount pools 10 17 17 10 10 10 9 9 
PCB 28/31 0.44 (0.023-0.76)a, b
16 (1.3-27) a, b
0.067 (0.017-0.66) a
4.2 (1.0-41) a
0.71 (0.07-1.3) a, b
35 (3.8-68) a, b, c
0.71 (0.048-1.1) a, b
32 (4.5-66) a, b, c
0.63 (0.056-1.7)a,b
30 (3.7-83) a,b, c 
0.56 (0.026-1.2)a,b
30 (2.2-42) a, b, c
1.5 (0.55-2.9)* 
28 (22-43)* 
4.5 (2.8-6.1) 
38 (33-54) 
PCB 52 0.68 (0.39-1.2) a, b
30 (18-39) a
0.69 (0.22-1.1) a
37 (16-60) a
1.4 (0.65-2.2) a, b
73 (40-130) b
1.6 (0.74-2.8) a, b
76 (37-130) b
1.3 (0.72-2.9) a, b
72 (53-190) b
1.2 (0.28-2.6) a, b
69 (36-120) b
6.1 (2.3-7.1)* 
97 (77-130)* 
17 (10-21) 
150 (130-180) 
PCB 101 1.3 (1.0-2.0) a
57 (39-80) a
1.9 (0.015-2.4 ) a
110 (3.7-160) a, b
2.6 (1.5-4.4) a
130 (87-260) b, c
2.6 (1.7-3.9) a
150 (110-220) b, c
2.8 (2.0-5.5) a
160 (110-260) b, c
4.0 (1.3-6.6) a
240 (130-380) c
22 (15-27)* 
360 (270-1100) 
41 (27-57) 
350 (310-470) 
PCB 138 3.1 (2.5-4.9) a
140 (89-190) a, c
4.4 (2.9-6.4) a
270 (130-800) a, b
5.2 (2.6-9.6) a
230 (110-830)b, c
4.1 (2.9-5.7) a
180 (140-510) a, b
5.3 (4.1-9.4) a
280 (160-940) a, b
9.3 (4.4-19) b
610 (250-1300) b,c
36 (20-44)* 
500 (370-2000)* 
83 (48-110) 
780 (600-960) 
PCB 153 0.96 (0.68-1.4) a
39 (25-72) a
1.0 (0.63-1.9) a
65 (31-250) a, b
1.3 (0.59-3.0) a, b
60 (27-270) a, b
0.87 (0.69-1.1) a
41 (32-99) a
1.1 (0.86-2.4) a, b
62 (33-240) a, b
2.0 (0.96-6.2) b
120 (56-390) b
23 (15-57)* 
370 (300-3100)* 
70 (41-87) 
640 (520-740) 
PCB 180 0.28 (0.22-0.32) a
11 (7.2-17) a
0.43 (0.3-0.5) b
23 (14-72)b
0.55 (0.41-0.66)c
28 (13-68) b
0.62 (0.53-0.79) c, d
34 (24-62) b, c
0.75 (0.66-1.0) d, e
43 (28-93) b, c
1.0 (0.5-1.8) e
61 (30-110) c
17 (8.7-31)* 
310 (130-910) 
39 (25-54) 
370 (290-570) 
Sum of  
Marker PCBs 
7.1 (5.2-10) a
290 (200-400) a
9.0 (4.9-11) a, b
490 (280-1200)b
12 (6.9-19) b, c
510 (310-1600) b, c
11 (8.3-14) a, b
560 (390-990) a, b, c
13 (9.3-18) b, c
640 (420-1600) b, c
18 (9.7-36) c
1200 (550-2200) c
120 (64-130)* 
1800 (1200-7200)* 
260 (150-310) 
2200 (1900-2800) 
PCB 77 22 (9.4-34) a
970 (590-1200) a
18 (5.3-26) a
970 (290-1600) a
22 (10-46) a
1100 (540-6700) a
24 (9.3-38) a
1200 (840-1800) a
28 (14-48) a
1200 (1050-2400) a
26 (8.3-39) a
1300 (840-7100) a
78 (9.7-130)* 
1500 (170-2200) 
120 (68-160) 
1030 (760-1400) 
PCB 81 NA NA NA NA NA NA 350 (130-550)* 
5800 (2900-9300) 
730 (490-900) 
6400 (5800-7400) 
PCB 126 8.2 (5.8-11) a
340 (270-440) a
11 (6.0-24) a, b
580 (340-1500) b
14 (ND-24)b, c
710 (ND-940) b
17 (13-24)c, d
1000 (680-1500) b, c
22 (18-33)d
1200 (830-2000) c
22 (16-45)d
1300 (700-5050) c
94 (48-160) 
1800 (730-2600)* 
110 (69-140) 
940 (810-1300) 
PCB 169 1.8 (1.2-3.1) a
76 (48-140) a
2.8 (2.1-4.3)b
160 (97-570) b
5.0 (ND-22)c
250 (ND-1300) b, c
7.6 (5.9-11)c, d
440 (270-620)c, d
11 (9.4-13)d
580 (350-1000)d
12 (6.1-20)d
680 (300-3200) d
39 (20-59) 
740 (300-2100) 
45 (30-77) 
410 (330-630) 
PCB 123 NA NA NA NA NA NA 3.9 (1.7-7.0) 
64 (33-220)* 
4.0 (2.5-6.7) 
35 (30-55) 
PCB 118 1.1 (0.80-2.8) a
54 (23-88) a
1.8 (0.87-2.5) a, b
100 (58-230) b
1.6 (0.95-5.1) a, b
100 (46-160) b
2.4 (1.3-3.8) b, c
130 (95-160) b, c
2.7 (1.8-4.9) b, c
130 (99-310) b, c
3.3 (1.9-6.3) c
160 (120-580) c
28 (17-44)* 
440 (330-2400) 
40 (27-64) 
350 (300-520) 
PCB 114 NA NA NA NA NA NA 0.69 (0.33-1.6) 
13 (6.9-49)* 
0.78 (0.55-1.3) 
7.2 (6.2-11) 
PCB 105 0.46 (0.31-1.2) a
23 (9.0-39) a
0.78 (0.60-1.2) a, b
41 (25-280) b
0.86 (0.4-2.2)b
47 (18-110) b
1.5 (0.94-2.6)c
87 (58-120) b, c
1.7 (1.3-3.4)c
89 (64-150)c
1.5 (1.3-3.3)c
91 (60-270) c
16 (6.9-30) 
280 (130-1030)* 
14 (9.3-25) 
120 (110-210) 
PCB 167 NA NA NA NA NA  NA 1.3 (0.66-2.4)* 
21 (12-70) 
2.5 (1.4-3.1) 
22 (18-30) 
PCB 156 0.071 (0.051-0.1)a
3.1 (2.0-3.9) a
0.1 (0.073-0.14) a, b
5.8 (3.0-18)b
0.17 (0.092-0.23)b, c
8.6 (3.9-18) b, c
0.27 (0.12-0.41) c, d
17 (5.5-26) c, d
0.31 (0.2-0.46)d
18 (8.0-33) c, d
0.31 (0.15-4.6) d
23 (7.4-200) d
4.7 (2.6-6.9)* 
94 (43-240) 
9.6 (5.4-13) 
87 (70-110) 
PCB 157 NA NA NA NA NA NA 1.0 (0.51-1.5)* 
17 (8.7-54) 
1.4 (0.89-2.2) 
13 (11-18) 
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Table 2 (continued)
 Gulf of Finland Gulf of Bothnia
PCB 170 NA NA NA NA NA NA 5.1 (2.8-8.9)* 
96 (40-360) 
13 (7.8-17) 
120 (97-190) 
PCB 189 NA NA NA NA NA NA 0.44 (0.26-0.84)* 
9.1 (4.4-16) 
1.2 (0.67-1.6) 
12 (8.7-18) 
Sum of PCBs1 9.4 (6.9-12) a
370 (270-530) a
12 (7.1-14) a, b
640 (380-1700) b
15 (9.6-23) b, c
790 (470-1800) b
15 (11-21) b, c
810 (580-1300) b, c
18 (13-27) c, d
890 (600-2100) b, c
24 (14-45) d
1600 (840-3100) c
280 (140-350)* 
4300 (2700-16000) 
490 (310-630) 
4300 (3700-5500) 
PCB-TEQ2 1.1 (0.77-1.4) a
44 (35-59) a
1.4 (0.88-2.8) a
79 (46-220) b
1.9 (0.22-3.0) a, b
96 (36-120) b
2.3 (1.8-3.3) b, c
140 (94-190) b, c
2.9 (2.4-4.5) c
160 (110-260) c
3.0 (2.2-6.0) c
190 (100-640) c
17 (9.8-30)* 
320 (200-860) 
25 (16-34) 
230 (190-280) 
WHOPCB-TEQ3 1.0 (0.77-1.4) a
43 (35-59) a
1.4 (0.87-2.8) a, b
78 (46-220) b
1.9 (0.2-3.0) a, b
95 (33-120) b
2.2 (1.7-3.3) b, c
140 (93-190) b, c
2.8 (2.4-4.5) c
160 (110-260) c
3.0 (2.2-6.0) c
190 (100-640) c
16 (9.4-29)* 
310 (190-820) 
23 (15-32) 
210 (180-270) 
Statistical significance of concentration differences in age groups 2-7 (tested with one-way ANOVA, significant level p < 0.05) are distinguished by different letter as superscript. 
Differences between concentrations of age groups 8-> 15 were tested separately from age groups 2-7, and statistically significant differences (tested with Mann-Whitney U test, 
significant level p < 0.05) are denoted here with an asterisk. 
ND = concentration below LOD. 
NA = not analysed. 
1 sum of 16 congeners in age groups 2-7 and sum of 36 congeners in age groups 8-> 15. 
2 incomplete PCB-TEq in age groups 2-7. 
3 incomplete WHOPCB-TEq in age groups 2-7.
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PCB-TEQ and WHOPCB-TEQ was defined because seven PCB congeners contributing TEQs 
were not measured in 1993. 
The results of the age groups 8 to > 15 years (Tables 1 and 2) were combined because of 
the selective sampling and the small number of large-sized herring in the pools. The fat 
percentage of herring in the Gulf of Finland was significantly lower than in the Gulf of Bothnia. 
There was no significant difference in weight, length, or Cf between the catchment areas. 
Concentrations in fresh weight in herring in the Gulf of Bothnia were higher than in the Gulf of 
Finland, partly due to their higher fat content. It was expected that differences in fat percentages 
would solely explain concentration differences in fresh weight basis. However, the 
concentrations on a fat basis were not equal. Especially in the marker PCBs, PCB 28/31, 52, 138, 
and 153 also the fat concentrations in the Gulf of Bothnia were significantly higher than in the 
Gulf of Finland. The concentrating effect of the lower amount of fat was most evident with 
congeners which bioaccumulated best, i.e. 1,2,3,7,8-PeCDD, 2,3,4,7,8-PeCDF, and PCB 169. 
Possible heavier exposure to some of PCDD/F and PCB congeners in the Gulf of Bothnia and/or 
differences in feeding habits of large herring might explain their higher concentrations also in 
fat. Herring feed mainly on zooplankton, but the older herring have a diet which also contains 
crustaceans and small fish, living in the upper trophic level. It is not known whether the large 
herring in the Gulf of Bothnia feed more frequently on crustaceans and small fish than large 
herring in the Gulf of Finland. The concentrations in these large herring must be considered as 
extreme values because of the method of sampling. Total WHO-TEQ in old herring reached 
value 34 pg/g fw in the Gulf of Finland, and 50 pg/g fw in the Gulf of Bothnia. The contribution 
of PCDD/Fs and PCBs to the total TEq was equal in both catchment area. 
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PCDD/F and PCB concentrations in 1999
In 1999 herring were caught in nine locations along the Finnish Baltic Sea coastline (Fig. 
2). The concentrations of PCDD/Fs, marker PCBs, and PCB congeners with dioxin-like toxicity 
are illustrated in Tables 3 and 4, and data on fat percentages, weights, lengths, and Cfs are 
included in Table 3. The ages of small and large herring in 1999 were obtained from the data of 
ICES (Fig. 1) using average weights of herring. It must be kept in mind that ages here are crude 
estimates since the variation of sizes within an age group is considerable wide. Fish from the 
catchment area number 6, Kustavi, are usually grouped together with fish in the Gulf of Finland 
in the herring stock assessments (ICES, 2001), but here results of Kustavi were included in the 
Gulf of Bothnia herring on the basis of their fat percentages (3.6% in small herring and 5.1% in 
large herring). 
Almost all fresh weight and fat concentrations of PCDD/Fs and PCBs in large herring 
were higher than in small herring in the Gulf of Finland but the differences were not significant. 
A similar finding was noted also with the 1993-1994 data (Tables 1 and 2), where the 
concentrations only seldom were significantly different in age groups over 4 years. The situation 
in the Gulf of Bothnia was different. Excluding those PCDD/Fs and PCBs which showed low 
bioaccumulation, the concentrations (fresh weight and fat basis) in large herring were 
significantly higher than in small herring. Some of this clear difference in concentrations 
between small and large herring in the Gulf of Bothnia can be explained by the greater gap in 
weights between small and large herring in the Gulf of Bothnia compared to the Gulf of Finland. 
Another explanation was also: small and large herring in the Gulf of Finland have similar 
feeding characteristics consuming mainly on zooplankton, but in the Gulf of Bothnia large 
herring feed relatively more on crustaceans and small fish, and hence are exposed to higher 
amounts of PCDD/Fs and PCBs. 
The greater exposure of large herring to PCDD/Fs and PCBs in the Gulf of Bothnia was 
supported by the differences of concentrations in small and large herring between the Gulf of 
Finland and the Gulf of Bothnia. In small herring, the fresh weight concentrations of PCDD/Fs 
and PCBs (Tables 3 and 4) were almost the same irrespective of whether they were caught in the 
Gulf of Finland or the Gulf of Bothnia, in spite of lower fat percentage in the Gulf of Finland 
herring. The lower percentages of fat in small herring from the Gulf of Finland resulted in fat 
based concentrations, which were twice or even more as high as concentrations in small herring 
in the Gulf of Bothnia. The concentrations (fresh weight and fat basis) in the small herring 
Table 3. 
Medians (range) of fat percentages, weights, lengths, condition factors (Cf), concentrations (pg/g fw and pg/g fat) of PCDD/Fs and toxic equivalents of 
PCDD/Fs in small and large Baltic herring, caught in 1999 in the Gulf of Finland and in the Gulf of Bothnia.
 Gulf of Finland  Gulf of Finland  Gulf of Bothnia 
 Small herring  Small herring Large herring  Small herring Large herring 
 1993-1994  1999 1999  1999 1999 
Age 5.5 (5-6)  5.5 (4.5-6)1 9.3 (9-10) 1  4.5 (4-5) 1 7.8 (5.5-9) 1
Number of pools 20  4 4  5 5 
Fat% 1.8 (0.99-3.5) 2.0 (1.5-2.9)** 2.4 (2.1-3.8)*** 4.9 (3.6-5.1) 4.9 (4.0-7.2) 
Weight 29 (23-35) 32 (27-33) ‡ 47 (44-54) 31 (29-33) ‡‡ 54 (41-56) 
Length 17.2 (16.7-18.3) 17.6 (17.1-17.9) ‡ 20.1 (19.8-20.7) 17.4 (17.1-17.5) ‡‡ 20.7 (19.7-20.8) 
Cf 0.56 (0.48-0.63)  0.58 (0.53-0.6) 0.59 (0.54-0.61)  0.6 (0.56-0.65) 0.6 (0.52-0.63) 
2378-TCDD 0.32 (0.15-0.76) 
16 (8.0-55) 
0.3 (0.23-0.38) 
14 (13-16)** 
0.34 (0.29-0.82) 
15 (13-22) 
0.4 (0.35-0.46) ‡‡
8.2 (6.8-13) ‡‡
0.74 (0.66-1.2) 
17 (9.2-24) 
12378-PeCDD 1.3 (0.71-2.5) 
68 (28-180) 
1.2 (0.86-1.4) 
60 (41-66)** 
1.5 (1.4-2.6)***
64 (59-73) 
1.4 (1.2-1. 5) ‡‡
29 (24-35) ‡‡
3.9 (2.3-4.0) 
79 (33-86) 
123478-HxCDD 0.082 (0.013-0.14)* 
4.1 (0.54-10) 
0.14 (0.13-0.15) ‡
7.1 (5.3-8.8)** 
0.19 (0.16-0.33) 
8.5 (6.7-9.1) 
0.18 (0.15-0.2) ‡‡
4.0 (2.9-4.7) 
0.31 (0.26-0.54) 
7.4 (3.6-11) 
123678-HxCDD 1.4 (0.47-3.8) 
66 (24-270) 
1.5 (0.89-2.0) 
74 (48-91)** 
2.2 (1.4-3.3)***
90 ( 59-100) 
1.9 (1.5-2.0) ‡‡
42 (35-47) ‡‡
5.4 (3.3-5.4) 
110 (46-120) 
123789-HxCDD 0.099 (ND-0.25)* 
5.8 (0.13-18) 
0.15 (0.14-0.18)** ‡
8.2 (5.2-9.2) 
0.21 (0.18-0.58) 
9.4 (7.9-15) 
0.31 (0.16-0.58) 
6.0 (4.3-14) 
0.47 (0.27-1.1) 
9.3 (3.8-23) 
1234678-HpCDD 0.28 (0.11-1.2)* 
14 (4.0-87)* 
0.11 (0.094-0.13) 
5.2 (4.1-7.0)** 
0.14 (0.12-0.2) 
5.7 (5.3-6.0) 
0.12 (0.11-0.14) ‡‡
2.5 (2.2-3.8) ‡‡
0.19 (0.15-0.37) 
3.9 (2.6-7.3) 
OCDD 0.78 (0.25-7.2)* 
38 (10-470)* 
 0.15 (0.086-0.19) 
7.2 (3.8-11) 
0.18 (0.079-0.38) 
6.0 (3.9-15) 
 0.1 (0.056-0.33) 
2.1 (1.3-9.0) 
0.19 (0.099-0.57) 
3.7 (2.5-11) 
Dioxins 4.6 (1.9-12) 
240 (78-810) 
3.6 (2.5-4.3) 
180 (120-200)** 
4.7 (3.8-7.9)***
210 (160-220) 
4.4 (4.1-4.8) ‡‡
93 (79-120) ‡‡
12 (7.2-13) 
240 (100-260) 
2378-TCDF 1.4 (0.59-3.1) 
76 (40-95) 
 1.7 (0.84-2.5) 
82 (55-86) 
1.9 (1.7-3.9) 
81 (80-100) 
 4.5 (1.8-5.2) 
94 (35-120) 
4.2 (2.9-5.8) 
92 (40-110) 
12378-PeCDF 1.0 (0.62-1.9) 
52 (33-110) 
1.3 (0.89-1.6) 
60 (56-64)** 
1.5 (1.4-3.1) 
68 (62-82) 
1.7 (1.4-1.9) ‡‡
37 (27-52) 
3.0 (2.4-4.9) 
75 (33-95) 
23478-PeCDF 7.4 (4.4-9.7)* 
390 (190-850) 
10 (7.3-12) 
480 (400-510)** 
13 (11-25)***
570 (460-650) 
12 (11-14) ‡‡
270 (230-360) ‡‡
36 (24-39) 
740 (340-800) 
123478-HxCDF 0.33 (0.17-2.0) 
20 (6.6-68) 
0.39 (0.32-0.52) 
20 (18-21)** 
0.51 (0.46-0.93)***
22 (19-27) 
0.54 (0.38-0.58) ‡‡
11 (9.3-16) ‡‡
0.98 (0.86-1.7) 
24 (12-33) 
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Table 3 (continued)
Gulf of Finland Gulf of Finland Gulf of Bothnia
Small herring Small herring Large herring Small herring Large herring 
1993-1994 1999 1999 1999 1999 
123678-HxCDF 0.42 (0.075-2.6) 
23 (3.5-88) 
0.6 (0.44-0.79) 
28 (28-32)** 
0.8 (0.73-1.4) 
35 (31-40) 
0.62 (0.52-0.83) ‡‡
13 (12-23) ‡‡
1.4 (1.2-2.4) 
32 (19-46) 
234678-HxCDF 0.75 (0.35-1.3)* 
41 (19-94)* 
0.49 (0.32-0.56) 
22 (19-26)** 
0.59 (0.52-1.1) 
27 (21-31) 
0.48 (0.4-0.65) ‡‡
9.9 (9.3-17) ‡‡
1.1 (0.96-1.8) 
24 (15-36) 
123789-HxCDF ND 0.024 (ND-0.034) 
1.1 (ND-1.5) 
0.041 (0.032-0.075) 
1.8 (1.4-2.0) 
0.032 (0-0.055) ‡‡
0.65 (0-1.1) 
0.078 (0.045-0.11) 
1.8 (0.63-2.2) 
1234678-HpCDF 0.28 (0.11-0.78)* 
16 (5.9-57)* 
 0.1 (0.057-0.16) 
4.7 (2.6-9.0)** 
0.13 (0.074-0.26) 
4.6 (3.2-11) 
 0.089 (0.071-0.12) 
2.2 (1.5-2.4) 
0.14 (0.067-0.28) 
3.0 (0.94-5.4) 
1234789-HpCDF ND  0.006 (ND-0.03) 
0.27 (ND-1.0) 
0.017 (ND-0.019) 
0.74 (ND-0.91) 
 0.14 (ND-0.042) 
0.28 (ND-0.86) 
0.029 (ND-0.064) 
0.64 (ND-1.3) 
OCDF 0.066 (0.015-0.27) 
3.5 (1.3-17) 
 ND ND  ND ND 
Furans 12 (6.6-20) 
620 (340-1300) 
15 (10-18)** 
690 (620-730)** 
18 (16-35)***
820 (690-930) 
20 (19-20) ‡‡
410 (380-560) ‡‡
47 (33-56) 
990 (460-1100) 
Sum of PCDD/Fs 18 (8. 6-26) 
830 (440-1900) 
19 (13-21)** 
880 (740-920)** 
23 (20-43)***
1030 (870-1100) 
24 (23-25) ‡‡
500 (460-670) ‡‡
58 (40-68) 
1200 (560-1300) 
I-TEQ 5.1 (3.0-7.7) 
260 (130-570) 
6.6 (4.7-7.5)** 
320 (260-330)** 
8.1 (7.1-16)***
360 (300-410) 
8.0 (7.7-8.6) ‡‡
170 (160-230) ‡‡
23 (15-25) 
460 (210-500) 
WHOPCDD/F-TEQ 5.7 (3.3-8.9) 
290 (150-650) 
7.2 (5.1-8.2)** 
350 (280-360)** 
8.8 (7.8-17)***
400 (340-450) 
8.7 (8.4-9.2) ‡‡
180 (170-250) ‡‡
24 (16-27) 
500 (230-540) 
To assess time trend, concentrations of five and six year old herring from the Gulf of Finland in 1993-1994 were added in the table on the basis of the similarity of 
their weights and lengths with small herring in 1999. Statistical significances of concentration differences (Mann-Whitney U test, significance level p < 0.05) between 
small herring in 1993-1994 and in 1999 are denoted here as (*); between groups small herring in the Gulf of Finland and in the Gulf of Bothnia as (**), and between 
groups large herring in the Gulf of Finland and in the Gulf of Bothnia as (***). Significances of difference of concentrations (Mann-Whitney U test, p < 0.05) 
between small and large herring in 1999 in the Gulf of Finland are denoted here as (‡); and between small and large herring in the Gulf of Bothnia as (‡‡).
ND = concentration below LOD. 
1 age estimation based on data from ICES 2001. 
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Table 4.  
Medians (range) of concentrations as ng/g fw and as ng/g fat of PCBs and as pg/g fw and as pg/g fat of co-PCBs and toxic 
equivalents of PCBs in different age groups of Baltic herring, caught in 1999 in the Gulf of Finland and in the Gulf of Bothnia.
 Gulf of Finland  Gulf of Finland  Gulf of Bothnia 
 Small herring  Small herring Large herring  Small herring Large herring 
 1993-1994  1999 1999  1999 1999 
PCB 28/31 0.63 (0.048-1.7) 
32 (3.7-83) 
 0.63 (0.41-0.71) 
29 (24-31) 
0.64 (0.56-1.2) 
29 (23-33) 
 0.85 (0.66-1.1) 
17 (14-30) 
1.2 (0.89-1.7) 
20 (18-33) 
PCB 52 1.3 (0.72-2.9) 
73 (37-190)* 
0.9 (0.63-1.1)** 
41 (37-50)** 
1.0 (0.78-2.3) 
44 (38-60) 
1.3 (0.95-1.4) ‡‡
25 (19-40) ‡‡
2.2 (1.7-3.9) 
44 (34-77) 
PCB 101 2.7 (1.7-5.5)* 
150 (110-260) 
4.0 (3.3-5.1) 
220 (140-220) ** 
5.6 (4.4-8.8)*** 
230 (220-240) 
4.3 (3.9-4.5) ‡‡
89 (79-130) ‡‡
11 (8.5-15) 
220 (120-280) 
PCB 138 4.3 (2.9-9.4)* 
240 (140-940) * 
11 (11-15) ‡
650 (380-700) ** 
17 (16-27) 
700 (660-860) 
9.9 (8.4-13) ‡‡
220 (170-350) ‡‡
29 (23-36) 
590 (350-710) 
PCB 153 0.97 (0.69-2.4)* 
54 (32-240) * 
15 (14-21) 
870 (530-930) ** 
22 (21-35) 
920 (850-1100) 
13 (12-17) ‡‡
320 (240-480) ‡‡
46 (33-53) 
960 (480-1100) 
PCB 180 0.7 (0.53-1.0)* 
37 (24-93) * 
5.0 (4.2-5.5) ‡
250 (190-280) ** 
6.6 (6.1-13) 
300 (250-340) 
5.1 (4.3-6.8) 
120 (87-170) 
16 (0.91-17) 
340 (23-370) 
Sum of  
Marker PCBs 
11 (8.3-18)* 
600 (390-1600) * 
37 (33-49) ‡
2100 (1300-2200) ** 
52 (50-87) 
2200 (2060-2600) 
34 (30-43) ‡‡
820 (610-1200) ‡‡
110 (69-130) 
2200 (1200-2500) 
PCB 77 27 (9.3-48) 
1200 (840-2400) 
26 (19-30) 
1300 (820-1600) ** 
30 (22-44) 
1200 (1100-1300) 
33 (20-39) ‡‡
720 (400-930) 
47 (37-63) 
1000 (520-1300) 
PCB 126 20 (13-33) 
1040 (680-2000) 
23 (18-29) 
1200 (820-1300) ** 
30 (25-48)*** 
1200 (1200-1300) 
26 (19-31) ‡‡
570 (370-740) 
54 (37-74) 
1300 (520-1500) 
PCB 169 9.7 (5.9-13) 
480 (270-1000) 
9.7 (8.8-12) ‡
510 (370-580) ** 
15 (13-23)*** 
590 (550-820) 
10 (8.9-12) ‡‡
230 (180-300) ‡‡
34 (22-39) 
680 (310-850) 
PCB 123 NA 0.62 (0.6-0.94) 
37 (21-41) ** 
0.95 (0.85-1.3) 
37 (34-49) 
0.5 (0.4-0.62) ‡‡
11 (8.1-17) ‡‡
1.2 (1.1-2.0) 
27 (15-40) 
PCB 118 2.5 (1.3-4.9)* 
130 (95-310) * 
6.5 (5.7-11) 
380 (210-440) ** 
9.4 (8.7-14) 
370 (360-480) 
5.0 (4.1-6.4) ‡‡
110 (84-180) ‡‡
14 (11-22) 
290 (170-420) 
PCB 114 NA 0.12 (0.1-0.18) 
6.4 (4.2-8.0) ** 
0.17 (0.14-0.26) 
6.9 (5.9-8.3) 
0.096 (0.079-0.12) ‡‡
2.1 (1.6-3.3) ‡‡
0.25 (0.21-0.4) 
5.3 (3.2-7.8) 
PCB 105 1.7 (0.94-3.4) 
88 (58-140) 
2.0 (1.8-3.0) 
120 (64-130) ** 
3.2 (2.4-3.8) 
120 (100-150) 
1.5 (1.4-1.9) ‡‡
35 (27-51) ‡‡
4.3 (3.1-5.8) 
88 (51-110) 
PCB 167 NA 0.24 (0.22-0.3) ‡
13 (8.6-14) **†
0.4 (0.35-0.58) 
16 (15-18) 
0.26 (0.23-0.33) ‡‡
6.3 (4.7-7.9) ‡‡
0.71 (0.46-0.9) 
14 (6.5-18) 
96
Table 4 (continued)
 Gulf of Finland Gulf of Finland Gulf of Bothnia
 Small herring Small herring Large herring Small herring Large herring 
 1993-1994 1999 1999 1999 1999 
PCB 156 0.29 (0.12-0.45)* 
17 (5.5-33) * 
1.0 (0.89-1.3) 
59 (33-59) ** 
1.5 (1.2-2.1) 
57 (52-74) 
0.89 (0.72-1.0) ‡‡
19 (15-28) ‡‡
2.7 (2.0-3.2) 
55 (29-63) 
PCB 157 NA 0.28 (0.19-0.4) 
17 (6.6-17) ** 
0.35 (0.32-0.45)*** 
14 (12-17) 
0.19 (0.13-0.24) ‡‡
3.8 (2.7-6.1) ‡‡
0.51 (0.38-0.73) 
10 (7.2-14) 
PCB 170 NA 2.9 (2.5-3.4) 
150 (110-160) ** 
3.2 (3.0-7.5)*** 
140 (130-200) 
2.9 (2.4-4.1) ‡‡
79 (49-84) ‡‡
7.9 (5.7-10) 
160 (110-200) 
PCB 189 NA 0.12 (0.096-0.15) 
5.7 (5.1-6.4) ** 
0.14 (0.11-0.3) 
6.6 (4.7-8.0) 
0.11 (0.08-0.16) ‡‡
2.4 (1.6-4.3) ‡‡
0.32 (0.26-0.44) 
6.8 (3.7-8.7) 
Sum of  PCBs1 16 (11-27) 
870 (580-2100) 
69 (60-91) ‡
3900 (2400-4000) ** 
94 (92-160) 
4040 (3800-4600) 
71 (54-77) ‡‡
1500 (1100-2100) ‡‡
180 (130-140) 
3700 (2100-4600) 
PCB-TEQ1 2.7 (1.7-4.5) 
150 (94-260) 
4.4 (3.6-5.8) 
240 (150-260) ** 
5.7 (5.4-9.3) 
250 (230-270) 
4.5 (3.9-4.7) ‡‡
93 (78-130) ‡‡
11 (8.0-14) 
220 (110-280) 
WHOPCB-TEQ1 2.7 (1.7-4.5) 
140 (93-260) 
4.0 (3.3-5.4) 
220 (140-240) ** 
5.4 (5.0-8.4) 
230 (220-250) 
4.1 (3.5-4.4) ‡‡
83 (68-120) ‡‡
9.5 (7.1-13) 
210 (99-250) 
To assess time trend, concentrations of five and six year old herring from the Gulf of Finland in 1993-94 are added in the table on the basis of the 
similarity of their weights and lengths with small herring in 1999. Statistical significances of concentration differences (Mann-Whitney U test, 
significance level p < 0.05) between small herring in 1993-1994 and in 1999 are denoted here as (*); between groups small herring in the Gulf of 
Finland and in the Gulf of Bothnia as (**), and between groups large herring in the Gulf of Finland and in the Gulf of Bothnia as (***). Significances 
of difference of results (Mann-Whitney U test, p < 0.05) between small and large herring in 1999 in the Gulf of Finland are denoted here as (‡); and 
between small and large herring in the Gulf of Bothnia as (‡‡).
1 Statistical significance between small herring in 1993-1994 and 1999 in the Gulf of Finland not tested because of the different number of congeners 
measured.
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indicated that these fish probably feed on zooplankton in both sea regions, and exposure to 
PCDD/Fs and PCBs was equal or slightly greater in the Gulf of Finland. In large herring most of 
the fresh weight and fat concentrations of PCDD/Fs and PCBs (Tables 3 and 4) in the Gulf of 
Bothnia were greater than in the Gulf of Finland. This may be due to the different feeding habits 
of large herring in the Gulf of Bothnia. 
The median value of total WHO-TEQ in small herring from the Gulf of Finland was 11 pg/g 
fw, and in large herring it increased to 14 pg/g. In the Gulf of Bothnia, median values in small and 
large herring were 13, and 34 pg/g fw, respectively. PCBs accounted for 37% of the toxic 
equivalents in the Gulf of Finland, but their contribution decreased to 30% in the Gulf of Bothnia. 
In the catchment area Korsnäs, from where two samples of mixed herring were analysed, 
the concentration of WHOPCDD/F-TEQ was 15 pg/g fw with the concentration of WHOPCB-TEQ 
being 5.8 pg/g fw. These values corresponded well with the average of small and large herring in 
the Gulf of Bothnia.
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Comparability of the results with other studies
Concentrations of PCDD/Fs and PCBs in this study were not compared to previously 
published studies because the methodology of sample collection and sample preparation were 
dissimilar. For example, Bignert et al. (1998) have collected most of their material in the autumn 
when the fat percentages in herring are very different from the values obtained in spring. In 
addition they skinned the herring prior to analysis, thus their herring samples were so different 
from ours that the comparison of results would be misleading. In this study we have analysed 
herring in the form they are sold for human consumption. 
Time-trends of PCDD/Fs and PCBs
To obtain time-trends of PCDD/Fs and PCBs in herring, concentrations of age groups 5 
and 6 were extracted from the data in 1993-1994 and are shown separately in the Tables 3 and 4. 
The basis for selection of these age groups was similarity of weights and lengths between these 
groups and small herring in 1999. Time-trend assessment was possible only with small herring in 
the Gulf of Finland. 
PCDD/F concentrations (Table 3) present in the small herring in the Gulf of Finland in 
1993-1994 and 1999 indicated that concentrations have not been decreasing during this time 
period. Since age was not determined by otoliths of herring in 1999, there is a possibility that 
small herring in 1999 were older than those assessed in Table 3. In Fig. 1 it can be observed that 
the size of herring in the Gulf of Finland has declined between 1993 and 1999, and this shrinkage 
as a function of time might obscure the possible downward trend in herring exposure to PCDD/Fs. 
Since no downward trend was evident, the rule of thumb of TEQs, based on 1993-1994 results, 
could be tested with the 1999 results. With the reservation that the age estimation of 1999 herring 
was only indicative, the measured I-TEQ and WHOPCDD/F-TEQ values in the Gulf of Finland, 6.6 
and 7.2 pg/g fw, respectively, corresponded quite well with the values estimated with the rule of 
thumb, 4.9 and 5.6 pg/g. Also the actual I-TEQ and WHOPCDD/F-TEQ values determined, i. e. 8.1 
and 8.8 pg/g fw, respectively for large herring in the Gulf of Finland corresponded quite well with 
estimated values, 8.8 and 9.9 pg/g, respectively. This suggested that the rule of thumb is still 
applicable when assessing TEQ concentrations in the Gulf of Finland. 
Differences in PCB concentrations (Table 4) of the small herring in the Gulf of Finland 
between 1993-1994 and 1999 gave contradictory information about time trends of PCBs. The 
results for the purely co-planar PCBs (PCB 77, 126 and 169) suggested, as with the PCDD/Fs, that 
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there has not been any decreasing trend during this time period. For some of the other PCBs, the 
time-trend of concentrations even seemed to be increasing. These results do not agree with earlier 
results about the PCB time-trends in Baltic Sea fauna reported by other study groups (Odsjö et al., 
1997; Bignert et al., 1998). The fact that PCB analytic methods have advanced from 1993-1994 to 
1999, for example there is now an increased number of standards (allowing at least one internal 
standard per each chlorination degree of PCBs), suggests that some of the results of other PCBs in 
1993-1994 herring might be systematically too low. 
If time-trends of PCDD/Fs and PCBs are evaluated through contributions to total TEQs 
there exist two possible scenarios. Either exposure to PCDD/Fs has increased or exposure to PCBs 
has continued to decrease as stated by Bignert et al. (1998), because the contribution of PCBs to 
total TEQ have dropped from 50% in 1993-1994 to 30-37% in 1999. 
Congener profiles of PCDD/Fs and PCBs
In Fig. 3 median percentage profiles of PCDD/F congeners from the sum of PCDD/Fs and 
from toxic equivalents are shown. The dominating congener in both profiles was 2,3,4,7,8-PeCDF 
followed by 2,3,7,8-TCDF, 1,2,3,7,8-PeCDF, 1,2,3,7,8-PeCDD, 1,2,3,6,7,8-HxCDD and OCDD in 
the sum of PCDD/Fs profile, and 2,3,7,8-TCDD and 1,2,3,7,8-PeCDD in the toxic equivalent 
profiles. Similar profiles of Baltic herring, and herring caught from the North Sea have been reported 
by Rappe et al. (1989). The PCDD/F profiles in Baltic herring were similar to those measured from 
seafood, in particular anchovy and mackerel, in the Adriatic Sea (Bayarri et al., 2001). 
Percentages of PCB congeners from sum of PCBs and from toxic equivalents in herring 
caught in 1999 are shown in Fig. 4. Congener profiles were consistent irrespective of the herring's 
age, sampling area or time. The dominant congeners in the profiles from sum of PCBs were PCB 
153, 138, 118, 180, 101, 110. In profiles of toxic equivalent, the dominant congeners were PCB 
126, 118, and 156. The PCB profile of anchovy, reported by Bayarri et al. (2001), greatly 
resembled the herring profiles found here, although the set of measured PCBs was not fully 
consistent. 
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Fig 3. Median percentages of PCDD/F congeners in Baltic herring in the 
1990's. (A) Percentages from sum of PCDDs (black bars) and PCDFs (white 
bars), and (B) percentages from toxic equivalents (I-TEQ: black bars; 
WHOPCDD/F-TEQ: white bars). 
Congeners: 1D: 2,3,7,8-TCDD; 2D: 1,2,3,7,8-PeCDD; 3D: 1,2,3,4,7,8-
HxCDD; 4D: 1,2,3,6,7,8-HxCDD; 5D: 1,2,3,7,8,9-HxCDD; 6D: 1,2,3,4,6,7,8-
HpCDD; 7D: OCDD; 1F: 2,3,7,8-TCDF; 2F: 1,2,3,7,8-PeCDF; 3F: 2,3,4,7,8-
PeCDF; 4F: 1,2,3,4,7,8-HxCDF; 5F: 1,2,3,6,7,8-HxCDF; 6F: 2,3,4,6,7,8-
HxCDF; 7F: 1,2,3,7,8,9-HxCDF; 8F: 1,2,3,4,6,7,8-HpCDF; 9F: 1,2,3,4,7,8,9-
HpCDF; 10F: OCDF.
The source of exposure of herring to PCDD/Fs and PCBs, air-zooplankton versus 
sediments-zooplankton or sediments-crustacean, remained obscure. PCDD/F congeners in 
zooplankton, and in sediments in open sea areas and in areas without additional sources both 
originate from air deposits (Rappe et al., 1989; Kjeller and Rappe, 1995), and because of that it is 
impossible to assess the origin of PCDD/Fs in zooplankton. In the eastern Gulf of Finland, there 
are many major point sources of PCDD/Fs, especially 1,2,3,4,6,7,8-HpCDF and OCDF (Verta et 
al., 1999). Herring caught in this particular area did not have higher concentrations of PCDD/Fs, 
and the profiles of those herring did not express increased percentages of 1,2,3,4,6,7,8-HpCDF or 
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OCDF. However this result does not exclude exposure via sediment, since those two major 
congeners in this point source do not bioaccumulate in herring. 
Fig. 4. Median percentages of PCB congeners in Baltic herring in 1999. (A) Percentages from 
sum of PCBs, and (B) percentages from toxic equivalents (PCB-TEQ: black bars; WHOPCB-TEQ: 
white bars). Congeners in A, left to right: PCB 77, 126, 169, 18, 28/31, 33, 47, 49, 51, 52, 60, 66, 
74, 99, 101, 105, 110, 114, 118, 122, 123, 128, 138, 141, 153, 156, 157, 167, 170, 180, 183, 187, 
189, 194, 206, and 209. 
5. CONCLUSIONS AND HUMAN EXPOSURE
Concentrations in herring measured in 1993-1994 in the Gulf of Finland showed a clear 
age dependency of PCDD/Fs. A rule of thumb was that there was one unit increase of TEQ 
concentration for every year of a herring's life. This was found to be valid also with herring 
sampled in 1999. For PCBs no such a rule could be produced because of the missing data in 1993-
1994 of congeners contributing to toxic equivalents. The higher fat percentage in herring and 
hence higher concentrations on a fresh weight basis in the Gulf of Bothnia limits the use of the 
rule of thumb to the herring caught from the Gulf of Finland. In small herring, the differences in 
fat percentage were the main reason for the differences in concentrations on a fresh weight basis. 
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With large herring it was concluded that the exposure source of PCDD/Fs and PCBs in the Gulf of 
Bothnia differs from exposure in the Gulf of Finland. Based on two time points, 1993-1994 and 
1999, the concentrations of PCDD/Fs and PCBs in herring in the Gulf of Finland did not reveal 
any clear decline. 
On average the consumption of herring in the Finnish population varies between 800 to 
1100 g per year as filleted weight (Finnish Game and Fisheries Research Institute, 2000; Kiviranta 
et al., 2001), but the assessment of the exposure of Finns to PCDD/Fs and PCBs via herring is 
quite difficult. There is no reliable information about the size or age distribution of consumed 
herring, and data on concentrations of harmful substances in herring in seasons other than spring 
are missing. Also proper age or size correlation data on PCDD/Fs and PCBs from the Gulf of 
Bothnia is currently missing. The age of herring for human consumption usually is 3-6 years or 
older. Hence, according to the rule of thumb created in this study, concentrations in a major 
fraction of the herring used by Finns as food, will exceed the limit value of 4 pg WHOPCDD/F-
TEQ/g set by EU. 
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1. ABSTRACT
We measured adipose tissue concentrations of polychlorinated dibenzo-p-dioxins, 
dibenzofurans (PCDD/Fs), and polychlorinated biphenyls (PCBs) in 420 general Finns living in 
southern Finland. The mean (median) concentrations of WHOPCDD/F-TEQ and WHOPCB-TEQ were 
29.0 (24.1) and 20.7 (16.7) pg g-1 fat, respectively. The concentrations clearly correlated with age. 
Expressing the concentrations as a function of subject’s ages revealed that the exposure of Finns 
has declined over the last 30 years. A downward gradient was found in the concentrations from 
the Baltic Sea coast to inland areas in Finland, and this was assessed to be due to consumption of 
the Baltic Sea fish, especially Baltic herring. Linear regression models for natural logarithm 
WHOPCDD/F-TEq, natural logarithm WHOPCB-TEq, and natural logarithm WHOtotal-TEq, explained 
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70%, 69%, and 72% of the variability, respectively. Age, lactation, place of residence, and fish 
consumption frequencies were significant predictors in the models. 
2. INTRODUCTION
The objective of this study was to determine the occurrence of polychlorinated dibenzo-p-
dioxins and dibenzofurans (PCDD/Fs), and polychlorinated biphenyls (PCBs) in the general adult 
Finnish population. The source of PCDD/Fs and PCBs is food, especially food of animal origin. In 
Finland, most of human exposure can be traced to consumption of fish, especially fatty Baltic Sea 
fish (Kiviranta et al., 2001). Therefore in this study we paid special attention to the fish 
consumption habits of our subjects. 
A decreasing gradient of PCDD/F and PCB concentrations from the Baltic Sea coast to 
inland areas has been described in mothers’ milk samples, which were collected during the late 
1980s (Vartiainen et al., 1997). The purpose of this study was to investigate if a similar decreasing 
concentration gradient could be seen in the average population body burdens. An exposure model 
would be a valuable tool in epidemiological studies to assess the exposure to PCDD/Fs and PCBs. 
The development of such a model would mean that the exposure of the population, even at the 
individual level, could be assessed, without actually measuring concentrations with expensive and 
time-consuming methods. We assessed linear regression models for toxic equivalents of PCDD/Fs 
(WHOPCDD/F-TEQ), PCBs (WHOPCB-TEQ), and the sum of these two parameters (WHOtotal-TEQ).
The models were also validated with concentration results of a reference population comparable to 
the original study population. 
3. MATERIALS AND METHODS
Subjects
PCDD/Fs and PCBs were determined from appendicitis patients who were chosen as 
controls in our case-control study of soft tissue sarcoma in 1997-1999 (Tuomisto et al., 2004). The 
concentrations were measured from a total of 420 subjects. The place of residence of all but three 
subjects, was southern Finland. They were operated in university, central, district or municipality 
hospitals in Espoo, Helsinki, Hyvinkää, Joensuu, Jyväskylä, Kotka, Kuopio, Lahti, Lappeenranta, 
Pori, Seinäjoki, Tampere, Turku, and Vaasa. The concentration data obtained from these subjects 
were used to depict concentrations in men and women of different ages and age groups, in 
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different classified subgroups of subjects, and to assess the average concentrations of PCDD/Fs 
and PCBs in the Finnish population. Concentration data served also as source for composing 
models to assess the exposure of Finns to the analytes of interest. The subjects were asked to 
complete a questionnaire about their intake of foods and about relevant demographic features and 
their lifestyle. 
The study subjects were classified by two different criteria: the age of the subjects (? 46 
years and > 46 years) and the place of residence (coastal area [Kotka, Pori, Seinäjoki, Turku, 
Vaasa], capital area [Espoo, Helsinki, Hyvinkää], and inland area [Joensuu, Jyväskylä, Kuopio, 
Lahti, Lappeenranta, Tampere]). Table 1 depicts the age, the body mass index (BMI), the number 
of children and duration of lactation in women, and the fish consumption statistics for all subjects 
as well as in the classified subgroups. Detailed questions about subjects’ fish consumption habits 
including favoured fish species were asked. 
The exposure models obtained from the concentration data of appendicitis patients were 
validated with the data obtained from the soft tissue sarcoma case patients (n = 148) (Tuomisto et 
al., 2004). The dioxin concentrations in cases and controls did not differ from each other as was 
described in the previous sarcoma study. 
Informed consent was obtained from all patients in writing before the operation. The study 
was approved by the Ethics Committees of the National Public Health Institute and the hospitals 
involved. 
Exposure assessment 
The concentrations of the 17 toxic PCDD/F congeners (Table 2) and of the 36 PCB 
congeners (Table 3) were measured from fat of a subcutaneous tissue sample (0.3-1.5 g of fat) 
which was obtained during an appendectomy or sarcoma operation. The toxic equivalents 
(WHOPCDD/F-TEQ and WHOPCB-TEQ) were calculated with the sets of toxic equivalency factors 
(TEF), recommended by WHO in 1998 (Van den Berg et al., 1998). 
Fat from tissue sample was extracted with toluene for 18-24 hours using the Soxhlet 
apparatus. The fat content was determined gravimetrically after changing the solvent to hexane 
using nonane as a keeper. Fat sample was spiked with a set of 13C-labeled internal standards: 
sixteen 2,3,7,8-chlorinated PCDD/F congeners, three non-ortho PCBs (PCB 77, 126, 169), and 
nine other PCBs (PCB 30 [12C-labeled], 80, 101, 105, 138, 153, 156, 180, 194). 
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The sample was defatted in a silica gel column containing acidic and neutral layers of 
silica, and all analytes were eluted with dichloromethane (DCM):cyclohexane (c-hexane) (1:1). 
PCDD/Fs were separated from PCBs on activated carbon column (Carbopack C, 60/80 mesh) 
containing Celite (Merck 2693). The first fraction including PCBs was eluted with DCM:c-hexane 
(1:1) following a back elution of the second fraction (PCDD/Fs) with toluene. Eluents from both 
of the fractions were evaporated using nonane as a keeper and then fractions in n-hexane were 
further cleaned by passing them through an activated alumina column (Merck 1097). The PCDD/F 
fraction was eluted from the alumina column with 20% DCM in n-hexane and recovery standards 
(13C 1,2,3,4-TCDD and 13C 1,2,3,7,8,9-HxCDD) were added to the fraction before DCM and n-
hexane were replaced by 10-15 μl of nonane. The PCB fraction was eluted from the alumina 
column with 2% DCM in n-hexane, and the fraction, after changing the eluent to n-hexane, was 
transferred to another activated carbon column (without Celite) in order to separate the non-ortho
PCBs from other PCBs. DCM (50%) in n-hexane was used to elute other PCBs while non-ortho
PCBs were back eluted with toluene. Recovery standards, PCB 159 for other PCBs and 13C PCB 
60 for non-ortho PCBs were added prior to analysis; the solvent for other PCBs (DCM:n-hexane,
1:1) was replaced by 300 μl of n-hexane, for non-ortho PCBs toluene was replaced by 10-15 μl of 
nonane. The quantitation was performed by selective ion recording mode using a VG 70-250 SE 
(VG Analytical, UK) mass spectrometer (resolution 10,000) equipped with a HP 6890 gas 
chromatograph with a fused silica capillary column (DB-DIOXIN, 60 m, 0.25 mm, 0.15 μm). Two 
μl were injected into a split-splitless injector at 270°C. The temperature programs for PCDD/Fs, 
non-ortho-PCBs, and other PCBs were: 
start, 140°C (4 min), rate 20°C min-1 to 180°C (0 min), rate 2°C min-1 to 270°C (36 min); 
start, 140°C (4 min), rate 20°C min-1 to 200°C (0 min), rate 10°C min-1 to 270°C (12 min); 
start, 60°C (3 min), rate 20°C min-1 to 200°C (0 min), rate 4°C min-1 to 270°C (14 min);  
respectively. 
Limits of quantitation (LOQ) for PCDD/Fs and non-ortho PCBs varied between 0.1-5 and 
1-5 pg g-1 fat, respectively, and for other PCBs between 0.02-0.1 ng g-1 fat, depending on each 
individual congener. Recoveries for internal standards were more than 50% for all congeners. 
Concentrations were calculated with lower bound method in which the results of congeners with 
concentrations below the LOQ were designated as nil.
Table 1. Descriptive statistics of the study subjects.
_______________________________________________________________________________________________________________________________________________ 
       Age subgroups   _________   Area   _______ 
   All subjects n = 420 ? 46 years n = 225 > 46 years n = 195 Coastal n = 147  Capital n = 104  Inland n = 166 
_______________________________________________________________________________________________________________________________________________ 
Age (years)  44,44,15,(13-81)  32,32,8.3,(13-46)  58,55,8.0,(46-81) 42,38,16,(13-73)** 42,42,15,(16-78) 47,49,15,(17-81) 
BMI (kg m-2)  26,25,3.8,(18-39)  25,24,3.7,(18-39)* 27,26,3.5,(20-39) 25,25,3.6,(18-39)  25,25,3.4,(19-39) 26,26,4.0,(19-39) 
Female (%)  51   50   53   47   51   57 
No. of children of women 1.8, 2.0, (0-7)  1.2, 1.0, (0-4)*  2.2, 2.0, (0-7)  1.4, 1.5, (0-4)**  1.7, 2.0, (0-5)  2.1, 2.0, (0-7) 
Total lactation, months 8.2, 5.0, 11, (0-72) 7.2, 0, 13, (0-72)  8.9, 6.0, 10, (0-72) 7.8, 4.0, 12, (0-72) 7.9, 5.0, 11, (0-45) 8.6, 5.0, 12, (0-72) 
Questinnaire returned (%) 77   74   81   84   74   72 
Fish consumption, times per month 
All fish   4.9,4.0, (0.5-24) 4.6,4.0, (0.5-24) 5.3,4.0, (0.5-24) 5.0,4.0, (0.5-24) 5.2,4.0, (0.5-24) 4.7,4.0, (0.5-16)
Baltic herring  1.2,0.5, (0.5-16) 0.9,0.5, (0-16)* 1.5,0.5, (0-16) 1.5,0.5, (0-16) 1.0,0.5, (0-4) 1.1,0.5, (0-8)
Farmed trout or salmon 2.0,2.0, (0.5-16) 1.7,2.0, (0-16)* 2.3,2.0, (0-16) 2.0,2.0, (0-16) 2.2,2.0, (0-16) 1.8,2.0, (0-8)
Other fisha  2.2,1.5, (0.5-15) 2.4,1.5, (0.5-15) 2.1,0.5, (0.5-15) 2.1,1.5, (0.5-12) 2.4,1.5, (0.5-15) 2.3,1.5, (0.5-15)
Mean, median, SD and (range) of age, body mass index (BMI), and total lactation. Mean, median, and (range) of number of chidren of women. The consumption frequency, 
mean, median and (range), of different types of fish per month. 
*Significantly different compared with the > 46 years group (p < 0.05 by independent samples T-test) 
** Significant difference between groups (p < 0.05 by one-way ANOVA) 
a Consists of pike, perch, burbot, pike perch, vendace, whitefish, bream, roach, frozen fish, canned fish and shrimps 
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Table 2.
Mean, median, SD, and (range) of PCDD/F concentrations and WHOPCDD/F-TEQs as pg g-1 fat in 
adipose tissue samples (n = 420) from general population in Finland.
_________________________________________________________________________________________________ 
Congener  Mean, median, SD, (range)  % of sum of congeners % of WHOPCDD/F-TEQ 
_________________________________________________________________________________________________ 
2,3,7,8-TCDD  2.55, 2.02, 1.84, (0.157–16.4)  0.650   9.03 
1,2,3,7,8-PeCDD  7.61, 6.21, 5.42, (0.986–43.2)  1.89   26.2 
1,2,3,4,7,8-HxCDD 2.73, 2.42, 1.58, (nq–12.1)  0.684   1.04 
1,2,3,6,7,8-HxCDD 44.3, 40.2, 23.7, (5.10–148)  11.3   16.9 
1,2,3,7,8,9-HxCDD 4.17, 3.72, 2.35, (nq–13.8)  1.04   1.66 
1,2,3,4,6,7,8-HpCDD 40.8, 33.1, 29.3, (nq–222)   9.57   1.67 
OCDD   263, 227, 169, (37.7–1730)  62.8   0.113 
2,3,7,8-TCDF  1.07, 0.747, 1.24, (nq–18.3)  0.274   0.379 
1,2,3,7,8-PeCDF  0.551, 0.380, 0.625, (nq–5.91)  0.138   0.094 
2,3,4,7,8-PeCDF  24.2, 18.2, 20.2, (2.30–165)  5.98   38.7 
1,2,3,4,7,8-HxCDF 4.34, 3.71, 2.66, (0.774–19.7)  1.11   1.67 
1,2,3,6,7,8-HxCDF 4.00, 3.35, 2.61, (0.663–22.8)  1.01   1.47 
2,3,4,6,7,8-HxCDF 1.53, 1.22, 1.11, (nq–6.93)  0.380   0.580 
1,2,3,7,8,9-HxCDF 0.052, nq, 0.110, (nq–0.658)  0.014   0.022 
1,2,3,4,6,7,8-HpCDF 10.6, 7.97, 10.7, (nq–148)   2.79   0.486 
1,2,3,4,7,8,9-HpCDF 0.057, nq, 0.180, (nq–1.88)  0.014   0.002 
OCDF   1.26, nq, 6.76, (nq–81.9)   0.373   0.0008 
Sum of PCDD/Fs  413, 364, 230, (78.0–2080) 
WHOPCDD/F-TEQ  29.0, 24.1, 19.7, (3.64–153) 
_________________________________________________________________________________________ 
Percentages of congeners of the sum of PCDD/Fs and of WHOPCDD/F-TEQ are also shown. 
Abbreviations: HpCDD, heptachlorodibenzo-p-dioxin; HpCDF, heptachlorodibenzofuran; HxCDD, 
hexachlorodibenzo-p-dioxin; HxCDF, hexachlorodibenzofuran; nq, below limit of quantitation; OCDD, 
octachlorodibenzo-p-dioxin; OCDF, octachlorodibenzofuran; PeCDD, pentachlorodibenzo-p-dioxin; PeCDF, 
pentachlorodibenzofuran; TCDD, tetrachlorodibenzo-p-dioxin; TCDF, tetrachlorodibenzofuran; WHOPCDD/F-TEQ, 
WHO toxic equivalency factors for PCDD/Fs. 
Quality control and assurance 
Fat samples were analyzed during and after the collection period 1997-1999. All analytical 
work was performed blind such that the chemistry laboratory knew only the code of the sample. 
The laboratory reagent and equipment blank samples were treated and analyzed with the same 
method as the actual samples, one blank for every eight to ten samples. Quality assurance of 
analysis was performed in two separate ways: a) two preformulated pools of human fat with 
different concentrations of PCDD/Fs [10.6 (n = 35) and 40.2 (n = 33) pg g-1 (WHOPCDD/F-TEQ in 
fat)] and PCBs [4.72 and 24.2 pg g-1 (WHOPCB-TEQ), respectively] were always run with each lot 
of samples and b) 36 individual fat samples with WHOPCDD/F-TEQs ranging from 6.9 to 116 pg g-1
and WHOPCB-TEQs from 4.6 to 95 pg g-1 were analyzed in duplicate. The coefficients of variation 
(CV) for WHOPCDD/F-TEQ in preformulated pools were 5.1% and 5.7%, respectively and for 
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WHOPCB-TEQ 12% and 9.0%, respectively. In duplicate analysis the CV was 6.2% for 
WHOPCDD/F-TEQ and 18% for WHOPCB-TEQ. 
The laboratory has successfully participated in several international quality control studies 
for the analysis of PCDD/Fs, and PCBs. Matrices in these studies have included cow milk, human 
milk and human serum. (Yrjänheikki, 1991; Rymen, 1994; WHO, 1996; Lindström et al., 2000). 
The laboratory of chemistry in the National Public Health Institute is an accredited testing 
laboratory (No T077) in Finland (EN ISO/IEC 17025). The scope of accreditation includes 
PCDD/Fs, non-ortho PCBs, and other PCBs from human tissue samples. 
Statistical Analysis 
Statistical analyses were carried out by means of SPSS software (for Windows, release 
10.1.3). Before the statistical tests, all concentrations were transformed to a natural logarithm (ln) 
scale in order to ensure the normal distribution of concentrations. For comparisons of two groups 
either the Mann-Whitney U nonparametric test or the independent samples T-test was used to test 
the statistical significances of the differences of concentrations/variables between two groups. One 
way analysis of variance (ANOVA) or Kruskal-Wallis H test were used to compare the 
differences of concentrations/variables between multiple groups and age as covariate was added to 
analysis of variance because there was a suspected dependence of concentrations and age. The 
differences with p < 0.05 were considered to be statistically significant. 
Linear regression models for dependent variables: ln WHOPCDD/F-TEQ, ln WHOPCB-TEQ, 
and their sum; ln WHOtotal-TEQ, were established. Continuous predictor variables in the models 
were: age (year), BMI (kg m-2), lactation (months), and fish consumption frequencies (times per 
month). Binary variables in the models were: living in the capital area (no/yes) and living in the 
inland area (no/yes). 
4. RESULTS
Demographics and fish consumption 
The average age of all study subjects was 44 years; in the groups classified by age the 
average ages were 32 (32 median) and 58 (55 median) years, respectively. The average age of the 
inland area group was higher than in the other groups (Table 1). There was no age difference 
between men and women. 
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The average BMI of all study subjects was 26 (25 median) kg m-2 with the BMI being 
significantly higher in the older population. There was no geographical difference in the BMI. 
With respect to all study subjects, men had significantly higher BMI than women, this being 
attributable to the higher BMI in younger men than women. Also in two places of residence, 
coastal and capital area, men had higher BMI than women. 
The number of children borne by women was on average 1.8 (2.0 median), and the number 
of children was significantly higher in the older population than the younger. There was a 
significant difference in number of children born in the different places of residence with most 
being born in the inland area. Lactation lasted on average for 8.2 months (5.0 median) and there 
were no significant differences in lactation between age subgroups or places of residence. 
About two thirds (66%) of our subjects consumed fish once a week or more. The fish 
consumption was on average four to five times per month and the difference between the 
subgroups of different ages and places of residence was not significant. Baltic herring and farmed 
trout or salmon were consumed significantly more often in the age subgroup > 46 years than in 
subgroup ? 46 years, and there was a trend that the fish group which consisted of other fish, was 
consumed more by the younger population. Thus younger subjects consumed significantly more 
frozen fish products and shrimps, which were included in the other fish group. Baltic herring was 
consumed more in the coastal area than in the other areas, but this trend was not statistically 
significant (Table 1). Only in the capital area was the monthly consumption of farmed trout or 
salmon significantly higher in women than in men. Otherwise there was no difference in fish 
consumption between genders. 
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Table 3.
Mean, median, SD, and (range) of PCB concentrations and WHOPCB-TEQs in adipose tissue 
samples (n = 420) from general population in Finland. 
_______________________________________________________________________________________________ 
Congener  Mean, median, SD, (range)  % of sum of congeners % of WHOPCB-TEQ 
_______________________________________________________________________________________________ 
Non-ortho-PCBs a
PCB 77   16.5, 10.9, 30.6, (nq–505)   0.0040   0.009 
PCB 126  75.2, 52.7, 75.0, (nq–817)   0.015   35.1 
PCB 169  67.4, 54.5, 51.7, (nq–399)   0.013   3.33 
Other PCBs b
PCB 18   0.441, 0.278, 0.546, (nq–4.35)  0.133 
PCB 28/31  4.61, 2.75, 6.92, (nq–99.5)  1.08 
PCB 33   0.267, 0.134, 0.444, (nq–5.02)  0.076 
PCB 47   0.455, 0.386, 0.348, (nq–0.412)  0.123 
PCB 49   0.172, 0.125, 0.199, (nq–2.72)  0.050 
PCB 51   0.021, 0.014, 0.033, (nq–0.429)  0.0067 
PCB 52   0.784, 0.606, 0.779, (0.053–8.54)  0.209 
PCB 60   0.674, 0.445, 1.23, (0.022–21.8)  0.137 
PCB 66   1.89, 1.25, 3.76, (0.240–70.8)  0.393 
PCB 74   8.63, 6.87, 7.77, (1.55–115)  1.77 
PCB 99   10.4, 7.71, 13.4, (0.283–216)  2.02 
PCB 101  1.40, 1.06, 2.02, (nq–36.2)  0.316 
PCB 105  4.21, 3.31, 3.54, (0.525–28.7)  0.814   2.04 
PCB 110  0.534, 0.344, 0.875, (nq–12.6)  0.130 
PCB 114  1.00, 0.800, 0.754, (0.114–4.88)  0.195   2.46 
PCB 118  19.9, 15.2, 16.9, (2.14–134)  3.84   9.57 
PCB 122  0.001, nq, 0.006, (nq-0.086)  0.0004 
PCB 123  0.835, 0.518, 1.75, (0.027–33.1)  0.150   0.355 
PCB 128  1.20, 0.986, 0.949, (0.082–7.98)  0.254 
PCB 138  74.7, 62.7, 52.9, (9.08–461)  14.9 
PCB 141  0.273, 0.172, 0.394, (nq–5.44)  0.068 
PCB 153  135, 116, 94.9, (16.8–958)  26.8 
PCB 156  16.2, 13.7, 11.9, (0.293–82.3)  3.14   40.2 
PCB 157  2.27, 1.93, 1.63, (0.204–10.9)  0.441   5.64 
PCB 167  2.29, 1.80, 1.85, (0.213–11.6)  0.437   0.109 
PCB 170  53.9, 48.3, 35.2, (5.80–313)  10.8 
PCB 180  106, 94.9, 74.8, (11.3–833)  20.9 
PCB 183  10.8, 8.64, 7.57, (1.38–64.9)  2.22 
PCB 187  23.0, 19.9, 16.2, (2.17–142)  4.56 
PCB 189  2.17, 1.91, 1.43, (0.187–9.60)  0.431   1.13 
PCB 194  15.3, 13.8, 10.4, (1.23–81.9)  3.01 
PCB 206  2.03, 1.77, 1.45, (0.175–9.04)  0.401 
PCB 209  0.716, 0.468, 0.711, (0.029–6.35)  0.146 
Sum of marker PCBsb 343, 294, 235, (43.4–2,360) 
Sum of PCBsb  502, 437, 338, (63.2–3,240) 
WHOPCB-TEQa  20.7, 16.7, 15.7, (2.46–129) 
_________________________________________________________________________________________ 
Percentages of congeners of the sum of congeners and of WHOPCB-TEQ are also shown. 
Abbreviations: nq, below limit of quantitation; PCB, polychlorinated biphenyl; WHOPCB-TEQ, WHO toxic 
equivalency factors for PCBs. 
a = concentrations are given in pg g-1 fat.  
b = concentrations are given in ng g-1 fat. 
Fig. 1. Percentages of PCDD/F congeners in tissue samples of average Finnish. A: percentages from sum of PCDD/Fs, 
and B: percentages from WHOPCDD/F-TEQ. Congeners: (1D) 2,3,7,8-TCDD; (2D) 1,2,3,7,8-PeCDD; (3D) 1,2,3,4,7,8-
HxCDD; (4D) 1,2,3,6,7,8-HxCDD; (5D) 1,2,3,7,8,9-HxCDD; (6D) 1,2,3,4,6,7,8-HpCDD; (7D) OCDD; (1F) 2,3,7,8-
TCDF; (2F) 1,2,3,7,8-PeCDF; (3F) 2,3,4,7,8-PeCDF; (4F) 1,2,3,4,7,8-HxCDF; (5F) 1,2,3,6,7,8-HxCDF; (6F) 
2,3,4,6,7,8-HxCDF; (7F) 1,2,3,7,8,9-HxCDF; (8F) 1,2,3,4,6,7,8-HpCDF; (9F) 1,2,3,4,7,8,9-HpCDF and (10F) OCDF. 
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Fig. 2. Percentages of PCB congeners in tissue samples of the general Finnish population. (A) percentages from sum of 
PCBs, and (B) percentages from WHOPCB-TEQ.
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Concentrations of PCDD/Fs and PCBs 
The mean and median concentrations, standard deviations, and ranges of PCDD/Fs and 
PCBs along with sums of congeners and TEQs in all subjects are summarized in Tables 2 and 3. 
The mean and median WHOPCDD/F-TEQ concentrations were 29.0 and 24.1 pg g-1 fat, respectively, 
and the congeners contributing most to the WHOPCDD/F-TEQ were in ranked order; 2,3,4,7,8-
PeCDF, 1,2,3,7,8-PeCDD, 1,2,3,6,7,8-HxCDD, and 2,3,7,8-TCDD (sum contribution 91%). On 
the other hand, the congeners contributing the most to the sum of congener’s mean and median 
concentrations (413 and 364 pg g-1 fat) were OCDD, 1,2,3,4,6,7,8-HpCDD, 1,2,3,6,7,8-HxCDD, 
and 2,3,4,7,8-PeCDF (Fig. 1). The mean and median WHOPCB-TEQ concentrations were 20.7 and 
16.7 pg g-1 fat, respectively, and the mean and median PCB sum concentrations 502 and 437 ng g-1
fat, respectively. In Fig. 2 the contributions of PCB congeners to sum of PCBs and to the 
WHOPCB-TEQ are depicted. Congeners PCB 153, 180, 138, and 170 were the most abundant 
congeners of the sum of PCBs, while PCB 156, 126, 118, and 157 dominated the congener 
profiles of WHOPCB-TEQ (91%). 
The age dependence of TEQ concentrations is illustrated in Figs. 3 and 4. The correlation 
of age and WHOPCDD/F-TEQ was r = 0.71, for age and WHOPCB-TEQ r = 0.67. The increase of 
WHOPCDD/F-TEQ concentration by age was best explained by the exponential function: y = 5.4071 
e0.0338 x. With respect to WHOPCB-TEQ, the function was y = 3.3201 e0.0363 x. The concentrations of 
men and women did not differ from each other in all subjects (p < 0.49 for WHOPCDD/F-TEQ, and 
p < 0.07 for WHOPCB-TEQ). In the age groups between 36 and 65 years, there was a pattern that 
the concentrations were lower in women than men, but only in the age group 36-40 years was this 
difference statistically significant. 
Concentrations, standard deviations, and ranges of the most abundant PCDD/Fs and PCBs 
along with sums of congeners and TEqs in the different subgroups are summarized in Tables 4 and 
5. The WHOPCDD/F-TEQ in the age group < 46 years was 17.2 pg g-1 fat (15.7 median) which was 
significantly lower than the corresponding concentration in the older population, 42.7 pg g-1 fat 
(39.5 median). The concentrations of all selected congeners were significantly lower in younger 
people. The covariate analysis of variance indicated that the age difference between the places of 
residence (Table 1) did affect the concentrations to the extent that the comparison between areas 
was not feasible. This was also the case with selected PCB congeners. Also the PCB 
concentrations were significantly lower in the younger population than in the older, e.g. the 
average WHOPCB-TEQ was 11.8 pg g-1 fat (10.3 median) in the younger population and 30.9 pg 
(26.6 median) in the older population. 
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In order to compare the concentrations between places of residence, we adjusted for age 
for every congener’s concentration to the entire study population. In this way, age adjusted mean 
and median concentrations of the most abundant PCDD/Fs and PCBs along with sums of 
congeners and TEQs in different areas are summarized in Table 6. In the age adjusted 
concentrations of PCDD/Fs, congeners 2,3,4,7,8-PeCDF, 2,3,7,8-TCDD, and 1,2,3,7,8-PeCDD 
showed the highest decreasing gradient of concentrations from the coastal area to inland area, 
while for the congeners 1,2,3,4,6,7,8-HpCDD and OCDD there was hardly any appreciable 
decreasing gradient in their concentrations. All selected PCB age adjusted concentrations showed 
a decreasing gradient, being highest in the coastal area and lowest in inland area.
Regression models of PCDD/Fs and PCBs 
The summary of the regression analyses conducted to determine predictors of the variance 
of natural logarithms of WHOPCDD/F-TEQ, WHOPCB-TEQ, and WHOtotal-TEQ is shown in Table 7. 
The models explained 70%, 69%, and 72% of the variance of the dependents, respectively. Age, 
lactation, living in the inland area, and Baltic herring and farmed trout/salmon consumption 
frequency predictors were significant regression predictors in all models. Age was the most 
important predictor with a contribution of at least 64% in all models. In each of these three 
models, the normal distribution of residuals was verified with normal probability plots. Variance 
inflation factors (VIF) showed no multicollinearity between predictors in any of the models. 
To validate the obtained regression models, we used the WHOPCDD/F-TEQ, WHOPCB-TEQ, 
and WHOtotal-TEQ data from soft tissue sarcoma case patients. Useful data was obtained from 102 
cases out of 148. In Fig. 5 the measured concentrations are shown with a ln scale as a function of 
the modelled concentrations. The correlations coefficients between modelled and measured 
concentrations for ln WHOPCDD/F-TEQ, ln WHOPCB-TEQ, and ln WHOtotal-TEQ were 0.81, 0.74, 
and 0.80, respectively. 
Fig. 3. WHOPCDD/F-TEQ concentrations in Finnish tissue samples as a function of the age of the subject (n = 420). In the 
inset median concentrations in age groups: (1) 16-20; (2) 21-25; (3) 26-30; (4) 31-35; (5) 36-40; (6) 41-45; (7) 46-50; (8) 
51-55; (9) 56-60; (10) 61-65; (11) 66-70 and (12) 71-80 years. 
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Fig. 4. WHOPCB-TEQ concentrations in Finnish tissue samples as a function of the age of subject (n = 420). In the inset: 
median concentrations in age groups: (1) 16-20; (2) 21-25; (3) 26-30; (4) 31-35; (5) 36-40; (6) 41-45; (7) 46-50; (8) 51-55; 
(9) 56-60; (10) 61-65; (11) 66-70; (12) 71-80 years. 
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5. DISCUSSION
Demographics and fish consumption 
With respect to their BMI values and fish consumption habits, the subjects in this study 
represented the general Finnish population. The mean and median BMI were similar to BMIs 
measured in the recent Finnish adult health study (Helakorpi et al., 2003) in which the proportion of 
subjects with BMI exceeding 25 kg m-2 was 50%. Also the higher BMI in young men versus women 
was reported in that study (Helakorpi et al., 2003). The proportions of subjects who had consumed fish 
at least once in the previous week was similar in both studies, 66% in this study and 72% in the 
Finnish adult health study. Although there were no statistical significances between the differences in 
fish species consumed in places of residence, it is likely that there was greater consumption of Baltic 
herring in the coastal area due to the proximity of this fish source. 
Concentrations of PCDD/Fs and PCBs  
Adipose tissue PCDD/F and PCB concentrations measured in this study showed that average 
exposure in Finland to these contaminants was similar to those recently reported in Belgium, France, 
Germany, Spain, Sweden, and US (Päpke, 1998; Wicklund Glynn et al., 2000; Wingfors et al., 2000; 
Arfi et al., 2001; Covaci et al., 2002; Koppen et al., 2002; Costabeber and Emanuelli, 2003; Schecter 
et al. 2003; Wicklund Glynn et al., 2003;) (Table 8). In India (Kumar et al., 2001) and Japan (Choi et 
al., 2002) the reported concentrations were slightly lower than those detected in Finland. However in 
the general Inuit populations in Greenland and Uelen/Russia, due to their consumption of meat and 
blubber of marine mammals, the PCB body burdens were about ten times higher than in the general 
population in Finland (Dewailly et al., 1999; Sandanger et al., 2003). The exposure of professional 
fishermen in Finland, especially Baltic Sea fishermen, to PCDD/Fs and PCBs was about four times as 
high as the general population (Kiviranta et al., 2002). PCB concentrations measured in fishermen in 
Latvia and Sweden were also higher than in the general population in Finland (Sjödin et al., 2000), but 
somewhat lower than in Finnish Baltic Sea fishermen. 
Similar PCDD/F congener profiles as in this study have been reported in other studies in the 
1990s (Päpke, 1998; Arfi et al., 2001; Kumar et al., 2001; Choi et al., 2002). In US and Canada the 
OCDD/F profile differs from the one in Finland. In WHOPCDD/F-TEQ profile the contributions of 
2,3,7,8-TCDD, 1,2,3,7,8-PeCDD, and 1,2,3,6,7,8-HxCDD to profile exceed the contribution of 
2,3,4,7,8-PeCDF, which is the main contributor in Finnish profile (Schecter et al., 1994; Schecter et 
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al., 2003). Although the comparison of PCB congener profiles between studies is difficult due to the 
different numbers of measured congeners, the dominant congeners reported in most studies are the 
same (PCB 153, 180, 138, and 170), as in this study. 
The concentrations of PCDD/Fs increased with ages of the subjects. If the half-life of 
congeners in humans is in the order of 7-8 years, then at a constant exposure this would mean that the 
body burden of a person would increase until about 40 years of age, and then achieve a steady state. At 
the population level, we did not detect this kind of upward convex curve probably indicating a 
previous higher exposure. The decreasing time trend of PCDD/F and PCB concentrations in human 
samples have been frequently reported (Päpke, 1998; Kiviranta et al., 1999; Norén and Meironyte, 
2000; He et al., 2001; Choi et al., 2002). The higher TEQ concentrations in men than in women in the 
age groups between 36 and 50 years may be explained by two obvious reasons. First, men in the age 
range of interest had higher BMI, which might correlate with higher intake of dietary fat, and hence 
higher exposure to PCDD/F and PCBs than in women. Second, breast-feeding results in a decreased 
body burden of PCDD/Fs and PCBs in women (Abraham et al., 1998; Päpke, 1998; Kiviranta et al., 
1999). The decreasing gradient of PCDD/F and PCB concentrations from the coast of the Baltic Sea to 
inland area in Finland was reported in Finnish mother’s milk samples collected in 1987 (Vartiainen et 
al., 1997). In order to investigate if this decreasing gradient would be present also in the general 
population concentrations, we classified the subjects according to place of residence. Coastal and 
inland groups were obvious groups based on the earlier mother's milk study. Although the capital area 
is located on the coastline of the Gulf of Finland in the Baltic Sea, we classified it as an intermediate 
group between coastal and inland areas. This was based on the fact that there has been a considerable 
internal emigration from inland areas to the capital area over the last 50 years. Therefore the 
population in the capital area is a mixture of coastal and inland area populations with respect to their 
PCDD/F and PCB exposure. When concentrations of PCDD/Fs and PCBs were age adjusted, this 
gradient of decreasing concentrations from coast to inland area was seen for all selected PCB 
congeners and also for certain PCDD/F congeners. This can be explained by the fact that most of the 
average exposure of Finns to PCDD/Fs and PCBs originates from fish, especially from Baltic herring 
(Kiviranta et al. 2003), and in this study Baltic herring was consumed most frequently in the coastal 
area, although not statistically significantly. Also the concentrations of PCDD/Fs and PCBs are higher 
in the Baltic Sea in most of the fish species when compared to the same fish species in inland areas, 
also resulting in higher population exposure to these contaminants in the coastal area. The failure to 
detect any clear decreasing gradient of exposure for 1,2,3,4,6,7,8-HpCDD and OCDD from the coastal 
Table 4.
Mean, median, SD, and (range) concentrations of selected PCDD/Fs and WHOPCDD/F-TEQs as pg g-1 fat in adipose tissue samples in age and 
regional subgroups of general population in Finland.   
__________________________________________________________________________________________________________________________________________________________ 
Congener          Age subgroups  ________      Area    ____________
   < 46 years n = 225  > 46 years n = 195  Coastal n = 147   Capital n = 104   Inland n = 166  
 _________________________________________________________________________________________________________________________________________________________
__
2,3,7,8-TCDD 1.59, 1.37, 0.926, (0.157–6.56)* 3.66, 3.23, 2.00, (0.794–16.4) 2.64, 1.95, 2.13, (0.551–16.4)** 2.39, 2.12, 1.52, (0.478–8.85) 2.57, 2.04, 1.76, (0.157–8.98) 
1,2,3,7,8-PeCDD 4.44, 4.05, 2.45, (0.986–17.6)* 11.3, 9.92, 5.60, (3.72–43.2) 7.87, 5.75, 6.37, (1.38–43.2)** 6.73, 5.70, 4.39, (1.56–25.6) 7.98, 6.90, 5.09, (0.986–27.0) 
1,2,3,6,7,8-HxCDD 30.5, 28.1, 16.2, (5.10–113)* 60.1, 56.2, 20.9, (24.3–148) 44.9, 39.7, 26.3, (5.10–148)** 40.9, 36.8, 22.4, (8.48–134) 45.9, 45.9, 22.0, (5.37–109) 
1,2,3,4,6,7,8-HpCDD30.2, 26.7, 18.6, (nq–107)* 53.0, 47.5, 34.2, (8.08–222) 38.1, 30.4, 25.6, (5.35–140)** 40.5, 34.6, 30.6, (3.37–206) 43.4, 35.1, 31.6, (nq–222) 
OCDD  217, 180, 124, (37.7–950)* 316, 261, 197, (68.7–1730) 257, 212, 161, (57.9–1090)** 254, 222, 157, (37.7–1030) 275, 237, 184, (67.8–1730) 
2,3,4,7,8-PeCDF 12.9, 10.5, 8.77, (2.30–60.9)* 37.2, 33.0, 21.7, (8.09–165) 27.5, 19.0, 24.3, (2.30–165)** 21.8, 16.2, 17.2, (2.86–106) 22.9, 18.6, 17.6, (2.32–112) 
Sum of PCDD/Fs 321, 290, 165, (78.0–1270)* 519, 456, 249, (163–2080) 408, 371, 221, (103–1450)** 392, 341, 220, (78.0–1420) 430, 380, 244, (109–2080) 
WHOPCDD/F-TEQ 17.2, 15.7, 9.26, (3.64–67.7)* 42.7, 39.5, 19.8, (13.4–153) 31.0, 22.9, 23.1, (4.92–153)** 26.2, 22.7, 17.1, (5.77–102) 29.2, 25.3, 18.0, (3.64–102) 
____________________________________________________________________________________________________________________________________________________ 
Abbreviations: HpCDD, heptachlorodibenzo-p-dioxm; HxCDD, hexachlorodibenzo-p-dioxin; nq, below limit of quantitation; OCDD, octachlorodibenzo-p-dioxin; PeCDD, pentachlorodibenzo-
p-dioxin; PeCDF, pentachlorodibenzofuran; TCDD, tetrachlorodibenzo-p-dioxin; WHOPCDD/F-TEQ, WHO toxic equivalency factors for PCDD/Fs. 
*Significantly different compared with the > 46 years group (p < 0.05 by independent samples T-test) 
** Age as a covariate significantly effects the concentration in different areas (covariate analysis of variance), and therefore areas are not comparable. 
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Table 5.
Mean, median, SD, and (range) concentrations of selected PCBs and WHOPCB-TEQs in adipose tissue samples in age and regional subgroups of general 
population in Finland. 
__________________________________________________________________________________________________________________________________________________________ 
Congener         Age subgroups         Area     _____
  < 46 years n = 225  > 46 years n = 195  Coastal n = 147   Capital n = 104   Inland n = 166 
__________________________________________________________________________________________________________________________________________________________
______ 
Non-ortho-PCBs a
PCB 126 40.9, 35.2, 27.7, (nq–170)* 115, 93.8, 91.3, (15.3–817) 81.3, 52.8, 88.5, (12.2–817)** 72.5, 51.1, 66.1, (11.9–454) 72.0, 56.1, 67.5, (nq–541) 
PCB 169 39.0, 32.1, 25.8, (nq–169)* 100, 86.2, 54.8, (36.4–399) 75.2, 55.1, 63.9, (5.63–399)** 63.6, 55.2, 45.4, (8.04–259) 63.4, 54.3, 42.5, (nq–295) 
Other PCBs b
PCB 118 11.8, 9.98, 8.13, (2.14–49.0)* 29.3, 25.4, 19.4, (4.19–134) 21.6, 15.4, 18.8, (3.24–100)** 20.2, 15.3, 18.2, (2.69–134) 18.4, 14.3, 14.3, (2.14–106) 
PCB 138 47.5, 42.7, 25.8, (9.08–167)* 106, 92.7, 58.5, (10.3–461) 81.6, 58.3, 67.1, (9.08–461)** 71.7, 62.9, 45.9, (9.89–244) 71.0, 64.8, 41.8, (11.2–251) 
PCB 153 85.9, 78.1, 46.9, (16.8–290)* 192, 165, 104, (30.2–958)  146, 107, 123, (16.8–958)** 131, 114, 82.0, (20.2–433) 129, 122, 70.8, (19.1–423) 
PCB 156 9.51, 7.86, 6.13, (0.293–43.0)* 24.0, 21.6, 12.3, (0.795–82.3) 17.6, 13.4, 14.9, (1.78–82.3)** 15.1, 12.6, 10.5, (0.795–47.0) 15.9, 14.5, 9.51, (0.293–49.3) 
PCB 157 1.34, 1.06, 0.866, (0.204–5.71)* 3.33, 2.94, 1.66, (0.530–10.9) 2.48, 1.91, 2.06, (0.243–10.9)** 2.12, 1.81, 1.40, (0.315–6.04) 2.19, 2.10, 1.32, (0.204–6.54) 
PCB 170 34.5, 29.5, 21.3, (5.80–132)* 76.2, 68.6, 34.8, (12.2–313) 56.1, 45.7, 42.8, (5.80–313)** 50.8, 44.1, 31.1, (7.32–146) 54.1, 51.1, 30.0, (7.49–157) 
PCB 180 65.7, 55.8, 40.3, (11.3–254)* 152, 135, 78.6, (23.8–833) 111, 88.7, 96.3, (11.3–833)** 101, 86.8, 62.7, (14.2–277) 105, 100, 58.9, (13.5–337) 
Sum of  
marker PCBsb 216, 190, 118, (43.4–744)* 488, 423, 251, (83.8–2360) 368, 280, 302, (43.4–2360)** 331, 296, 204, (48.4–1110) 329, 307, 180, (53.0–1080) 
Sum of PCBsb 317, 282, 175, (63.2–1110)* 716, 622, 354, (124–3240) 540, 414, 433, (63.2–3240)** 482, 437, 294, (73.5–1590) 485, 460, 260, (79.2–1530) 
WHOPCB-TEQa 11.8, 10.3, 6.93, (2.46–43.1)* 30.9, 26.6, 16.8, (7.89–129) 22.4, 16.3, 19.3, (2.89–129)** 19.7, 16.4, 14.2, (3.00–92.8) 19.9, 17.4, 12.9, (2.46–86.5) 
__________________________________________________________________________________________________________________________________________________________ 
Abbreviations: nq, below limit of quantitation; PCB, polychlorinated biphenyl; WHOPCB-TEQ, WHO toxic equivalency factors for PCBs. 
*Significantly different compared with the > 46 years group (p < 0.05 by independent samples T-test) 
** Age as a covariate significantly effects the concentration in different areas (covariate analysis of variance), and therefore areas are not comparable. 
a = concentrations are given in pg g-1 fat. 
b = concentrations are given in ng g-1 fat
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Table 6.
Mean and median age adjusted concentrations of selected PCDD/Fs, WHOPCDD/F-TEQs, PCBs, and WHOPCB-TEQs in adipose 
tissue samples in regional subgroups of average population in Finland.   
_____________________________________________________________________________________________________________________________________ 
Congener    Area    Congener    Area   
   Coastal  Capital  Inland     Coastal  Capital  Inland 
   n = 147  n = 104  n = 166     n = 147  n = 104  n = 166 
_____________________________________________________________________________________________________________________________________ 
PCDD/Fsa        Non-ortho-PCBs a
2,3,7,8-TCDD  2.77, 2.55 2.55, 2.34 2.34, 2.04 PCB 126  82.5, 71.8 80.1, 73.5 65.5, 57.7 
1,2,3,7,8-PeCDD  8.30, 7.55 7.22, 6.71 7.24, 6.69 PCB 169  80.0, 72.5 69.4, 66.9 58.5, 54.4 
1,2,3,6,7,8-HxCDD 47.7, 44.3 43.6, 40.2 42.6, 40.6 
1,2,3,4,6,7,8-HpCDD 39.7, 36.0 44.0, 38.4 40.7, 34.9 Other PCBs b
OCDD   277, 248 268, 230 262, 233 PCB 118  23.0, 20.7 21.1, 18.8 16.7, 15.2 
         PCB 138  86.5, 81.8 74.3, 68.3 64.9, 62.8 
2,3,4,7,8-PeCDF  28.8, 26.5 24.1, 22.9 20.4, 18.7 PCB 153  155, 141 137, 129 118, 112 
         PCB 156  18.6, 16.6 15.7, 15.1 14.5, 13.7
Sum of toxic congeners 435, 406 417, 373 407, 362 PCB 157  2.64, 2.43 2.23, 2.13 1.99, 1.86
         PCB 170  60.5, 54.4 53.2, 52.2 49.5, 47.9
WHOPCDD/F-TEQ  32.6, 30.1 28.5, 27.2 26.4, 24.4 PCB 180  120, 105 106, 104 96.2, 90.4 
         Sum of marker PCBsb 392, 359 345, 326 302, 288 
         Sum of PCBsb 574, 524 502, 476 445, 425 
         WHOPCB-TEQa 23.4, 21.6 21.1, 19.5 18.1, 17.4 
_____________________________________________________________________________________________________________________________________ 
Abbreviations: HpCDD, heptachlorodibenzo-p-dioxin; HxCDD, hexachlorodibenzo-p-dioxin; nq, below limit of quantitation; OCDD, octachlorodibenzo-p-
dioxin; PeCDD, pentachlorodibenzo-p-dioxin; PeCDF, pentachlorodibenzofuran; PCB, polychlorinated biphenyl; TCDD, tetrachlorodibenzo-p-dioxin; 
WHOPCB-TEQ, WHO toxic equivalency factors for PCBs; WHOPCDD/F-TEQ, WHO toxic equivalency factors for PCDD/Fs.
a = concentrations are given in pg g-1 fat. 
b = concentrations are given in ng g-1 fat.detect any clear decreasing gradient 
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Table 7.
Predictors of the variance of natural logarithms of WHOPCDD/F-TEQ, WHOPCB-TEQ, and 
total WHO-TEQ for population in Finland.
___________________________________________________________________________ 
Predictor variable    Parameter estimate SE  p-Value
_________________________________________________________________________________________ 
Dependent variable: ln WHOPCDD/F-TEQ 
Constant      1.73   0.15 < 0.0001 
Age (years)      0.0348   0.002 < 0.0001 
BMI (kg m-2)      - 0.00354  0.006 < 0.54 
Lactation (months)     - 0.0106   0.002 < 0.0001 
Living in the capital area (no/yes)    - 0.089   0.053 < 0.093 
Living in the inland area (no/yes)    - 0.116   0.048 < 0.015  
Consumption of baltic herring (times per month)  0.037   0.014 < 0.009 
Consumption of farmed trout or salmon (times per month) 0.0374   0.012 < 0.002 
Consumption of other fish (times per month)  0.0087   0.008 < 0.25 
ln WHOPCDD/F-TEQ model percentage r2 = 0.70 
Dependent variable: ln WHOPCB-TEQ  
Constant      1.19   0.16 < 0.0001 
Age (years)      0.037   0.002 < 0.0001 
BMI (kg m-2)      - 0.0017   0.006 < 0.79 
Lactation (months)     - 0.0101   0.002 < 0.0001 
Living in the capital area (no/yes)    - 0.0196   0.059 < 0.074 
Living in the inland area (no/yes)    - 0.145   0.053 < 0.007  
Consumption of baltic herring (times per month)  0.0377   0.016 < 0.017 
Consumption of farmed trout or salmon (times per month) 0.0504   0.013 < 0.0001 
Consumption of other fish (times per month)  - 0.0000987  0.008 < 0.99 
ln WHOPCB-TEQ model percentage r2 = 0.69 
Dependent variable: ln WHOtotal-TEQ 
Constant      2.19   0.15 < 0.0001 
Age (years)      0.0357   0.002 < 0.0001 
BMI (kg m-2)      - 0.00304  0.006 < 0.60 
Lactation (months)     - 0.0104   0.002 < 0.0001 
Living in the capital area (no/yes)    - 0.0573   0.053 < 0.28 
Living in the inland area (no/yes)    - 0.126   0.047 < 0.008  
Consumption of baltic herring (times per month)  0.0368   0.014 < 0.009 
Consumption of farmed trout or salmon (times per month) 0.0422   0.012 < 0.001 
Consumption of other fish (times per month)  - 0.00492  0.020 < 0.51 
ln WHOtotal-TEQ model percentage r2 = 0.72
___________________________________________________________________________
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Fig. 5.
Measured concentrations as functions of modelled concentrations: (A) ln WHOPCDD/F-TEQ; (B) ln WHOPCB-TEQ; and (C) 
ln WHOtotal-TEQ.
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Table 8.
Adipose and serum fat concentrations of sum of PCDD/Fs, WHOPCDD/F-TEQ, PCB 126, PCB 153, PCB 180, markes PCBs, and WHOPCB-TEQ
in various countries during 1990s.
________________________________________________________________________________________________________________________ 
Adipose tissue studies: 
Origin   Finland  Spain  Japan  Belgium  India  France  Sweden  Greenland Germany 
Year of sampling 1997-1099 1996-1997 2000  2000  2000  1999  Unknown 1992-1994 1996 
Number of samples 420  123  10  20  21  16  28  26  139 
Mean age of subjects 44 (13-81) 51 (15-87) 40-50  47 (19-77) 20-69  53 (30-94) 68  60  37 (18-71) 
Population  Men/women Men/women Men/women Men/women Men/women Men/women Men/women Men/women Men/women 
Sum of PCDD/Fsa 413    171    550  490  804    403 
WHOPCDD/F-TEQa 29.0    11.9    14.4  35.6  32.8    16.1 
PCB126a  75.2    72    125    180     
PCB153b  135  121    211      300  1689   
PCB180b  106  134    105      200  1147   
marker PCBsb  343  432          778  4242   
WHOPCB-TEQa  20.7    15.3    14.4         
Reference  this study Costabeber and Choi et al. Covaci et al. Kumar et al. Arfi et al. Wingfors et al. Dewailly et al. Päpke 
     Emanuelli (2003)(2002)  (2002)  (2001)  (2001)  (2000)  (1999)  (1998) 
 ________________________________________________________________________________________________________________________________________________ 
Serum/blood studies: 
Origin   Finland  Sweden  Uelen/Russia Belgium  Sweden  Latvia  Sweden  Åland/Finland US 
Year of sampling 1997  1996-1997 2001  1999  1991  1993  late 1990s mid 1990s 2002 
Number of samples 47  205  50  200  43  67  120  30  249 
Age of subjects  58 (27-77) 63 (50-74) 37 (20-70) 58 (50-65) 42 (23-69) 48 (24-79) 63 (40-75) 30 (19-40) adults 
Population  Fishermen Women  Men/women Women  Fishermen Fishermen Men  Women  Men/women 
Sum of PCDD/Fsa 1700      999          505   
WHOPCDD/F-TEQa 180      48          19.3 
PCB126a  300    1200  102         
PCB153b  600  223  744  168  360  403  296  56 
PCB180b  370  152  220  104  233  194  218  32 
marker PCBsb  1460    1410  389      675   
WHOPCB-TEQa  89      23.7         
Reference  Kiviranta et al. Wicklund Glynn Sandanger et al. Koppen et al. Sjödin et al. Sjödin et al. Wicklund Glynn Hagmar et al. Schecter et al. 
   (2002)  et al. (2003) (2003)  (2002)  (2000)  (2000)  et al. (2000) (1998)  (2003) 
________________________________________________________________________________________________________________________________________________ 
a = concentrations are given in pg g-1 fat. 
b = concentrations are given in ng g-1 fat
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area to the inland area is also in line with the previous consideration that fish are not the source of 
these congeners (Kiviranta et al., 2003). However fish are the source of 2,3,4,7,8-PeCDF, 2,3,7,8-
TCDD, 1,2,3,7,8-PeCDD, and also 1,2,3,6,7,8-HxCDD. For those congeners, the decreasing 
gradient of concentrations from coast to inland area was most clearly evident. 
Regression models of PCDD/Fs and PCBs 
In the regression models the goal was to develop a suitable model to assess a population 
body burden of PCDD/Fs and PCBs in order to avoid measuring those concentrations with 
expensive and time-consuming methods. According to previous and this present study, the predictor 
variables were chosen according to the criteria that these variables would contribute most to the 
Finnish body burdens of PCDD/Fs and PCBs, and that they would be easy to enquire from a 
questionnaire. Age, weight, length, lactation, place of residence, and fish consumption frequencies 
fulfilled those criteria. The analysis showed that age was the most significant predictor in all three 
models, but also lactation, place of residence, and frequency of consumption of Baltic herring and 
farmed trout or salmon were significant variables in the models. The correlations between modelled 
and measured concentrations for TEQs were quite satisfactory. On the individual basis, the models 
failed most often to assess the concentrations of older people. Changes in food habits and also 
changes in PCDD/F and PCB concentrations in food items throughout the years are most evident in 
older subjects, resulting in more scattering between the modelled and measured concentrations. 
6. CONCLUSION
We found that the body burdens of PCDD/Fs and PCBs in Finland were at the same levels 
as other countries in Europe, and there existed a downward trend in concentrations from coastal to 
inland areas. This decreasing trend in concentrations was most likely a result from consumption of 
more contaminated fish from the Baltic Sea in the coastal area compared to the inland area. The 
age dependence of concentrations was shown to be strong. Concentrations as a function of age 
also revealed that the exposure of Finns to PCDD/Fs and PCBs has declined over the last 30 years. 
By asking subjects age, height, weight, place of residence, and fish consumption frequencies it 
would be possible to obtain an estimate of their PCDD/F and PCB TEQ body burdens. 
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1. ABSTRACT
Word Health Organization, WHO/EURO, has coordinated two rounds of follow-up 
studies on levels of  PCDDs, PCDFs, and PCBs in human milk which were analyzed as two 
pooled samples from each participating country, one from urban and the other one from rural 
area. Finland has taken part to both of those studies and we are now reporting results of all the -
second round randomly sampled human milk samples (84 samples) from Southern (20) and 
Eastern (64) Finland. The levels of PCDD/Fs and PCBs in human milk in Southern Finland were 
considerably higher than in Eastern Finland. The level of PCDD/Fs in human milk in Southern 
Finland was the same as in the Central Europe but the level in Eastern Finland was similar to 
levels in Norway and eastern parts of Europe. The concentrations of PCDD/Fs and PCBs showed 
a significant decrease from 1987 to 1994. Declining of PCDD/Fs and PCBs was 36 and 49 % in 
primiparae mothers= milk, respectively. This decrease in concentrations of PCDD/F and PCB 
was slightly greater in Eastern than in Southern Finland. 
2. INTRODUCTION
Polychlorinated dibenzo-p-dioxins and dibenzofurans (PCDD/F) are globally distributed 
toxic chemicals  in the environment and were found in human milk in the 1980s [1,2]. Food is 
the main source of PCDD/Fs and polychlorinated biphenyls (PCB) in humans [3]. In Finland, 
meat, milk and milk products  were quite clean of PCDD/Fs but sometimes eggs contained 
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PCDD/Fs, because the feed of poultry had contained fish products [4]. The Baltic Sea is highly 
contaminated with PCDD/Fs and PCBs causing also contamination of Baltic herring and salmon 
[5]. PCB concentrations in Finnish food have been reported to be low, except for Baltic fish, on 
average 32 ?g/kg in beef, 11 ?g/kg in pork, 9 ?g/kg in chicken, 29 ?g/kg in eggs, and 0.21 pg/kg 
in milk containing 1.9% fat [6]. The total intake of PCDD/Fs as international toxic equivalent (I-
TEq) in Finland was assumed to be about 94 pg/day per person [7] and total PCB intake 1.64 
?g/day per person [6].  
The decrease of concentrations of PCDD/Fs between 1986 and 1993 in human blood and 
milk has been reported from Germany and the Netherlands [8,9]. Concentrations of PCBs have 
also been diminishing but not as clearly as concentrations of PCDD/Fs [9]. The studies conclude 
that measures taken to reduce the PCDD/F and PCB emissions to the environment have resulted 
in a reduction of human body burdens of these compounds.       
WHO/EURO has coordinated two rounds of follow-up studies on levels of PCDDs, 
PCDFs and PCBs in human milk. Finland participated in both of them [10,11]. The objectives in 
this study are to describe the concentrations of PCDD/Fs and PCBs in human milk in two areas 
in Finland between 1992 and 1994, and to evaluate the time trend of the concentrations of 
PCDD/Fs and PCBs between 1987 and 1994. 
3. METHODS
Sample Collection
 The study was part of a follow-up study coordinated by WHO/EURO on levels of 
PCDDs, PCDFs and PCBs in human milk. In Finland, we carried out a larger population-based 
study in two geographic areas, in Helsinki, the capital, and in Kuopio and its surroundings, 
which is located approximately 400 km north-east from Helsinki. All consecutive women giving 
birth were recruited from one of the maternity clinics in Helsinki and from the maternity clinic of 
Kuopio University Hospital between March 1992 and August 1994, in WHO/EURO study 
between April 1992 and August 1993. The study population who collected and returned the milk 
sample constituted a total of 84 mothers, 20  (24 % of the total number) in Helsinki and 64 (76 
%, respectively) in Kuopio. In the urban and rural areas 14 and 28 mothers were primiparae, 
respectively. In the rural area, human milk sample from a mother nursing her thirteenth child 
was found, and in the urban area a sample from a mother nursing her fourth child. The study 
population is described in Table 1.
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Table 1.
Number of mothers, ages of mothers and fat contents of human milk in urban (N=20) and rural 
(N=64) areas of Finland between 1992-1994. Numbers in the panel indicate the number of child 
mother was nursing. 1./(WHO) indicates that mother was primipara between 20-30 years and she 
had lived in the community at least the five last years (the pooled sample of these mothers was 
included in the WHO/EURO study).
____________________________________________________________________________________________ 
mother/parity 
1. 1./(WHO) 2. 3. 4. 6 13. 
____________________________________________________________________________________________ 
Urban area, Helsinki
Number of mothers 
14 10 3 2 1 -  - 
Age of mothers
mean ± s.d. 27.9 ± 4.6 27.0 ± 3.1 25.3 ± 0.6 32.5 34 
range  19-36 23-32 25-26 31-34  
Fat content of human milk
mean ± s.d. 3.75 ± 1.52 3.91 ± 1.03 4.62 ± 1.06 3.64 3.31 -  - 
range  0.63 - 6.61 1.82 - 5.13 3.71 - 5.78 2.73 - 4.55 - -  - 
Rural area, Kuopio and surroundings
Number of mothers
28 23 19 11  4 1 1 
Age of mothers
mean ± s.d.  27.0 ± 4.7 25.4 ± 2.6 29.5 ± 4.7 33.5 ± 3.3 32.0 ± 0.8 32 42 
range  18-39 18-30 23-44 27-38 31-33 
Fat content of human milk
mean ± s.d. 3.88 ± 0.99 3.99 ± 1.05 4.36 ± 1.61 4.01 ± 1.31 4.18 ± 1.05 5.13 3.57 
range  1.58 - 5.93 1.58 - 5.93 1.36 - 7.74 1.12 - 5.94 2.72 - 5.21 - - 
____________________________________________________________________________________________ 
Determination of PCDDs, PCDFs, and PCBs
 The concentrations of 17 toxic PCDD/Fs, of three non-ortho (IUPAC 77, 126, and 169) 
PCB congeners, of five mono-ortho (IUPAC 105, 114, 118, 156 and 157) PCB congeners, and of 
28 di-ortho (IUPAC 18, 28, 33, 47, 49, 51, 52, 60, 66, 74, 99, 101, 110, 122, 123, 128, 138, 141, 
153, 167, 170, 180, 183, 187, 189, 194, 206 and 209) PCB congeners, the total sum of PCDD/F 
(?PCDD/F) and PCB (?PCB) congeners, and toxic equivalents, I-TEqs (TEqs, for PCBs) of  
them were determined from human milk samples. About 40 ml of each human milk sample, 
equivalent to 1.2 g fat, was spiked with 115 pg of  13C-labeled PCDD and PCDF standards 
(seventeen 2,3,7,8-chlorinated PCDD/F congeners), with 100 pg of  13C-labeled non-ortho PCB 
standards (PCB 77, 126, and 169), and with 9600 pg of 13C-labeled  PCB standards (PCB 30 [12C-
labeled], 80, 101, 153, 180, Cambridge Isotope Laboratories). Milk fat was extracted with diethyl 
ether/hexane and the fat content determined. The extract was defatted in a silica gel column and 
initially purified on activated carbon column (Carbopack C, 60/80 mesh) containing Celite (Merck 
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2693) to separate PCDD/Fs from PCBs and both fractions further cleaned with an activated 
alumina column (Merck 1097, standardized, activity level II-III). The separated PCB fraction was 
further purified, after having  analyzed for mono- and di-ortho PCB congeners, on another 
activated carbon column (without Celite) and the non-ortho PCBs were also analyzed with high 
resolution mass spectrometer equipped with a fused silica capillary column (DB-DIOXIN, 60 m, 
0.25 mm, 0.15 ?m). The quantitation was performed by selective ion recording using a VG 70-250 
SE (VG Analytical, UK) mass spectrometer (resolution 10,000). The levels of 17 most toxic 
PCDD/Fs were expressed in TCDD toxic equivalents (I-TEq) calculated by using the international 
toxic equivalency factors [12]. Toxic equivalency factors used for PCBs were  0.1 for PCB 126, 
0.01 for PCB 169, 0.0005 for PCBs 77, 114, 156, and 157, 0.0001 for PCBs 105, 118, 123, 170 
and 189, and 0.00001 for PCB 167 [13].  The laboratory reagent and equipment blank samples 
were treated and analyzed by the same method as the actual samples, one blank for every five 
samples. Detection limits for the different  PCDD/F congeners were 0.1 - 1.0 pg/g in fat  and for 
the different PCB congeners 1-10 pg/g fat. Recoveries for internal standards were more than 60% 
for all congeners. The laboratory has participated successfully in international quality control 
studies for the analysis of  PCDDs and PCDFs in cow milk samples organized by EU/BCR-project 
in 1993 [14, 15]. Laboratory is also an accredited testing laboratory (No T77) in Finland (SFS-EN 
45001 and ISO/IEC Guide 25). The scope of accreditation includes PCDD/Fs, PCBs, and non-
ortho PCBs from human milk. Statistical analysis was carried out by means of SPSS (for 
Windows, version 6.1.3). Mann-Whitney U nonparametric test was used to test the statistical 
significance of results. 
4. RESULTS
Fat, PCDD/F, and PCB contents of human milk
 Fat content in human milk of primiparae was on average 3.75% in the urban and 3.88% 
in the rural area (Table 1). In this study data are given on fat basis, as PCDD/Fs and PCBs are 
conventionally reported.  PCDD/F concentrations as I-TEqs were between 4.90 pg/g fat (thirth 
child in rural area)  and 34.4 pg/g fat (primipara, in urban area), and ?PCDD/F concentrations 
were between 51.6 pg/g fat (second child in rural area) and 559 pg/g fat (primipara in urban 
area) (Tables 2a and 2b). ?PCB concentrations ranged from 52.6 (second child in rural area) to 
464 ng/g fat (primipara in urban area), and TEqs were between 2.37  (second child in rural area) 
and 32.8 pg/g fat  (primipara in urban area) (Tables 3a and 3b). The average ?PCDD/F and 
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?PCB concentrations of all primiparae were in the urban area 381 pg/g and 296 ng/g fat, 
respectively, and in the rural area 217 pg/g and 198 ng/g fat, respectively. The average I-TEqs 
and TEqs of all primiparae were in the urban area 19.9 pg/g and 18.5 pg/g fat, respectively, and 
in the rural area 13.6 pg/g and 11.6 pg/g fat, respectively. 
Table 2a.
PCDD/F concentrations and I-TEqs (mean  ±  standard deviation and range as pg/g fat) in the 
mother's milk from the urban area in Finland, in 1992-94. Asterisks indicate a statistically 
significant difference to the rural area (*p<0.01, **p<0.005, ***p<0.001). 1,2,3,7,8,9-Cl6DF and 
1,2,3,4,7,8,9-Cl7DF were below the detection limits. Other conditions as in Table 1. 
_______________________________________________________________________________________________ 
congener       1. 1./(WHO) 2. 3.     4. 
_______________________________________________________________________________________________ 
2,3,7,8-Cl4DF  1.93 ± 0.74*** 1.83 ± 0.62***  1.34 ± 0.2  2.64  1.47 
0.99 - 3.31 0.99 - 2.79 1.22 - 1.57 2.39 - 2.89 
2,3,7,8-Cl4DD   2.66 ± 1.46 2.48 ± 1.24 1.88 ± 0.61 2.87    1.03  
1.11 - 5.81 1.35 - 5.2 1.37 - 2.54 2.72 - 3.02 
1,2,3,7,8-Cl5DF  0.79 ± 0.44* 0.73 ± 0.47 0.61 ± 0.2  0.99 0.88  
<0.1 - 1.39 <0.1 - 1.27 0.48 - 0.83 0.89 - 1.09 
2,3,4,7,8-Cl5DF  16.3 ± 7.0* 17.0 ± 6.13** 7.95 ± 3.25 15.2 7.08  
5.2 - 27.7 7.9 - 24.8 5.15 - 11.5 12.2 - 18.2 
1,2,3,7,8-Cl5DD  6.22 ± 2.16* 6.61 ± 1.67** 3.9 ± 1.15 5.56 2.01  
2.23 - 9.71 3.95 - 8.64 2.57 - 4.57 5.31 - 5.8 
1,2,3,4,7,8-Cl6DF 4.91 ± 1.55 5.13 ± 1.0 2.81 ± 0.81 3.81 2.41  
2.45 - 8.15 4.01 - 6.75 2.0 - 3.63 3.14 - 4.48 
1,2,3,6,7,8-Cl6DF 3.44 ± 1.54 3.34 ± 1.42 2.37 ± 0.67 3.26 2.07 
1.34 - 6.59 1.34 - 6.3 1.93 - 3.14 2.63 - 3.88 
2,3,4,6,7,8-Cl6DF 1.88 ± 0.88  1.91 ± 0.91 1.19 ± 0.49 1.95  1.21  
0.91 - 4.0 1.0 - 4.0 0.89 - 1.75 1.59 - 2.31 
1,2,3,4,7,8-Cl6DD 2.69 ± 1.33 2.68 ± 1.34 1.68 ± 0.34  2.21 1.09 
1.22 - 5.91 1.33 - 5.91 1.32 - 2.0 2.02 - 2.4 
1,2,3,6,7,8-Cl6DD 33.2 ± 8.94 34.3 ± 6.34** 22.8 ± 4.49  26.9  11.7  
15.2 - 49.9 26.7 - 46.9 19.9 - 27.9 26.4 - 27.4 
1,2,3,7,8,9-Cl6DD 3.03 ± 3.0 2.61 ± 3.12 2.98 ± 0.63 4.3 1.72  
0.96 - 9.68 0.95 - 9.68  2.29 - 3.53 3.92 - 4.68 
1,2,3,4,6,7,8-Cl7DDF 9.79 ± 7.86 7.83 ± 7.43 11.8 ± 2.84 17.9 16.6  
1.35 ± 25.8 1.35 - 25.8 9.6 - 15.0 16.4 - 19.5 
1,2,3,4,6,7,8-Cl7DD 51.7 ± 25.8*** 53.8 ± 25.0*** 24.9 ± 10.9 47.5 21.6  
15.1 - 110 27.5 - 110 13.6 - 35.4 40.1 - 54.9 
OCDF   11.7 ± 9.2*** 12.9 ± 10.6** 9.03 ± 4.22 9.87  11.5 
<1 - 29.9 <1 - 29.9 5.92 - 13.8 9.41 - 10.3 
OCDD   230 ± 80.9*** 251 ± 63.4*** 102 ± 56.2 177 127 
58.0 - 349 177 - 349 66.4 - 167 161 - 194 
 
3 PCDD/F  381 ± 120*** 404 ± 94.9*** 197 ± 83.4 323 210 
128 - 559 267 - 559 140 - 293 292 - 353 
I-TEq   19.9 ± 7.42* 20.4 ± 6.01** 11.8 ± 2.95 18.7 8.31 
7.7 - 34.4 12.3 - 29.0  8.92 - 14.8 16.6 - 20.7 
_______________________________________________________________________________________________ 
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Table 2b.
PCDD/F concentrations and I-TEqs (mean + standard deviation and range as pg/g fat) in the 
mother's milk from the surroundings of the rural area in Finland,in 1992-94. 1,2,3,7,8,9-Cl6DF
ans 1,2,3,4,7,8,9-Cl7DF were below the detection limits. Other conditions as in Table 1. 
_____________________________________________________________________________________________________ 
congener       1. 1./(WHO) 2. 3.  4. 6. 13.  
_____________________________________________________________________________________________________ 
2,3,7,8-Cl4DF   0.49 ± 0.44  0.43 ± 0.44  0.5 ± 0.33  0.74 ± 0.42  0.67 ± 0.25 1.44 0.9  
<0.1 - 1.8 <0.1 - 1.8 <0.1 - 1.30 0.25 - 1.81 0.4 - 0.95  
2,3,7,8-Cl4DD   1.71 ± 0.68  1.7 ± 0.69 1.03 ± 0.33 1.61 ± 0.52   1.08 ± 0.2  0.88 0.99  
0.4 - 3.03 0.4 - 3.03 0.24 - 1.5 0.91 - 2.42 0.87 - 1.34 
1,2,3,7,8-Cl5DF  0.33 ± 0.42 0.33 ± 0.45 0.15 ± 0.23  0.23 ± 0.21 0.2 ± 0.16 0.3 0.2  
<0.1 - 1.39 <0.1 - 1.4 <0.1 - 0.92 <0.1 - 0.54  <0.1 - 0.38  
2,3,4,7,8-Cl5DF  10.1 ± 4.65 9.51 ± 2.85 7.27 ± 2.74 9.32 ± 3.18 7.01 ± 1.4 5.05 3.66  
3.24 -25.7 3.25 - 15.5 1.23 - 12.6 4.05 - 15.5 5.03 - 8.2  
1,2,3,7,8-Cl5DD  4.36 ± 1.56 4.25 ± 1.31 3.0 ± 1.05  3.56 ± 1.05 2.94 ± 0.52 1.35 2.36  
1.67 - 7.09 1.67 - 6.35 0.47 - 4.91 1.31 - 5.52 2.25 - 3.5 
1,2,3,4,7,8-Cl6DF 3.94 ± 1.85 4.12 ± 1.73 2.1 ± 1.0 2.31 ± 1.07 2.16 ± 0.58  0.6 1.39  
0.79 - 7.42 1.66 - 7.42 <0.1 - 3.77 0.48 - 4.29 1.55 - 2.85 
1,2,3,6,7,8-Cl6DF 2.8 ± 1.15 2.78 ± 0.85 1.66 ± 0.77 2.04 ± 0.89 1.47 ± 0.3 0.62 1.05  
0.8 - 6.27 0.95 - 4.21 <0.1 - 3.02 0.61 - 3.9 1.3 - 1.91 
2,3,4,6,7,8-Cl6DF 1.28 ± 0.92  1.28 ± 0.9 0.64 ± 0.41 0.91 ± 0.46  0.74 ± 0.37  0.43 0.48  
<0.1 - 2.98 <0.1 - 2.71 <0.1 - 1.37 0.29 - 1.88 0.21 - 1.06 
1,2,3,4,7,8-Cl6DD 1.87 ± 0.95 1.94 ± 0.94 1.04 ± 0.65 1.27 ± 0.54 0.76 ± 0.66 <0.1 0.72 
<0.1 - 3.76 <0.1 - 3.76 <0.1 - 2.2 <0.1 - 2.11 <0.1 - 1.39 
1,2,3,6,7,8-Cl6DD 26.9 ± 8.16 26.3 ± 5.49 23.4 ± 7.69  26.7 ± 8.61  17.0 ± 2.46 4.24 13.4  
10.3 - 47.9 17.5 - 39.4 5.63- 37.6 9.62 - 43.6 13.4 ± 19.0 
1,2,3,7,8,9-Cl6DD 2.19 ± 1.63 2.09 ± 1.45 2.1 ± 1.5 2.4 ± 2.24 2.01 ± 1.07 <0.1 1.94   
<0.1 - 5.51 <0.1 - 5.02  <0.1 - 4.09 <0.1 - 7.22 0.48 - 2.9 
1,2,3,4,6,7,8-Cl7DF 5.99 ± 4.09 6.3 ± 4.25 4.19 ± 3.37 5.64 ± 4.18 5.48 ± 1.33 1.32 7.29  
1.3 ± 19.2 2.52 - 19.2 <0.1 - 11.5 0.49 - 13.1 4.25 - 7.28 
1,2,3,4,6,7,8-Cl7DD 28.3 ± 11.3 28.6 ± 12.0 22.6 ± 9.98 26.6 ± 9.87 27.6 ± 6.29 7.55 14.9  
9.35 - 62.8 9.35 - 62.8 8.04 - 47.6 10.0 - 40.9 18.8 - 32.9 
OCDF   <1 ± 1.47 <1 ± 1.6 <1 <1  <1 ± 1.31 <1 <1  
<1 - 7.49 <1 - 7.49    <1 - 2.62 
OCDD   126 ± 55.7 129 ± 58.3 114 ± 43.3 126 ± 61.9 120 ± 31.1 47.4 62.3  
62.7 - 310  62.7 - 310 36.0 - 223 43.5 - 259 82.4 - 157 
3 PCDD/F  217 ± 76.5 219 ± 77.3 184 ± 59.8 210 ± 84.4 191 ± 35.1 71.3 112 
118 - 455 122 - 455 51.6 - 305 72.5 - 390 145 - 225 
I-TEq   13.6 ± 4.57 13.0 ± 3.21 9.7 ± 3.06 12.1 ± 3.48 9.0 ± 1.33 4.97 6.28  
6.06 - 26.0 6.06 - 18.4 1.77 - 14.1 4.9 - 17.7 7.03 - 9.81 
_____________________________________________________________________________________________________  
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Table 3a.
PCB concentrations and TEqs (mean  ±  standard deviation and range, ng/g fat) of non- and 
mono-ortho PCB congeners and of the di-ortho congeners which showed the highest 
concentrations of PCBs in the mother's milk from the urban area in Finland, in 1992-94. Asteriks 
indicate significant difference to the rural area (*p<0.01, **p<0.005, ***p<0.001). Other 
conditions as in Table 1. 
__________________________________________________________________________________________ 
congener       1. 1./(WHO) 2. 3. 4. 
____________________________________________________________________________________________ 
PCB 77a   47.4 ± 38.8***  44.1 ± 42.3***  32.3 ± 14.6  77.0  25.5 
<1 - 134 <1 - 134 20.9 - 48.9 73.1 - 81.0 
PCB 126a  89.7 ± 41.7***  90.1 ± 36.0*** 50.1 ± 5.62 100   31.9  
29.8 - 173 47.4 - 155 45.7 - 56.4 86.5 - 113 
PCB 169a   38.5 ± 13.0*** 40.6 ± 11.2*** 24.4 ± 9.47  33.7 15.5  
13.1 - 58.5 24.3 - 58.5 14.0 - 32.5 32.6 - 34.9 
PCB 105b  3.75 ± 1.88 3.9 ± 1.68 1.78 ± 0.21  4.64  1.21  
0.86 - 6.9 1.94 - 5.9 1.58 - 2.0 3.51 - 5.78 
PCB 114b  0.61 ± 0.28 0.64 ± 0.24 0.38 ± 0.06  0.64  0.19  
0.17 - 1.09 0.36 - 0.98 0.32 - 0.43 0.48 - 0.79 
PCB 118b  17.7 ± 9.59 18.1 ± 8.81 9.91 ± 1.57 20.1 6.34  
4.74 - 34.9 8.27 - 32.2 8.14 - 11.2 14.9 - 25.3 
PCB 156b  7.83 ± 2.66 8.14 ± 1.99 5.21 ± 2.03 7.04  2.41 
2.35 - 12.6 5.23 - 11.0 2.93 - 6.8 6.65 - 7.43 
PCB 157b  1.32 ± 0.46** 1.41 ± 0.33*** 0.76 ± 0.25 1.14  0.37 
0.38 - 2.08 0.9 - 1.86 0.48 - 0.91 1.02 - 1.27 
PCB 28   2.39 ± 1.77 2.58 ± 1.7 1.46 ± 2.53 0.36  1.99 
0.2 - 5.9 0.43 - 5.9 <0.001 - 4.38 <0.001- 0.71 
PCB 74   11.2 ± 5.67*** 11.6 ± 4.32*** 6.61 ± 1.84 15.0 2.57 
2.18 - 23.0 7.51 - 20.2 4.68 - 8.34 14.6 - 15.4 
PCB 99   11.1 ± 5.36*** 12.0 ± 5.16*** 6.06 ± 1.89 10.7  3.32  
2.54 - 22.9 5.95 - 22.9 4.7 - 8.21 8.06 - 13.4 
PCB 153  92.3 ± 33.7** 96.1 ± 27.0*** 54.0 ± 19.8 77.0 34.0  
24.3 - 148 60.3 - 137  32.0 - 70.3 65.3 - 88.7 
PCB 138  56.8 ± 22.9*** 59.7 ± 19.4*** 32.6 ± 10.1 50.4 18.7  
14.2 ± 92.5 36.5 - 85.5 23.6 - 43.5 39.9 - 61.0 
PCB 180  39.2 ± 11.8 42.6 ± 8.0** 22.4 ± 10.7 29.2 14.5 
9.85 - 60.5 29.9 - 60.5 10.5 - 31.2 29.2 - 29.2 
PCB 170  19.5 ± 5.92 20.6 ± 4.33 12.5 ± 5.8 15.8 7.15 
5.31 - 30.0 14.8 - 30.0 6.27 - 17.8 15.7 - 16.0 
PCB 187  12.3 ± 4.25 13.4 ± 3.3** 5.8 ± 2.54 9.18 4.83 
2.46 - 19.9 8.84 - 19.9 2.88 - 7.48 8.64 - 9.72 
PCB 183   6.05 ± 2.28** 6.64 ± 1.85*** 2.99 ± 1.17 4.41 2.23 
1.14 - 10.6 4.39 - 10.6 1.78 - 4.12 3.5 - 5.32 
PCB 194   3.49 ± 1.07* 3.5 ± 0.82** 2.71 ± 1.45 3.62 2.28 
1.16 - 5.3 2.31 - 4.69 1.19 - 4.08 3.35 - 3.89 
3 PCB    296 ± 108** 312 ± 85.3*** 170 ± 48.6 275 106 
73.8 - 464 200 - 442 115 - 207 256 - 295 
TEqc   18.5 ± 7.48** 18.9 ± 6.13** 10.9 ± 2.33 18.9 6.34 
5.68 - 32.8 10.8 - 29.4 8.47 - 13.1 16.6 - 21.2 
____________________________________________________________________________________________ 
aNon-ortho-substituted PCBs, given as pg/g fat 
bMono-ortho-substituted PCBs 
c given as pg/g fat 
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Table 3b.
PCB concentrations and TEqs (mean + standard deviation and range, ng/g fat) of non- and 
mono-ortho PCB congeners and of the di-ortho congeners which showed the highest 
concentrations of PCBs in the mother's milk from the surroundings of the rural area from 
Finland, in 1992-94. Conditions as in Table 1 and 3a.  
_____________________________________________________________________________________________________ 
congener 1. 1./(WHO) 2. 3. 4. 6. 13.  
_____________________________________________________________________________________________________ 
PCB 77a  1.74 ± 2.41 1.79 ± 2.47 1.62 ± 3.33  3.87 ± 5.59  5.27 ± 2.77 <1 2.73  
<1 - 9.44 <1 - 9.44 <1 - 12.1 <1 - 17.6 2.15 - 8.68 
PCB 126a 42.9 ± 18.6  40.6 ± 16.1 29.6 ± 14.9 43.0 ± 15.4   38.0 ± 4.95 34.4 31.6  
10.5 - 87.4 10.5 - 70.8 <1 - 56.2 18.5 - 67.6 31.6 - 43.4 
PCB 169a 23.7 ± 18.5 22.0 ± 17.9 16.8 ± 8.48  19.7 ± 6.57 13.5 ± 4.03  11.2 8.48  
5.64 - 98.0 5.64 - 98.0 <1 - 37.9 8.01 - 29.4 8.16 - 17.1 
PCB 105b 2.35 ± 1.12 2.37 ± 1.1 1.51 ± 0.59  1.8 ± 0.7  1.48 ± 0.2 1.36 1.45  
0.47 - 5.27 0.47 - 5.27 0.45 - 2.61 1.06 - 3.34 1.25 - 1.72 
PCB 114b 0.5 ± 0.23 0.49 ± 0.2 0.28 ± 0.1  0.37 ± 0.11  0.24 ± 0.05 0.16 0.15  
0.14 - 1.08 0.14 - 0.93 0.05 - 0.47 0.16 - 0.59 0.18 - 0.31 
PCB 118b 11.1 ± 4.59 11.2 ± 4.49 6.88 ± 2.48 8.34 ± 2.76 6.87 ± 0.89 5.63 5.36  
3.14 - 22.3 3.14 - 22.3 1.25 - 10.4 4.0 - 13.3 6.04 - 7.88 
PCB 156b 6.46 ± 3.64 6.03 ± 3.0 5.65 ± 3.11 6.11 ± 3.42  3.87 ± 1.02 1.34 2.71  
1.81 - 17.8 1.81 - 13.8 1.08 - 13.0 1.88 - 13.9 2.85 - 5.26 
PCB 157b 0.84 ± 0.46 0.77 ± 0.31 0.67 ± 0.29 0.8 ± 0.35  0.51 ± 0.11 0.24 0.37  
0.25 - 2.57 0.25 - 1.43 0.13 - 1.11 0.26 - 1.54 0.43 - 0.68 
PCB 28  4.04 ± 4.1 4.23 ± 4.36 2.0 ± 1.91 2.2 ± 2.8  2.05 ± 0.5 <0.001 1.95  
0.21 - 23.1 0.25 - 23.1 <0.001 - 6.61 <0.001 - 8.2 1.53 - 2.7 
PCB 74  5.84 ± 2.24 5.82 ± 1.94 3.91 ± 1.44 4.22 ± 1.88 3.46 ± 0.41 1.54 1.79  
2.06 - 10.5 2.41 - 8.95 0.39 - 5.98 1.52 - 8.72 2.99 - 3.98 
PCB 99  5.62 ± 2.42  5.91 ± 2.34 3.99 ± 1.76 3.51 ± 1.01  3.02 ± 1.15 2.3 3.09  
1.84 - 10.8 2.19 - 10.8 0.72 - 8.08 1.87 - 5.42 1.99 - 4.65 
PCB 153 57.7 ± 24.9 55.3 ± 22.4 55.8 ± 26.9 49.5 ± 19.9 36.9 ± 9.68 15.9 26.6  
18.2 - 110 22.4 - 110  10.6 - 115 23.0 - 83.1 25.0 - 48.0 
PCB 138 32.4 ± 12.7 31.6 ± 12.2 32.0 ± 15.2 26.9 ± 10.2 23.0 ± 7.53 9.22 20.0  
9.04 ± 59.5 12.7 - 59.5 5.21 - 68.4 11.7 - 44.4 12.4 - 28.5 
PCB 180 31.9 ± 17.5 29.2 ± 15.2 38.8 ± 26.9 34.5 ± 12.6 21.5 ± 4.66 12.4 15.2  
10.8 - 78.5 10.8 - 68.2 9.18 - 116 19.1 - 63.3 17.7 - 28.1 
PCB 170 17.2 ± 9.93 15.9 ± 8.98 20.1 ± 13.8 18.1 ± 8.03 10.9 ± 2.15 5.42 8.12  
5.92 - 42.7 5.92 - 42.6 4.5 - 59.7 9.14 - 37.9 9.47 - 14.1 
PCB 187 9.26 ± 4.43 8.66 ± 3.79 9.26 ± 4.16 8.87 ± 2.32 5.61 ± 1.7 4.63 4.16  
2.85 - 21.0 2.85 - 17.0 3.39 - 22.3 7.01 - 13.5 3.86 - 7.75 
PCB 183  3.91 ± 1.7 3.77 ± 1.49 4.8 ± 2.15 3.8 ± 0.93 2.87 ± 0.5 2.02 2.83  
1.62 - 8.73 1.62 - 7.58 1.72 - 9.44 2.24 - 5.34 2.34 - 3.51 
PCB 194  2.52 ± 1.55 2.24 ± 1.3 3.44 ± 2.61 3.21 ± 1.1 2.01 ± 0.67 1.66 2.01  
0.78 - 7.04 0.78 - 5.83 0.66 - 10.5 2.15 - 5.76 1.48 - 2.9 
3 PCB   198 ± 80.8 190 ± 71.9 194 ± 94.5 177 ± 63.3 129 ± 25.8 66.6 100  
75.7 - 371 80.4 - 352 52.6 - 409 91.9 - 301 103 - 162 
TEqc  11.6 ± 5.03 11.0 ± 4.16 9.37 ± 3.77 11.1 ± 4.06 8.24 ± 1.27 5.72 6.41 
3.86 - 26.3 3.86 - 20.3 2.37 - 17.9 4.54 - 19.1 7.24 - 10.1 
_____________________________________________________________________________________________________ 
aNon-ortho-substituted PCBs, given as pg/g fat. 
bMono-ortho-substituted PCBs 
c given as pg/g fat
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Geographical Aspects
 When expressed as ?PCDD/F, primiparae human milk concentrations were significantly 
higher in the urban area than in the rural area resulting from the fact that concentrations of the 
congeners which contribute mostly to ?PCDD/F were statistically significantly higher in the 
urban area than in the rural area. The concentrations of the congeners which contribute mostly to 
I-TEqs were only moderately higher in urban area than rural area. Consequently, the PCDD/F I-
TEqs  concentrations were higher in the urban than in rural area in primiparae but statistically 
less significantly than ?PCDD/F (Table 2). ?PCB and TEq concentrations were significantly 
higher among urban than rural primiparae (see Table 3). 
Correlation between PCDD/F and PCB concentrations
 The correlations between I-TEq and ?PCB concentrations among primiparae mother 
milk samples in the urban and rural area are shown in Fig. 1. The linear regression correlation 
coefficient (R) for the primiparae mother milk was 0.87 (0.91 in the urban and 0.76 in the rural 
area). R value for all milk samples was 0.82 (0.93 in the urban and 0.70 in the rural area).
Fig. 1. Correlation between ΣPCB and PCDD/F (as I-TEq) concentrations in 
human milk. Primiparae of all milk samples included.  
Time trends of PCDD/F and PCB concentrations 
The concentrations of PCDD/Fs and PCBs (primiparae mothers) in this study are 
compared in Figure 2. with those found in 1987 in Finland  [16]. Average decreases in 
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primiparae concentrations of PCDD/Fs and PCBs between 1987 and 1994 were 36 and 49%, 
respectively. Decreases of PCDD/Fs in urban and rural areas were 27 and 45%, respectively, and 
of PCBs 47 and 52%, respectively. The decreases of toxic equivalents of PCDD/F in urban and 
rural areas were 24 and 32%, respectively, and the corresponding values for PCB toxic 
equivalents were 50 and 56%, respectively. The changes of congeners 1,2,3,7,8-Cl5DF,
1,2,3,4,7,8-Cl6DF, OCDF and PCB 77 are excluded from the examination above due to low 
levels of congeners or analytical differences between years 1987 and 1994. 
5. DISCUSSION
 Ages of the mothers and milk fat contents did not differ statistically significantly from 
each other when comparing urban and rural primiparae mothers in this study. Furthermore,  ages 
and milk fat contents in this study did not differ statistically from those in our previous study 
[16]. This makes it possible to compare the concentrations and time trend of concentrations of 
PCDD/Fs and PCBs in primiparae mother milk of urban and rural areas between 1987 and 1994. 
 The difference between urban and rural concentrations of  PCDD/Fs and PCBs in 
primiparae mother milk remained when comparing current results with 1987 results. In fact, the 
differences in concentrations between areas have expanded. When the rural concentrations of 
3PCDD/F, I-TEq, 3PCB and TEq were 90, 76, 80, and 73%, respectively, of the concentrations 
in urban area in 1987, the current percentages are 57, 68, 67 and 63, respectively.  
 Like in 1987, the correlation between I-TEq and 3PCB concentrations in 1994 was 
statistically significant (linear correlation coefficient R = 0.82; p < 0.0001)  in the whole material 
and especially significant (R = 0.93; p < 0.0001) when examining the primiparae mothers in the 
urban area. These high correlation values give further confidence to the hypothesis that the 
sources of PCDD/Fs and PCBs are the same in Finland. 
 The well documented [1,2,16,17] decrease of PCDD/F and PCB concentrations in human 
milk with the increasing number of children was observed also in this study, though the 
concentrations of mothers having their third child exceeded the concentrations of mothers having 
their second child. This was most probably because of the low numbers of mothers nursing their 
third child, in this study. The lowest PCDD/F and PCB levels were found in Eastern Finland in milk 
of the mother who was breast-feeding her sixth child, 4.97 pg I-TEq/g fat and 5.72 pg TEq/g fat. 
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Fig. 2. PCDD/F and PCB concentrations for Finnish primiparae human 
milk samples in 1994 in percents when compared to 1987 concentrations. 
 WHO/EURO analyzed two pooled Finnish human milk samples in the second round of 
WHO-coordinated exposure study [11]. Milk samples were the same as in this study marked as 
1./(WHO). Pooling for WHO study was performed by us on volume basis. The average I-TEqs 
analyzed in this study (20.4 pg/g fat for urban area and 13.0 pg/g fat for rural area) are in good 
agreement with those values measured in the WHO study (21.5 pg/g fat for urban area and 12.0 
pg/g fat for rural area) [11]. Also the sums of marker PCBs (IUPAC 28, 52, 101, 138, 153 and 
180) as ng/g fat in this study (192 and 127, for urban and rural area, respectively) are similar to 
those values measured in the WHO/EURO study (189 and 134, for urban and rural area, 
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respectively). However the concentrations of non-ortho PCBs in this study differ considerably 
from those measured from the pooled samples in the second round of WHO-coordinated 
exposure study [11].
 Primiparae mother milk I-TEq values of Helsinki (19.9 pg I-TEq/g fat) were similar to 
those measured in Europe (Belgium, Germany, The Netherlands and Spain), while values of 
Kuopio area (13.6 pg I-TEq/g fat) were similar to values measured in Norway, Austria and 
eastern parts of Europe.  
 The decrease of concentrations of PCDD/Fs between 1986 and 1993 in human blood and 
milk has been reported from Germany and the Netherlands [8,9]. There is a specific uncertainty 
about the declining of concentrations of PCBs in human milk in the Central Europe [9] though 
the duplicate diet study showed a significant decline in the dietary exposure to PCBs in the 
period 1978-1994 [18]. In this study, the decrease of PCDD/Fs and PCBs in primiparae 
mothers= milk was found to be 36% and 49%, respectively, when compared to the 
concentrations of the primiparae mothers= milk in 1987 [16]. The declining of PCDD/Fs and 
PCBs seems to be  greater in rural (45 and 52%, respectively) than in urban (27 and 47%, 
respectively) area. In the WHO/EURO study there was a value 2.2% reported for the annual 
percentual decrease of dioxin levels (in pg I-TEq/g fat) in Finland, in between 1988-1993 [11]. 
That annual decrease was based on the results of two different laboratories [10,11]. The 
estimation of 5-6% for annual declining of PCDD/Fs in this study is based on the results of the 
same laboratory with similar methods. The differences between annual decrease can be 
explained with the differences of analytical methods. In Europe the declining of PCDD/Fs and 
PCBs in humans have been connected to measures taken to reduce PCDD/F and PCB emissions 
from industry [8,9]. There is not data available for the time trends of PCDD/Fs and PCBs in 
Finnish food between 1987-1994 and therefore the cause of the possible decrease of 
concentrations of PCDD/Fs and PCBs in human milk is unclear. In Finland, only one small 
municipal incinerator is functioning in comparison with the hundreds in Central Europe, but the 
prevailing winds may also carry their emissions towards Finland. Since 40% of the total SO2
deposit in Finland comes via the air from Central Europe, it may be assumed that also a major 
proportion of the total PCDD/F load is carried by the wind from other parts of Europe. This 
proportion most probably has decreased. 
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1. ABSTRACT 
We measured plasma concentrations of polychlorinated dibenzo-p-dioxins and 
dibenzofurans (PCDD/Fs), and polychlorinated biphenyls (PCBs) in fishermen from the Finnish 
Baltic Sea area and fishermen fishing in inland lakes. The concentrations clearly correlated with 
the frequency of fish meals and consumption of Baltic fatty fish. The body burden of PCDD/Fs 
reached the median level of 170 pg/g toxic equivalents (I-TEq) in fat for Baltic Sea fishermen, 
with the maximum being 420 pg/g. Results for 2,3,7,8-tetrachlorodibenzo-p-dioxin (range = 4.9-
110 pg/g fat) showed that lifetime exposure in a population consuming much Baltic fatty fish can 
reach the levels of exposures seen in Seveso, Italy, in 1976. After we summed the PCB-TEqs, 
the total median exposure of Baltic Sea fishermen increased to 290 pg/g TEq in fat, and the 
highest concentration was 880 pg/g. There was a noted individual variation in fishermen's 
PCDD/F congener patterns, and it was possible to associate this variation with congener patterns 
of PCDD/Fs in the fish species that the fisherman reported they had consumed. Linear regression 
models for ln WHOPCDD/F-TEq, ln WHOPCB-TEq, and ln total WHO-TEq, from the World Health 
Organization, explained 48%, 60%, and 53% of the variability, respectively. Age was the only 
significant predictor of ln WHOPCDD/F-TEq, whereas age, amount of fish eaten, and place of 
residence were significant predictors of ln WHOPCB-TEq, and ln total WHO-TEq. 
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2. INTRODUCTION 
Polychlorinated dibenzo-p-dioxins and dibenzofurans (PCDD/Fs) and polychlorinated 
biphenyls (PCBs) are fat-soluble pollutants, persistent in the environment, and because many of 
them are resistant to metabolism, they can bioaccumulate. They are present in human food and 
are considered potential health hazards. 
In Finland in the early 1990s, the contributions of different foodstuffs to the PCDD/F 
intake were estimated (1), and fish and fish products were determined to be responsible for 63% 
of the daily PCDD/F intake. The impact of fish and fish products on the intake of PCDD/Fs was 
considerably higher in Finland than in many other countries (2). A re-evaluation of the PCDD/F 
daily intake in Finland was conducted in 2000 (3). The contribution of fish and fish products to 
the daily PCDD/F intake had risen to 80%, mainly because of the decrease in the concentrations 
of these pollutants in cow milk and eggs. 
About 75% of the total fish catch in Finland comes from the Baltic Sea, with Baltic 
herring representing the major catch (4). Fatty fishes such as Baltic herring and salmon have 
been found to be contaminated with PCDD/Fs and PCBs (5, 6). PCDD/Fs accumulate in herring 
at the rate 1 pg/g toxic equivalents (I-TEq) per year, wet weight (ww) basis (6), so herring used 
for human consumption carry a body burden of 5-8 pg/g I-TEq on a ww basis. In nonfatty fishes 
(e.g., pike, pike perch, perch, bream), the concentrations of PCDD/Fs on a ww basis have been 
below 1 pg/g I-TEq, and concentrations in nonfatty fishes in the Baltic Sea are slightly higher 
than in the inland lakes (7-9).
Individuals consuming fish frequently may be at risk of increasing their body burden 
levels of PCDD/Fs and PCBs. The risk is especially high in persons eating Baltic fatty fish. One 
distinct group that has a high consumption of fish is professional fishermen. In Sweden, study 
groups have found that Baltic Sea fishermen with high consumption of fish can be exposed to 
high levels of PCDD/Fs and PCBs (10-13). In 1998 there were 2,948 registered professional 
fishermen in the Baltic Sea area in Finland, of whom 1,071 were full-time fishermen. In the 
inland areas of Finland, there were 1,192 fishermen, of whom 230 were full-time fishermen (14).
In this study, we analysed blood samples from a sample of Finnish Baltic Sea and inland 
fishermen for PCDD/Fs and PCBs to relate the body burden levels of these environmental 
contaminants to fish consumption frequencies and to the fish species consumed. We published 
preliminary PCDD/F-TEq data from this study previously (15), and now we provide the 
complete congener-specific data for PCDD/Fs and PCBs, along with a more detailed description 
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of the study population. In addition, we used regression analyses to identify significant 
predictors of the variability of toxic equivalents of PCDD/Fs and PCBs. 
3. MATERIALS AND METHODS 
Subject selection and data collection 
Forty-seven male fishermen who had registered at the Employment and Economic 
Development Centre for southeast Finland volunteered for the study in 1997. These men were 
living on the southeastern coast of the Gulf of Finland and in the area to the north along the 
River Kymijoki. The study group subjects were asked to complete a questionnaire about their 
intake of foods and about the relevant demographic features of their lifestyle (Table 1). 
The study group was classified using two different criteria according to information 
obtained from the questionnaires: the frequency of fish meals consumed and place of residence. 
Twenty-six fishermen were designated as exposed fishermen because they ate fish at least twice 
per week. The other fishermen (n = 21) ate fish meals once or less per week. Two groups were 
assigned based on a place of residence: the coastal group (n = 25) and the Kuusankoski group (n
= 22; Figure 1). The average distances of these groups from the coast of the Gulf of Finland were 
6 km and 45 km, respectively. The coastal fishermen can be regarded as sea-area fishermen, and 
the Kuusankoski subjects as inland fishermen. To obtain more information about their fish 
consumption, we asked the study subjects to rank their preference for different fish species. 
Seven fish species or group of fish species were available in this ranking: Baltic herring; 
cultivated rainbow trout; Baltic salmon; imported salmon; vendace; group consisting of pike, 
pike perch, perch, and bream; and frozen or canned fish. 
All subjects signed informed consents, and Ethical Committee of the National Public 
Health Institute the approved the design of the study. 
Blood sampling and laboratory analysis 
After subjects fasted for 12 hr, 250 mL of venous blood was drawn from each subject 
into centrifuge tubes that did not contain anticoagulants or a serum separator. The samples were 
allowed to clot for at least 40 min, and then were centrifuged for 20 min. The serums were 
transferred into glass vials and coded; the codes were broken only after the results had been 
calculated. 
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We analysed 17 toxic PCDD/Fs and 36 PCBs from each serum sample using a method 
described previously (16). Proteins from serum were precipitated with ethyl alcohol and 
ammonium sulfate. Fat was extracted with hexane, and fat content was determined 
gravimetrically. The analyzing method involved multiple cleanup steps, and finally high 
resolution mass spectrometry was used for quantification. All the results were reported on a fat 
basis, and limits of determination (LOD) for PCDD/Fs, non-ortho PCBs and other PCBs were 
0.5-5, 1.5, and 50 pg/g, respectively, depending on the isomer studied. Recoveries for internal 
standards were more than 60% for all congeners. We calculated toxic equivalents (TEq) for 
PCDD/Fs and PCBs using the following toxic equivalency factors (TEF): the North Atlantic 
Treaty Organization (NATO) factors for PCDD/Fs (I-TEq) (17), factors by Ahlborg et al. (18)
for PCBs (PCB-TEq), and factors recommended by the World Health Organization (WHO) in 
1998 for both PCDD/Fs and PCBs (WHOPCDD/F-TEq and WHOPCB-TEq, respectively) (19). In 
the calculations of toxic equivalents, results below the LOD were considered zero. In addition to 
concentration data of PCDD/Fs and PCBs, we studied the impact of fish species eaten most 
frequently by comparing congener profiles of individual fisherman with profiles originating from 
the fish species consumed most. 
Our laboratory has participated in several international quality control studies for the 
analysis of PCDD/Fs, and PCBs. Matrixes in these studies have included cow milk, human milk, 
human serum, and fish. (20-22). The laboratory is an accredited testing laboratory (No T077) in 
Finland [European Standard/International Organization for Standardization/International 
Electrotechnical Commission (EN ISO/IEC) 17025]. The scope of accreditation includes 
PCDD/Fs, PCBs, and non-ortho PCBs from serum samples. 
Statistical analysis 
We performed statiatical analysis with SPSS software (Windows, release 9.0.1; SPSS 
Inc., Chicago, IL, USA). WE used the Mann-Whitney U nonparametric test to test the statistical 
significance of the differences in concentration results. We tested proportional differences in fish 
consumption frequencies, preferences in fish species consumed, and differences in use of other 
food items with either the ?2 test or the Fisher exact test between classified subgroups.  
Linear regression models for dependent variables -WHOPCDD/F-TEq, WHOPCB-TEq, and 
sum of these (total WHO-TEq) - were established. Predictor variables in the models were age 
(year), body mass index (BMI, kg/m2), amount of fish eaten (kg/week), and place of residence. 
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Before to the regression analyses were done, all the toxic equivalents were transformed to the 
natural logarithm (ln) scale. The categorical predictor variable "amount of fish eaten" was 
transformed as a weighted continuous factor which was also transformed to the natural logarithm 
scale. In weighting fish amount, the average fish meal portion size, fish consumption frequency, 
preference in fish species consumption, and average PCDD/F and PCB TEq-concentrations of fish 
species were used. The predictor variable "place of residence" was used as categorical variable.
Table 1.
Mean, median, and (range) of age, BMI, and length of time of residence for fishermen and 
classified fishermen subgroups.
_____________________________________________________________________________ 
    Fish consumption frequency  Place of residence  
  All subjects exposed fishermen other fishermen coast  Kuusankoski  
Characteristics n = 47  n = 26   n = 21  n = 25  n =22 
Age (years) 58, 59 (27-77) 60, 60 (27-77)  56, 59 (42-73) 58, 59 (27-76) 58, 60 (42-77) 
BMI  27, 26 (23-36) 27, 27 (23-35)  27, 26 (23-36) 28, 27 (23-36) 27, 26 (23-33) 
Time at present 
residence (years) 45, 50 (4-77) 43, 51 (4-77)  47, 47 (9-73) 47, 50 (6-73) 42, 49 (4-77) 
____________________________________________________________________________________________ 
4. RESULTS 
Demographics and fish consumption 
The average age of the 47 study subjects was 58 years; in the groups classified by fish 
consumption frequency and place of residence, average ages were almost identical, and the 
differences were not statistically significant. Also BMI (27 kg/m2 for all subjects) and time of 
residence (45 years for all subjects) were very similar between groups, and the differences were 
not statistically significant (Table 1). 
In the group of exposed fishermen, the subjects ate fish at least twice per week; in the 
other fishermen group, the frequency of fish consumption was once or less per week. When we 
compared the fish consumption frequency by place of residence (i.e., the coastal group vs. the 
Kuusankoski group), the ?2 test did not reach statistically significant difference, (p < 0.334). A 
slightly larger proportion of subjects in the coastal group (15 of 25) ate fish at least twice a week 
compared with the Kuusankoski group (11 of 22). 
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Fig 1. Study area showing fishermen subgroups according to place of residence. 
Table 2 summarizes the ranked results of the two most favoured fish species or group of 
fish species in classified subgroups of subjects. In the subgroups created according to fish 
consumption frequency, the proportions of primary and secondary fishes were not statistically 
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significantly different according to Fisher’s exact test. For the coastal and Kuusankoski groups, 
there were statistically significant differences between proportions of fish species in both 
primary and secondary fishes (p < 0.003 and p < 0.001, respectively). In the coastal group, Baltic 
herring or salmon was the primary fish species being consumed by 10 subjects, but no subjects 
in the Kuusankoski group chose these species as the primary species. For secondary fish species, 
vendace was the dominant in the Kuusankoski group (14 subjects), whereas no subjects in the 
coastal group ranked vendace as their primary or secondary fish. No subjects ranked imported 
salmon or frozen or canned fish as being within the two most favoured fish species. 
Consumption frequency patterns of milk, milk products, and meat and current and past 
smoking patterns were very similar among the classified subgroups and were not statistically 
significantly different (data not shown).
Serum levels of PCDD/Fs and PCBs 
Mean levels, median levels, and ranges of 17 toxic PCDD/Fs and TEqs in all 47 subjects 
and in classified subgroups are summarized in Table 3. The overall median and mean I-TEq 
concentrations were 120 and 150 pg/g fat, respectively. The four congeners contributing the 
most to TEq median (mean) concentrations in fat were in ranked order: 1) 2,3,4,7,8-
pentachlorodibenzofuran [2,3,4,7,8-PeCDF; 45.5 (50) pg/g I-TEq]; 2) 1,2,3,7,8-
pentachlorodibenzo-p-dioxin [1,2,3,7,8-PeCDD; [26.5 (31) pg/g I-TEq]; 3) 1,2,3,6,7,8- 
hexachlorodibenzo-p-dioxin [1,2,3,6,7,8-HxCDD; 24 (30) pg/g I-TEq]; and 4) 2,3,7,8-
tetrachlorodibenzo-p-dioxin [2,3,7,8-TCDD; 13 (19) pg/g I-TEq]. 
More frequent fish consumption produced higher median concentrations for all PCDD/F 
congeners, and the differences between exposed (median = 170 pg/g) and other fishermen 
(median = 87 pg/g) I-TEqs were statistically significant (p < 0.05). In the exposed fishermen 
group, 2,3,7,8-TCDD concentrations were as high as 110 pg/g, and I-TEq concentrations reached 
levels up to 420 pg/g. The coastal group fishermen were significantly more exposed to dioxins 
compared with the Kuusankoski group. One distinctive exception to this trend was the 
concentration of 1,2,3,6,7,8-HxCDD, because concentrations in Kuusankoski group were higher 
than in coastal group (270 vs. 210 pg/g fat, respectively). 
Sum concentrations of 36 PCB congeners, along with individual congener concentrations 
and PCB toxic equivalents, are presented in Table 4. Mean and median sum PCB concentrations 
in all 47 fishermen were 2,100 and 1,400 ng/g fat, respectively, with the maximum value being 
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8,700 ng/g. The median PCB-TEq level (80 pg/g fat; mean = 110 pg/g fat) was slightly smaller 
than that in PCDD/Fs, but it did achieve values as high as 460 pg/g fat. The four main congeners 
accounting for 75% of the median sum PCB concentration were International Union of Pure 
Applied Chemistry (IUPAC) 138, 153, 170, and 180. The most dominant non-ortho-PCB was 
IUPAC 126, ranging from 35 to 1,500 pg/g fat in all subjects. 
More frequent fish consumption produced greater concentrations of all PCB congeners, 
and PCB-TEq mean and median values were 130 and 120 pg/g fat, respectively. Place of 
residence produced an even bigger difference between the subgroups than the classification by 
fish consumption. The median PCB-TEq value in the coastal group (140 pg/g) was over twice 
that in the Kuusankoski group (65 pg/g), and for IUPAC 153, the difference in concentration 
between the groups was about 3-fold (800 vs. 280 ng/g fat, respectively). 
The ratio between sum concentrations of PCBs and I-TEq in all subjects was about 
14,200:1. In subgroups according to fish consumption, the ratio was comparable to the value in all 
subjects, but in subgroups according to place of residence, the ratio in the coastal group was 
16,400:1 (ranging from 8,100:1 to 25,800:1), and the ratio in the Kuusankoski group was 11,300:1 
(ranging from 6,000:1 to 14,900:1); this difference was statistically significant (p < 0.001). A 
similar difference was observed when the proportion of PCB-TEq was calculated from the total 
TEq. In the coastal group, PCB-TEq contributed 44% of the total TEq (320 pg/g fat), whereas in 
the Kuusankoski group, PCB-TEq accounted for 35% of  the total TEq (186 pg/g fat). In both 
groups classified by fish consumption, the contribution of PCB-TEq to total TEq was 42%. 
Figure 2 illustrates the impact of fish species consumed on the congener profile of an 
individual fisherman, the congener profiles of three fish species (Baltic herring/salmon, pike, and 
bream) and three fishermen. All three fishermen reported that they consumed solely or mostly 
the respective fish species. 
Table 5 summarizes the regression analyses conducted to determine predictors of the 
variance of natural logarithms of WHOPCDD/F-TEq, WHOPCB-TEq, and total WHO-TEq. Age was 
the only significant regression predictor of ln WHOPCDD/F-TEq, and the whole model explained 
48% of the variance of ln WHOPCDD/F-TEq. Age and the amount of fish consumed were the most 
important predictors, with contributions of 22.5% and 19.3%, respectively. Place of residence, 
age, and amount of fish consumed were significant regression predictors of both ln WHOPCB-
TEq and ln total WHO-TEq. For PCBs, the most important predictor was place of residence, 
with a 35.4% contribution, followed by age, with a 17.7% contribution. The most important 
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predictors of variance for ln total WHO-TEq were the same as those for ln WHOPCDD/F-TEq - 
age and amount of fish consumed - with the contributions being 21.5% and 23.6%, respectively. 
In each of these three models, the normal distribution of residuals was verified with normal 
probability plots. Variance inflation factors (VIF) showed no multicollinearity between 
predictors in any of these three models. 
Table 2. 
Ranking frequencies of the two most favored fish species in subgroups of fishermen.
_____________________________________________________________________________________________________________________ 
      Fish consumption frequency    Place of residence  
     Exposed fishermen Other fishermen  Coast    Kuusankoski  
Ranking of fish species   n = 26   n = 21   n = 25    n = 22
_______________________________________________________________________________________________________________ 
Primary fish (n)
Baltic herring    5   4   9    0 
Baltic salmon    1   0   1    0 
Cultivated rainbow trout   4   5   5    4 
Pike, pike perch, perch, bream  16   10   10    16 
Vendace     0   2   0    2 
Secondary fish (n)
Baltic herring    5   4   6    3 
Baltic salmon    2   2   3    1 
Cultivated rainbow trout   5   4   7    2 
Pike, pike perch, perch, bream  6   5   9    2 
Vendace     8   6   0    14 
154
Table 3.
Mean, median, and (range) of PCDD and PCDF congeners and TEqs in blood samples for fishermen according to subgroupsa.
________________________________________________________________________________________________________________________________
        Fish consumption frequency   Place of residence  
   All subjects   Exposed fishermen Other fishermen  Coast   Kuusankoski 
Congener  n = 47    n = 26   n = 21   n = 25   n = 22  _____
2,3,7,8- TCDF  7.4, 5.6 (ND-30)   8.8, 7.1 (1.1-30)  5.6, 4.4 (ND-18)  8.4, 7.0 (0.57-30)  6.2, 4.3 (ND-24) 
1,2,3,7,8- PeCDF  3.5, 2.6 (ND-33)   4.0, 3.0 (ND-33)  3.0, 2.4 (ND-11)  2.5, 2.9 (ND-8.7)  4.8, 2.5 (ND-33) 
2,3,4,7,8- PeCDF  100, 91 (22-280)   120, 120 (39-280)* 82, 61 (22-260)  130, 130 (37-280)** 71, 57 (22-220) 
1,2,3,4,7,8- HxCDF 22, 17 (5.3-84)   24, 20 (6.0-84)  18, 16 (5.3-39)  24, 21 (8.3-69)**  19, 15 (5.3-84) 
1,2,3,6,7,8- HxCDF 24, 19 (5.2-100)   27, 21 (7.1-100)  19, 15 (5.2-42)  25, 21 (7.1-53)  22, 15 (5.2-100) 
2,3,4,6,7,8- HxCDF 7.5, 6.3 (1.1-35)   8.9, 7.1 (1.1-35)*  5.7, 4.5 (1.9-14)  8.0, 6.8 (2.8-21)  7.0, 5.1 (1.1-35) 
1,2,3,7,8,9- HxCDF 1.2, 0.50 (ND-10)  1.5, 0.52 (ND-10) 0.88, 0.36 (ND-4.3) 1.9, 0.99 (ND-10)** 0.46, 0.28 (ND-3.9) 
1,2,3,4,6,7,8-HpCDF 75, 43 (11-1,100)   98, 42 (11-1,100)  47, 44 (17-92)  100, 52 (14-1,100) 47, 33 (11-160) 
1,2,3,4,7,8,9-HpCDF 0.23, ND (ND-5.0)  0.31, ND (ND-5.0) 0.12, ND (ND-1.4) ND, ND**  0.490, ND (ND-5.0) 
OCDF   42, ND (ND-1,900)  74, ND (ND-1,900) 1.2, ND (ND-11)  76.5, ND (ND-1,900)** 1.8, ND (ND-11) 
2,3,7,8- TCDD  19, 13 (2.7-110)   25, 19 (4.9-110)*  11, 10 (2.7-32)  27, 21 (4.1-110)** 9.5, 7.3 (2.7-27) 
1,2,3,7,8- PeCDD 62, 53 (9.1-180)   79, 76 (15-180)*  42, 34 (9.1-140)  78, 78 (22-180)** 44, 34 (9.1-150) 
1,2,3,4,7,8- HxCDD 8.3, 7.6 (ND-31)   8.8, 7.7 (ND-31)  7.6, 7.2 (ND-23)  7.5, 7.0 (ND-23)  9.2, 7.6 (ND-31) 
1,2,3,6,7,8- HxCDD 300, 240 (46-1,700)  370, 290 (46-1,700)* 220, 190 (74-640) 260, 210 (46-650) 360, 270 (74-1,700) 
1,2,3,7,8,9- HxCDD 73, 46 (ND-320)   82, 59 (ND-320)  62, 36 (12-290)  87, 53 (ND-320)  56, 39 (12-160) 
1,2,3,4,6,7,8- HpCDD 120, 110 (21-340)  120, 120 (21-340) 120, 110 (43-330) 140, 110 (44-330) 110, 95 (21-340) 
OCDD   800, 610 (230-2,900)  790, 780 (230-2,900) 810, 600 (290-2,600) 830, 630 (310-2,600) 770, 600 (230-2,900) 
Sum of toxic congeners 
   1,700, 1,400 (580-5,800)  1,800, 1,600 (580-5,800) 1,500, 1,100 (630-4,100) 1,800, 1,500 (580-4,600) 1,500, 1,200 (630-5,800)
I-TEq   150, 120 (30-420)  180, 170 (51-420)* 110, 87 (30-280)  180, 170 (62-420)** 120, 92 (30-350) 
WHOPCDD/F-TEq  180, 150 (34-500)  220, 210 (58-500)* 130, 100 (34-340) 220, 210 (75-500)** 140, 110 (34-420) __
Abbreviations: HpCDD, heptachlorodibenzo-p-dioxin; HpCDF, heptachlorodibenzofuran; HxCDD, hexachlorodibenzo-p-dioxin; HxCDF, hexachlorodibenzofuran; I-TEq, 
NATO toxic equivalency factors; ND, below limit of determination; OCDD, octachlorodibenzo-p-dioxin; OCDF, octachlorodibenzofuran; PeCDD, pentachlorodibenzo-p-
dioxin; PeCDF, pentachlorodibenzofuran; TCDD, tetrachlorodibenzo-p-dioxin; TCDF, tetrachlorodibenzofuran; WHOPCDD/F-TEq, WHO toxic equivalency factors for 
PCDD/Fs. aConcentrations are given in pg/g fat. *Significantly different compared with the other fishermen group (p < 0.05 by Mann-Whitney U-test). **Significantly 
different compared with the Kuusankoski place of residence group (p < 0.05 by Mann-Whitney U-test). 
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Table 4. 
 Mean, median, and (range) of non-ortho-PCBsa, other PCBsb, and TEqsa in blood samples for fishermen and the various subgroups.
_________________________________________________________________________________________________________________________ 
       Fish consumption frequency   Place of residence  
Congener  All subjects  Exposed fishermen Other fishermen  Coast  Kuusankoski 
IUPAC no.  n = 47   n = 26   n = 21   n = 25  n = 22  
Non-ortho-PCBs 
77   63, 55 (ND-190)  77, 68 (13-190)*  45, 37 (ND-100)  79, 68 (28-190)** 44, 30 (ND-150) 
126   300, 230 (35-1,500) 360, 260 (49-1,500)* 240, 150 (35-950) 430, 360 (61-1,500)** 160, 150 (35-330) 
169   160, 130 (50-490) 190, 180 (72-490)* 130, 100 (50-280) 190, 190 (67-490) 130, 110 (50-300) 
Other PCBs 
18   0.88, 0.53 (ND-3.7) 0.94, 0.52 (ND-3.7) 0.82, 0.53 (ND-3.3) 0.54, 0.23 (ND-2.4)** 1.3, 0.90 (ND-3.7) 
28/31   13, 9.5 (0.24-94)  15, 10 (0.54-94)  9.9, 4.4 (0.24-36)  17, 13 (0.24-94) 8.0, 5.8 (0.54-33) 
33   1.0, 0.13 (ND-4.4) 1.1, 0.43 (ND-4.4) 0.92, 0.045 (ND-4.1) 0.72, ND (ND-3.5) 1.4, 0.76 (ND-4.4) 
47   1.1, 0.90 (ND-6.8) 1.4, 1.1 (ND-6.8)  0.85, 0.78 (0.11-2.3) 1.3, 1.2 (ND-6.8) 0.91, 0.78 (0.19-2.3) 
49   0.66, 0.53 (ND-2.0) 0.71, 0.56 (ND-2.0) 0.60, 0.48 (ND-2.0) 0.43, 0.41 (ND-1.3)** 0.93, 0.82 (0.063-2.0) 
51   0.063, 0.034 (ND-0.23) 0.068, 0.043 (ND-0.22) 0.056, 0.028 (ND-0.23) 0.035, ND (ND-0.17)** 0.095, 0.078 (ND-0.23) 
52   2.2, 1.6 (ND-14)  2.5, 1.9 (0.69-14)* 1.9, 1.3 (ND-11)  2.3, 1.6 (ND-14) 2.1, 1.7 (0.67-11) 
60   2.8, 1.5 (0.20-35)  3.7, 1.6 (0.54-35)  1.6, 1.0 (0.20-5.8) 4.2, 2.8 (0.33-35)** 1.2, 0.93 (0.20-3.6) 
66   16, 5.1 (0.54-200) 22, 6.8 (1.6-200)  8.2, 3.5 (0.54-35)  27, 19 (2.1-200)** 3.4, 2.6 (0.54-11) 
74   55, 36 (4.7-460)  72, 41 (9.4-460)  34, 23 (4.7-110)  87, 56 (17-460)** 18, 15 (4.7-51) 
99   59, 34 (6.0-290)  74, 53 (8.2-290)*  40, 28 (6.0-140)  90, 82 (22-290)** 24, 21 (6.0-57) 
101   4.7, 3.7 (0.27-26)  5.8, 4.7 (0.27-26)* 3.5, 3.1 (0.42-13)  6.4, 5.2 (0.87-26)** 2.9, 3.0 (0.27-6.5) 
105   31, 22 (2.7-150)  38, 27 (4.2-150)*  21, 11 (2.7-84)  47, 39 (5.7-150)** 12, 10 (2.7-23) 
110   3.0, 2.5 (0.21-13)  3.6, 2.9 (0.40-13)* 2.3, 1.7 (0.21-8.0) 4.0, 3.8 (0.94-13)** 1.9, 1.9 (0.21-3.4) 
114   5.7, 4.0 (0.81-22)  6.9, 6.0 (1.3-22)*  4.2, 2.6 (0.81-11)  8.4, 8.1 (1.9-22)** 2.6, 2.4 (0.81-5.9) 
118   150, 110 (16-730) 180, 140 (24-730)* 110, 59 (16-410)  220, 180 (45-730)** 66, 58 (16-120) 
122   ND, ND   ND, ND   ND, ND   ND, ND  ND, ND 
123   6.2, 4.1 (0.56-25)  7.6, 5.5 (0.70-25)* 4.5, 2.6 (0.56-17)  9.5, 8.7 (1.0-25)** 2.5, 2.4 (0.56-5.1) 
128   4.5, 2.4 (ND-20)  5.8, 4.6 (ND-20)* 2.9, 1.1 (ND-14)  7.9, 6.9 (1.1-20)** 0.61, 0.22 (ND-3.3) 
138   320, 210 (41-1,600) 400, 340 (77-1,600)* 220, 180 (41-660) 450, 400 (140-1,600)** 160, 150 (41-420) 
141   1.4, 0.97 (ND-6.3) 1.7, 1.2 (ND-6.3)* 0.90, 0.69 (ND-5.5) 1.9, 1.4 (ND-6.3)** 0.73, 0.69 (ND-1.6) 
153   600, 380 (87-2,600) 740, 590 (180-2,600)* 430, 290 (87-1,400) 860, 800 (240-2,600)** 310, 280 (87-840) 
156   58, 50 (14-230)  70, 63 (22-230)*  43, 40 (14-89)  72, 71 (23-230)** 42, 39 (14-120) 
157   11, 7.9 (2.0-45)  13, 11 (3.2-45)*  8.0, 6.5 (2.0-22)  15, 15 (4.1-45)** 6.0, 6.0 (2.0-16) 
167   17, 14 (2.4-81)  20, 18 (4.1-81)*  12, 9.4 (2.4-35)  24, 21 (6.2-81)** 9.0, 8.8 (2.4-21) 
170   190, 160 (48-670) 220, 200 (79-670)* 140, 130 (48-270) 220, 200 (87-670)** 140, 130 (48-390) 
180   370, 300 (84-1,200) 440, 370 (130-1,200)* 280, 230 (84-620) 470, 460 (190-1,200)** 260, 230 (84-750) 
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183   37, 25 (4.5-150)  45, 35 (11-150)*  26, 21 (4.5-80)  49, 46 (15-150)** 22, 20 (4.5-54) 
187   83, 65 (15-340)  100, 100 (29-340)* 57, 48 (15-130)  110, 110 (38-340)** 57, 48 (15-160) 
189   7.2, 6.4 (1.8-24)  8.5, 7.7 (2.6-24)*  5.5, 4.3 (1.8-11)  8.8, 9.1 (3.8-24)** 5.3, 4.3 (1.8-14) 
194   44, 41 (12-140)  51, 47 (18-140)*  34, 30 (12-57)  52, 50 (22-140)** 34, 29 (12-88) 
206   7.4, 6.0 (1.8-22)  8.7, 7.9 (3.2-22)*  5.8, 5.1 (1.8-12)  9.7, 9.4 (4.1-22)** 4.8, 4.7 (1.8-10) 
209   3.6, 3.4 (0.95-9.0) 4.1, 3.8 (0.95-9.0)* 3.0, 2.6 (1.2-6.5)  4.2, 4.0 (1.5-9.0)** 2.9, 2.9 (0.95-5.7) 
Sum of PCBs  2,100, 1,400 (360-8,700) 2,600, 2,200 (680-8,700)* 1,500, 1,200 (360-4,200) 2,900, 2,700 (950-8,700)**1,200, 1,200 (360-3,100) 
PCB-TEq  110, 80 (21-460)  130, 120 (30-460)* 81, 68 (21-230)  140, 140 (45-460)** 66, 65 (21-150) 
WHOPCB-TEq  89, 66 (17-400)  110, 96 (22-400)* 67, 52 (17-200)  120, 110 (34-400)** 51, 50 (17-110)_________
ND, below limit of determination. 
a Concentrations are given in pg/g fat. b Concentrations are given in ng/g fat * Significantly different compared with the other fishermen group (p < 0.05 by Mann-Whitney 
U-test). ** Significantly different compared with the Kuusankoski place of residence group (p < 0.05 by Mann-Whitney U-test). 
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5. DISCUSSION 
Because the median age and distributions of ages among classified subgroups were so 
similar, we did not adjust the concentrations of PCDD/Fs and PCBs for age. The mean time of 
residence at the current address in the subgroups was also so long that each person would have 
adopted the local exposure pattern to PCDD/Fs and PCBs via their living habits. All persons 
with time of residence ? 9 years had been living in the same area earlier only at a different 
address. 
Results of this study clearly associated higher body burden of PCDD/Fs and PCBs with 
higher intake of fish. Consuming fish at least twice a week resulted in plasma concentrations of 
PCDD/Fs over five times those found in a corresponding nonfisherman population in Finland 
(15). Fishermen who reported eating fish once a week or less also had elevated blood levels of 
PCDD/Fs and PCBs. Between the exposed fishermen and other fisherman subgroups, there was 
no difference in the species of fish consumed; therefore, the difference between these groups 
must be assumed to derive solely from the frequency of fish consumption. When the fishermen 
were grouped according to place of residence, the frequency of fish consumption did not have a 
critical effect on concentrations of PCDD/Fs and PCBs, although subjects in the coastal group 
ate fish more frequently than subjects in the Kuusankoski group. The species of fish consumed 
had a more critical effect because subjects in the coastal group ate fatty Baltic fish species more 
frequently than did subjects in the Kuusankoski group. Also, the consumption of rainbow trout 
by the coastal group was more frequent than by the Kuusankoski group, and one must bear in 
mind that in the Baltic sea, fishes in the class "pike" also have a higher content of PCDD/Fs and 
PCBs in their tissues compared with inland lakes "pikes" (7, 8).
The ratio between sum concentrations of PCBs and I-TEq in the coastal group was 
statistically significantly different from the corresponding ratio in the Kuusankoski group. This 
could be a result of the relatively more severe contamination of Baltic fish by PCBs than of fish 
in inland lakes. Furthermore, this ratio between the sum concentrations of PCB and I-TEq varied 
significantly within groups, from 8,100:1 to 25,800:1 in the coastal group and from 6,000:1 to 
14,900:1 in the Kuusankoski group. Because the correlation between PCB congener IUPAC 153 
and the sum concentrations of PCBs was almost 1, the use of IUPAC 153 as an indicator of 
dioxin TEqs can produce misleading results. 
When we compared I-TEq congener patterns, we discovered individual differences. 
Because the role of fish is profound with respect to the fishermen's intake of PCDD/Fs, and 
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because there were no statistically significant differences in other food consumption habits or 
smoking habits between the classified subgroups, we hypothesized that these differences in the I-
TEq congener patterns were caused by consumption of different fish species. If a
Fig 2.Congener I-TEq profiles of individual fishermen and profiles of fish species that each 
fisherman reported he prefers to consume. Congeners: 1: 2,3,7,8-TCDD; 2: 1,2,3,7,8-PeCDD; 3: 
1,2,3,4,7,8-HxCDD; 4: 1,2,3,6,7,8-HxCDD; 5: 1,2,3,7,8,9-HxCDD; 6: 1,2,3,4,6,7,8-HpCDD; 7: 
OCDD; 8: 2,3,7,8-TCDF; 9: 1,2,3,7,8-PeCDF; 10: 2,3,4,7,8-PeCDF; 11: 1,2,3,4,7,8-HxCDF; 12: 
1,2,3,6,7,8-HxCDF; 13: 2,3,4,6,7,8-HxCDF; 14: 1,2,3,7,8,9-HxCDF; 15: 1,2,3,4,6,7,8-HpCDF; 
16: 1,2,3,4,7,8,9-HpCDF; 17: OCDF. 
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fisherman reported that he was consuming mainly one kind of fish species, it was often possible 
to detect a similar I-TEq congener profile in his fasting blood sample. Figure 2 shows that only 
the congener 2,3,7,8-tetrachlorodibenzofuran (2,3,7,8-TCDF) was missing from the fishermen's 
profiles. This is a result of rapid metabolism of this congener in humans. Almost half of the 
fishermen in the Kuusankoski group fish from a lake famous for its bream catches. Examination 
of I-TEq congener pattern reveals that 1,2,3,6,7,8-HxCDD is the main congener in bream, which 
might explain why the 1,2,3,6,7,8-HxCDD concentrations in the Kuusankoski group were higher 
than in coastal group, in contrast to the general trend. It was not possible to discern a similar 
effect when studying PCB congener patterns (i.e., the consumption of a certain fish species by 
one individual fisherman was not reflected in his blood PCB congener profile). 
PCDD/F concentrations (in all subjects, 120 pg I-TEq/g in fat) assayed in this study are 
comparable to body burdens found in Swedish Baltic fishermen of the same age (12). Therefore, 
fishermen in Finland and all around the Baltic Sea area can accumulate via their diet dioxin body 
burdens that are comparable to the concentrations found in Seveso, Italy, after the accidental 
release of 2,3,7,8-TCDD. In our study 2,3,7,8-TCDD concentrations rose up to 110 pg/g fat, 
which is at the same level found in Seveso B zone (23). The PCDD/F concentrations found in 
this study were somewhat higher than those found in Canada among the Inuits (39.6-56.7 pg/g I-
TEq in fat) (24, 25). The PCDD/F concentrations in frequent consumers of fish from the Great 
Lakes in the United States (26) also showed considerably lower levels (13.9-19.6 pg/g I_TEq in 
fat) than those found in the present study. 
In this study,  the median value for 36 PCB congeners was 1,400 ng/g fat, ranging up to 
8,700 ng/g in the coastal area in those fishermen eating fish at least twice a week. In Swedish 
studies, the range of PCBs has been from 1,600 to 5,300 ng/g fat, but in those studies the number 
of congeners is not comparable to those in our study (12, 13). The values for one of the main 
congeners of PCBs, IUPAC 153, are about the same in the Swedish studies (280-1,700 ng/g fat) 
as in our study (87-2,600 ng/g fat). In our study, the lower end of the PCB range comes from the 
inland lake fishermen; therefore, it would be better to compare the coastal group results from our 
study with the Swedish results. The range of IUPAC 153 in the coastal group from our study was 
from 240 to 2,600 ng/g fat, which is almost identical to concentrations measured in Sweden. The 
dominant congener in PCB-TEq is IUPAC 126. In our study, the concentrations of IUPAC 126 
were slightly lower (median = 230 pg/g fat for all subjects and 360 pg/g fat for the coastal group) 
than those found in Sweden (from 560 to 1,050 pg/g fat) (12). In contrast to PCDD/Fs, the PCB 
concentration levels in Canada seem to be somewhat higher than those in our study. Ryan et al. 
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(25) reported the sum PCB concentration for 11 congeners to be 6,000 ng/g fat and the 
concentration for IUPAC 126 to be 619 pg/g fat. The mean concentration of 20 PCBs in adult 
Inuits living in Nunavik was reported to be 4,000 ng/g, ranging up to 9,870 ng/g, and levels of 
IUPAC 153 ranged from 240 to 3,070 ng/g fat (24).
We used only four predictor variables in the linear regression analyses of ln WHOPCDD/F-
TEq, ln WHOPCB-TEq, and ln total WHO-TEq. Using more variables with these 47 subjects 
would have increased the predictability of the models, but it would have reduced the model's 
generalization and limited the model’s use with other Finnish fishermen samples. Age was the 
only significant predictor in all three models. The amount of fish consumed was the second 
dominating predictor of variance of ln WHOPCDD/F-TEq in contrast to the predictor of variance of 
ln WHOPCB-TEq, which was place of residence. This might be caused by differences in dioxin 
congener profiles among fish species, because fish species eaten was taken into account when 
weighted fish amounts were calculated. We detected no difference in PCB profiles among fish 
species similar to that seen in dioxin profiles. This might explain why place of residence, not 
consumption of fish, was the second dominating predictor of variance of ln WHOPCB-TEq. 
In conclusion, we found that in Finland, fish consumption can cause elevated levels of 
PCDD/Fs and PCBs. Especially high levels of these contaminants can result from consumption 
of fatty Baltic fish. It was possible to determine the type of fish species that an individual 
fisherman consumed most from his blood I-TEq congener pattern. 
Table 5.
Predictors of the variance of natural logarithms of WHOPCDD/F-TEq, WHOPCB-TEq, and total WHO-TEq for Finnish fishermen.
______________________ _______________________________________________________________________ 
Predictor variable   Parameter estimate  SE  p-Value   
Dependent variable: ln WHOPCDD/F-TEq 
Constant    2.4    0.67  < 0.001 
Age     0.028    0.007  < 0.0001 
BMI     0.034    0.021  < 0.12 
Amount of fish consumed   0.12    0.064  < 0.062 
Place of residence   0.26    0.18  < 0.14    
ln WHOPCDD/F-TEq model percentage r2=0.48 
Dependent variable: ln WHOPCB-TEq 
Constant    1.9    0.65  < 0.005 
Age     0.027    0.006  < 0.0001 
BMI     0.021    0.02  < 0.31 
Amount of fish consumed   0.15    0.062  < 0.02 
Place of residence   0.53    0.17  < 0.003    
ln WHOPCDD/F-TEq model percentage r2=0.60 
Dependent variable: ln total WHO-TEq 
Constant    2.9    0.65  < 0.0001 
Age     0.027    0.006  < 0.0001 
BMI     0.030    0.021  < 0.16 
Amount of fish consumed   0.13    0.062  < 0.041 
Place of residence   0.35    0.17  < 0.05    
ln total WHO-TEq model percentage r2=0.53          
____________________________________________________________________________________
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CHAPTER 8 
GENERAL DISCUSSION 
1. GENERAL ADULT INTAKE OF PCDD/Fs AND PCBs
 On average, the Finnish adult daily intake of PCDD/Fs was 60 pg or 0.79 pg WHO-
TEq/kg bw, being very similar to other European intakes. The calculation methods selected had a 
major impact in assessments of the intake of PCDD/Fs. If we chose to use SIFF method and 
lower bound concentrations of congeners in foodstuffs and I-TEFs for the calculations of TEqs, 
then the daily intake was 46 pg I-TEq or 0.61 pg I-TEq/kg bw. The use MBM-method and upper 
bound concentrations and WHOPCDD/F-TEFs resulted in intake assessments of 75 pg WHOPCDD/F-
TEq or 0.99 pg WHOPCDD/F-TEq/kg bw. When using upper bound concentrations of PCDD/Fs in 
foodstuffs and the same set of TEFs, then the PCDD/F intake would increase by 22-29%, when 
compared to the use of lower bound concentrations. 
With respect to PCB TEqs, the difference between lower and upper bound intake 
assessments was less than 2%, irrespective of the TEF set used. The intake of PCBs was similar 
to PCDD/F intake, being on average 0.74 pg TEq/kg bw/day. This was somewhat less than has 
been assessed elsewhere in Europe. 
Total adult exposure in Finland to PCDD/Fs and PCBs via the diet was hence assessed to 
be on average 116 pg/day or 1.5 pg TEq/kg bw/day, for a person weighing 76 kg. This intake as 
well as the maximum, upper bound, daily intake of PCDD/Fs and PCBs (1.8 pg WHO-TEq/kg 
bw/day), was below the EU SCF  TDI of 2 pg WHO-TEq/kg bw/day (European Commission 
2001), though the margin was quite narrow, and it can be assumed that a considerable portion of 
the Finnish population exceed this TDI.  It was not possible to assess the proportion of the 
Finnish population exceeding EU SCF’s TDI in this study since that would require data on 
individual based intake assessments including all age-classes. 
Finland is one of those countries where the consumption of fish is high compared to 
many other European countries (Welch et al. 2002), about 15 kg/person/year 
(http://www.rktl.fi/www/uploads/pdf/taskutilasto2004.pdf). Nevertheless, high consumption of 
fish together with the fact that the origin of a considerable part of the fish originate from the 
Baltic Sea which is contaminated with PCDD/Fs and PCBs explain the high contribution of fish 
and fish products to the intake of PCDD/Fs and PCBs. Depending on the calculation method 
(lower- or upper bound) the contribution of fish accounted for 60% to 95% of the PCDD/F 
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intake. The contribution of Baltic herring alone to the intake was 50%. The lower or upper 
bound contributions from milk products were 1% to 15%, respectively, and the contribution of 
meat and eggs was from 2% to 17%, respectively. Fish also contributed the main part to the PCB 
intake, accounting for 80%. 
A similar decrease in PCDD/F intake, as in other countries worldwide, could be detected 
when comparing Finnish intake assessments from the beginning of 1990s to the assessments at 
the end of 1990s. Hallikainen and Vartiainen (1997) reported the daily intake of PCDD/Fs to be 
95 pg N-TEq which was comparable to lower bound I-TEq estimate of 46 pg I-TEq/day obtained 
with the SSIF-method in this study. Hence, we detected an annual decrease of 6%, which was 
close to other reported decreases in the intake of PCDD/Fs (see CHAPTER 1, Fig. 2). The 
decline of dietary intakes of PCDD/Fs and PCBs in Finland was probably affected by two 
equally important reasons. First the concentrations in foodstuffs, especially in cow’s milk and 
eggs, had been declining. Secondly, the consumption habits of Finnish people have been 
changed to favour less fatty products, especially with regards to milk, cheese, and meat products. 
This changing of diets to consumption of less fatty foods has continued since the above studies 
(Helakorpi et al. 2004). In the future, dietary habit changes may be more crucial in reducing the 
PCDD/F and PCB intakes rather than changes in concentrations of PCDD/Fs and PCBs actually 
present in the foodstuffs. A decrease in the concentrations of PCDD/Fs and PCBs in fish 
products would be the most effective way to diminish Finnish exposure to these contaminants. 
However, the concentrations in Baltic herring, which can be used as a proxy to domestic wild 
fish, have not been decreasing during the last decade, according to this study and a more recent 
report (Hallikainen et al. 2004, Isosaari et al. 2005). The control measures taken by the EU 
Commission to decrease the PCDD/F and PCB concentrations in feedstuffs (EC 2002) will 
probably decrease the concentrations in cultivated fish and eggs, but a similar dramatic decrease 
as occured during the 1990s cannot be anticipated.   
Since fish are the main source of PCDD/Fs and PCBs in Finland one way to reduce the 
exposure to these contaminants is to advice people to avoid eating fish. However this is not 
recommended in Finland. Instead there is a recommendation given by the National Nutrition 
Council and the National Food Agency (http://www.elintarvikevirasto.fi/english/ -> Press 
releases 2004) to consume fish at least twice a week but alternating the fish species in the diet 
(Annex 1). There are specific recommendations to eat large Baltic herring or wild salmon only 
once or twice a month in order to avoid excessive exposure to PCDD/Fs and PCBs. This also 
applies to consumption of pike in order to avoid exposure to mercury. In their global assessment 
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of organic contaminants in farmed salmon, Hites et al. (2004) and later Foran et al. (2005) 
concluded that in order to diminish the risk of cancer, farmed salmon should not be eaten more 
than once per month. This risk assessment by Hites et al. was challenged by Tuomisto et al. 
(2004) who conducted a risk-benefit analysis for eating farmed salmon. It was concluded that by 
following the recommendations of Hites et al., the number of cancer deaths would decrease by 
40 cases per year, but the number of cardiac deaths would increase by over 5000 cases per year 
in Europe. This would be due to a decrease in the intakes of omega-3 fatty acids. In addition to 
healthy fatty acids, fish contain several vitamins, minerals, and are also a protein-rich food 
source. Fish are a particularly good source of vitamin D for the elderly population in Finland. 
Instead of losing the beneficial health effects by not using fish (because it is contaminated) we 
should further diminish the European and global releases of PCDD/Fs and PCBs in order to 
lower the concentrations of these contaminants in the marine environment. One way to decrease 
the concentrations of PCDD/Fs and PCBs in the Baltic fish for human consumption would be 
more efficient exploitation of herring stocks and a transition to utilizing smaller herring in the 
manufacture of prepared fish dishes.     
2. ADIPOSE TISSUE CONCENTRATIONS OF PCDD/Fs AND PCBs IN THE GENERAL 
POPULATION  
 Since the concentrations of PCDD/Fs and PCBs in this study correlated with the age of 
the subject, an adjustment according to age had to be done before any comparisons between 
countries, studies or time periods could be made. Also the sample collection period should be the 
same, due to the decreases occurring in exposure to and the adipose tissue concentrations of 
PCDD/Fs and PCBs. When taking the age and sample collection period into account, the 
concentrations of PCDD/Fs and PCBs in Finland were very similar to concentrations reported in 
other European countries, as can be seen from figures 1 and 2 depicting TEq concentrations in 
six, and PCB 153 concentrations in four European countries, respectively. 
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Fig 1. Mean TEq concentrations in six European countries at the end of 1990s and at 
the beginning of 2000 (mean age of studied population). Data from: CHAPTER 5 
(Table 4), Päpke 1998, Wingfors et al. 2000, Bocio et al. 2004, Arfi et al. 2001, 
Koppen et al. 2002.     
Fig 2. Mean PCB-congener PCB 153 concentrations in different countries in Europe 
at the end of 1990s and at the beginning of 2000 countries (mean age of studied 
population). Data from: CHAPTER 5 (Table 5), Costabeber and Emanuelli 2003, 
Wingfors et al. 2000, Koppen et al. 2002, Covaci et al. 2002, Wicklund Glynn et al. 
2000, Wicklund Glynn et al. 2003, Wallin et al. 2003. 
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A decrease in the concentrations of PCDD/Fs and PCBs from coastal to inland areas, 
similar to breast milk samples in 1994, was detected in adipose tissue samples of the general 
population in Finland. With the older population, the decrease was more pronounced towards 
inland areas when compared with the younger population. This was consistent with the results 
from breast milk samples in 2000 (Leeuwen and Malisch 2002) failing to confirm any 
differences in concentrations between Helsinki area and Kuopio. Also the food frequency 
questionnaire from the general population revealed that younger population’s fish consumption 
around Finland was already quite uniform with respect to frequency of fish and fish species 
consumed. Among the older population, Baltic herring (as well as other Baltic fish species) was 
consumed more in coastal areas when compared to inland areas, and this is the explaination for 
the more pronounced decline in adipose tissue concentrations between areas. 
It was not possible to determine the annual decrease in the exposure of Finnish 
population to PCDD/Fs and PCBs from the adipose tissue data available. Nevertheless, at the 
population level the PCDD/F concentrations did not follow the upward convex curve, reaching 
steady state at about the age of 40 years, which would be the case if the exposure had been 
stable. This indicates that the exposure has decreased during recent decades.
3. PCDD/Fs AND PCBs IN BREAST MILK 
 The estimated annual declines in PCDD/F and PCB TEqs in Finnish breast milk samples 
during the time period between 1987 and 1994 were 4% and 8%, respectively. This was in line 
with the reported decreases in breast milk samples worldwide and was also comparable to the 
annual decrease in PCDD/F intake (6%) in Finland reported in the present study. The paper of 
the third round of WHO breast milk studies described the most recent analysis of pooled breast 
milk concentrations from the year 2000 (Leeuwen and Malisch 2002). The average Finnish 
WHOPCDD/F-TEq concentration in breast milk was 9.4 pg/g fat which is 85% of the average 
concentration in Western Europe. The concentration of WHOPCB-TEq, 5.9 pg/g fat, was at the 
lower end of WHOPCB-TEq concentrations in Western Europe, representing 57% of the average 
Western European concentrations. The time-trend between 1987 and 2000 in Finland (see Fig 3) 
suggested an annual decrease of 5% and 6% of WHOPCDD/F-TEq and WHOPCB-TEq, 
respectively.  
A decrease in breast milk PCDD/F and PCB concentrations from the capital area to 
inland (Kuopio) area was found in the 1994 study confirming an earlier study in 1987 
(Vartiainen et al. 1997). By the year 2000, this regional difference no longer existed. One 
171 
explanation might be that in 1987 and still at the beginning of 1990s, the fish consumed in 
capital area included more Baltic herring or other Baltic fish than fish consumed in the Kuopio 
area, resulting in higher concentrations of PCDD/Fs and PCBs in breast milk of mothers in the 
capital area. Since the mid 1990s, the fish consumption habits in the two areas have converged. 
This change depicts the increasing consumption of cultivated salmon imported from Norway (in 
1992 the imported amount of Norwegian cultivated salmon was 0.1 million kg, while in 2000 it 
was already 6.6 million kg (Finnish custom statistics 2004, received by phone from the Finnish 
Game and Fisheries Research Institute)). It is assumed that young women prefer to use cultivated 
salmon fillet or frozen ready fish meals instead of Baltic herring or other fish species. 
For the year 2000 the intakes of exclusively breast feeding infants were calculated to be 
53 and 33 pg/kg bw/day of WHOPCDD/F-TEq and WHOPCB-TEq, respectively, presuming an 
infant weight of 5 kg and a daily consumption of 800 ml of breast milk with 3.5% fat. Thus the 
total exposure of an infant would exceed the TDI proposed by EU SCF, by a factor of 40. This is 
at the lower end when compared to the corresponding values in other countries. Since the TDI 
suggestion is based on lifelong exposure, it is probable that this relatively short period of high 
exposure to PCDD/Fs and should not cause hazardous health effects to infants. Instead, because 
of the many beneficial health effects of breast milk, breast feeding has been encouraged by the 
WHO (WHO 2000). 
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Fig 3. Time-trend of WHOPCDD/F-TEqs (diamonds) and WHOPCB-TEqs (open squares) 
as pg/g fat in breast milk in Finland between 1987 and 2000. Results from 1987 and 
1994 from this study, results from 1995 are unpublished data, results from 1997 partly 
published by Hölttä et al. (2001), results from 1999 published by Alaluusua et al. 
(2002), and results from 2000 published by Leeuwen and Malisch (2002).  
4. PCDD/Fs AND PCBs IN A SAMPLE OF FISHERMEN 
 A pilot study of 47 professional fishermen, population anticipated to be highly exposed to 
these environmental pollutants, was conducted, because the previous intake studies of PCDD/Fs 
and PCBs had indicated that fish are the major source of these agents in Finland. Of the studied 
fishermen 55% consumed fish at least once a week, compared to 40% of Finnish males in 
general. The fishermen preferred to consume wild fish more often than the general population. 
Fishermen’s serum fat concentrations of PCDD/Fs and PCBs were 2 to 4 times higher than those 
of the general population men of the same age (Fig. 4). The concentrations were higher in the 
Baltic Sea fishermen compared to inland lake fishermen. This was attributable to the fact that 
they ate more Baltic wild fish, which are more contaminated with PCDD/Fs and PCBs in 
comparison with inland lake fish (Hallikainen et al. 2004). High exposures of fishermen 
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populations have been reported from Sweden, with respect to Swedish Baltic Sea fishermen, and 
from North America, with respect to sport anglers fishing in the Great Lakes (Svensson et al. 1991, 
Svensson et al. 1995, Sjödin et al. 2000, Cole et al. 1997, Anderson et al. 1998, He et al. 2001).
      
Fig 4. Median year class (CHAPTERS 5 and 7) concentrations of A: WHOPCDD/F-TEq,
and B: WHOPCB-TEq in fishermen (dots) and in general population men of the same age 
in Finland (crosses). 
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5. CONGENER OCCURRENCE AND ACCUMULATION 
Figures 5 to 8 depict the congener profiles of PCDD/Fs and PCBs as percentages of the 
total concentrations and as percentages of the WHO-TEqs in market baskets representing the 
exposure of a general population in Finland. In addition, profiles of PCDD/F and PCB in 
deposition between 1997 and 2004 are illustrated in figures 5 to 8 (unpublished data from joint 
research between The Finnish Environment Institute and KTL). Deposition of PCDD/Fs and PCBs 
will contribute to the exposure of population directly via non-animal origin foodstuffs, cereals, 
vegetables, fruits and berries etc. in which the profiles of PCDD/Fs and PCBs were quite similar to 
corresponding deposition profiles. Higher chlorinated PCDD/Fs dominated the concentration 
profiles, while in PCBs the lower chlorinated congeners expressed relatively high contribution to 
the profile. Different bioaccumulation properties of PCDD/F and PCB congeners in food chains 
resulted in differences in congener profiles in animal origin foodstuffs when compared to non-
animal origin foodstuffs. Tetra and penta chlorinated PCDD/Fs expressed higher accumulation 
efficiency than the hepta and octa chlorinated congeners. Especially in many fish species these 
lower chlorinated PCDD/Fs: 2,3,4,7,8-PeCDF, 2,3,7,8-TCDF, 1,2,3,7,8-PeCDD, and 2,3,7,8-
TCDD bioaccumulate efficiently. The total diet WHOPCDD/F-TEq profile resembled very much the 
corresponding profile in Baltic herring, salmon, and rainbow trout. The contribution of the fish 
basket to the total basket was the largest due to the high concentrations of contaminants in fish. 
OCDD dominated the concentration based profile due to OCDD load from non-animal origin 
foodstuffs and also because the occurrence of OCDD in pork meat, poultry, and eggs was 
abundant. With PCBs, due to their different bioaccumulation potencies, the congener abundance 
pattern changed from lower chlorinated congeners towards higher chlorinated compounds. The 
most abundant congeners in the total diet were PCB 153, 138, 118, and 180. 
Comparison of the average Finnish exposure profiles of PCDD/Fs with the corresponding 
profiles in adipose tissue or serum samples in different subgroups of Finnish population (Fig 9 and 
10) revealed that dioxins bioaccumulate more efficiently from the food into humans than furans do. 
Especially the higher chlorinated dioxin congeners (hexa to octa substituted) made a higher 
contribution to the PCDD/F profile in human samples than in the total diet. On the contrary, the 
contribution of all ten furans diminished when moving from the total diet to human samples. The 
stronger contributions of dioxin than furan congeners in PCDD/F profiles as one moved from the 
total diet to the general population was in accordance with the reported half-lives of PCDD/Fs in 
humans (Flesch-Janys et al. 1996, Liem and Theelen 1997). In almost all chlorination patterns, 
dioxin congeners have been reported to have longer half-lives than the corresponding furan 
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congeners. One exception does exist, the half-life of 2,3,4,7,8-PeCDF have been reported to be 9.9 
or 19.6 years by Liem and Theelen (1997) and Flesch-Janys et al. (1996), respectively, while the 
corresponding half-life of dioxin congener 1,2,3,7,8-PeCDD were 8.6 or 15.7 years, respectively. 
On the basis of half-life of 2,3,4,7,8-PeCDF, one would have expected it to make a considerable 
addition to the contribution of this congener in the profile in general population. 
The contributions of the different PCDD/F congeners in profiles in young women (breast 
milk samples) and general population (adipose tissue samples) were very similar. Only with 
congener 2,3,4,7,8-PeCDF was the contribution slightly lower within young women. This might 
be due to their lower consumption of fish as compared to the general population. It was expected 
that the contribution of 2,3,4,7,8-PeCDF would be the highest among fishermen, but this proved 
not to be the case (Fig 9 and 10). It transpired that our sample of fishermen was not optimal for 
the purpose of comparing average contributions of different PCDD/F congeners between 
fishermen and other population subgroups. There were only 46 fishermen in the study 
(CHAPTER 7) and half of them were inland lake fishermen, mostly fishing from the same lake. 
By chance, a relatively large proportion of the inland lake fishermen preferred bream over other 
fish species and therefore congeners contributing the most in bream, 1,2,3,7,8-PeCDD and 
1,2,3,6,7,8-HxCDD, also contributed relatively strongly in average fishermen profile (Fig 9 and 
10). The crucial effect of fish species mainly consumed on congener profiles in an individual 
was reported in CHAPTER 7. Some of the individual fishermen in the study reported that they 
consumed exclusively or at least mostly one species of fish. The congener profiles of those 
individual fishermen were very similar to the profiles measured in the fish in the corresponding 
areas. We have further, still unpublished, data from professional Baltic Sea fishermen, and in 
that data the contribution of 2,3,4,7,8-PeCDF exceeds the corresponding contribution in other 
population subgroups. 
   
Fig 5. Congener profiles of PCDD/Fs as concentration basis in deposition and in Finnish diet. Profiles: I=Total diet, II=Animal origin market 
baskets, III=Non-animal origin market baskets, IV=Average deposition profile in Finland during 1997-2004. Congeners: 1D: 2,3,7,8-TCDD; 
2D: 1,2,3,7,8-PeCDD; 3D: 1,2,3,4,7,8-HxCDD; 4D: 1,2,3,6,7,8-HxCDD; 5D: 1,2,3,7,8,9-HxCDD; 6D: 1,2,3,4,6,7,8-HpCDD; 7D: OCDD; 1F:
2,3,7,8-TCDF; 2F: 1,2,3,7,8-PeCDF; 3F: 2,3,4,7,8-PeCDF; 4F: 1,2,3,4,7,8-HxCDF; 5F: 1,2,3,6,7,8-HxCDF; 6F: 2,3,4,6,7,8-HxCDF; 7F:
1,2,3,7,8,9-HxCDF; 8F: 1,2,3,4,6,7,8-HpCDF; 9F: 1,2,3,4,7,8,9-HpCDF; 10F: OCDF. (Market basket data from CHAPTER 3, deposition data
from joint research between The Finnish Environment Institute and KTL). 
0
10
20
30
40
50
60
70
80
P
e
r
c
e
n
t
a
g
e
1
D
2
D
3
D
4
D
5
D
6
D
7
D
1
F
2
F
3
F
4
F
5
F
6
F
7
F
8
F
9
F
1
0
FI
II
III
IV
Congener
176
Fig 6. Congener profiles of PCDD/Fs as WHOPCDD/F-TEq basis in deposition and in Finnish diet.. Profiles: I=Total diet, II=Animal origin market 
baskets, III=Non-animal origin market baskets, IV=Average deposition profile in Finland during 1997-2004. Congeners: 1D: 2,3,7,8-TCDD; 
2D: 1,2,3,7,8-PeCDD; 3D: 1,2,3,4,7,8-HxCDD; 4D: 1,2,3,6,7,8-HxCDD; 5D: 1,2,3,7,8,9-HxCDD; 6D: 1,2,3,4,6,7,8-HpCDD; 7D: OCDD; 1F:
2,3,7,8-TCDF; 2F: 1,2,3,7,8-PeCDF; 3F: 2,3,4,7,8-PeCDF; 4F: 1,2,3,4,7,8-HxCDF; 5F: 1,2,3,6,7,8-HxCDF; 6F: 2,3,4,6,7,8-HxCDF; 7F:
1,2,3,7,8,9-HxCDF; 8F: 1,2,3,4,6,7,8-HpCDF; 9F: 1,2,3,4,7,8,9-HpCDF; 10F: OCDF. (Market basket data from CHAPTER 3, deposition data
from joint research between The Finnish Environment Institute and KTL). 
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Fig 7. Congener profiles of PCBs as concentration basis in deposition and in Finnish diet. Profiles: I=Total diet, II=Animal origin market
baskets, III=Non-animal origin market baskets, IV=Average deposition profile in Finland during 1997-2004. (Market basket data from 
CHAPTER 3, deposition data from joint research between The Finnish Environment Institute and KTL). 
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Fig 8. Congener profiles of PCBs as WHOPCB-TEq basis in deposition and in Finnish diet. Profiles: I=Total diet, II=Animal origin market 
baskets, III=Non-animal origin market baskets, IV=Average deposition profile in Finland during 1997-2004. (Market basket data from 
CHAPTER 3, deposition data from joint research between The Finnish Environment Institute and KTL). 
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Fig 9. Average congener profiles of PCDD/Fs as concentration basis in the average Finnish diet and in different human samples. Profiles:
I=Total diet, II=General Finnish population, and III=Inland lake and Baltic Sea fishermen. Congeners: 1D: 2,3,7,8-TCDD; 2D: 1,2,3,7,8-
PeCDD; 3D: 1,2,3,4,7,8-HxCDD; 4D: 1,2,3,6,7,8-HxCDD; 5D: 1,2,3,7,8,9-HxCDD; 6D: 1,2,3,4,6,7,8-HpCDD; 7D: OCDD; 1F: 2,3,7,8-TCDF;
2F: 1,2,3,7,8-PeCDF; 3F: 2,3,4,7,8-PeCDF; 4F: 1,2,3,4,7,8-HxCDF; 5F: 1,2,3,6,7,8-HxCDF; 6F: 2,3,4,6,7,8-HxCDF; 7F: 1,2,3,7,8,9-HxCDF; 
8F: 1,2,3,4,6,7,8-HpCDF; 9F: 1,2,3,4,7,8,9-HpCDF; 10F: OCDF.
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Fig 10. Average congener profiles of PCDD/Fs as WHOPCDD/F-TEq basis in the average Finnish diet and in different human samples. Profiles: 
I=Total diet, II=General Finnish population, and III=Inland lake and Baltic Sea fishermen. Congeners: 1D: 2,3,7,8-TCDD; 2D: 1,2,3,7,8-
PeCDD; 3D: 1,2,3,4,7,8-HxCDD; 4D: 1,2,3,6,7,8-HxCDD; 5D: 1,2,3,7,8,9-HxCDD; 6D: 1,2,3,4,6,7,8-HpCDD; 7D: OCDD; 1F: 2,3,7,8-TCDF;
2F: 1,2,3,7,8-PeCDF; 3F: 2,3,4,7,8-PeCDF; 4F: 1,2,3,4,7,8-HxCDF; 5F: 1,2,3,6,7,8-HxCDF; 6F: 2,3,4,6,7,8-HxCDF; 7F: 1,2,3,7,8,9-HxCDF; 
8F: 1,2,3,4,6,7,8-HpCDF; 9F: 1,2,3,4,7,8,9-HpCDF; 10F: OCDF. 
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Fig 11. Average congener profiles of PCBs as concentration basis in the average Finnish diet and in different human samples. Profiles: I=Total 
diet, II=General Finnish population, and III=Inland lake and Baltic Sea fishermen.
0
5
10
15
20
25
30
P
e
r
c
e
n
t
a
g
e
7
7
1
2
6
1
6
9
1
8
2
8
3
3
4
7
4
9
5
1
5
2
6
0
6
6
7
4
9
9
1
0
1
1
0
5
1
1
0
1
1
4
1
1
8
1
2
2
1
2
3
1
2
8
1
3
8
1
4
1
1
5
3
1
5
6
1
5
7
1
6
7
1
7
0
1
8
0
1
8
3
1
8
7
1
8
9
1
9
4
2
0
6
2
0
9I
II
III
Congener
182
Fig 12. Average congener profiles of PCBs as WHOPCB-TEq basis in the average Finnish diet and in different human samples. Profiles: I=Total 
diet, II=General Finnish population, and III=Inland lake and Baltic Sea fishermen. 
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According to changes in PCB congener contributions between the total diet/exposure and 
human samples, it is obvious that congeners with five or less chlorine substituents are not 
bioaccumulating in humans from food to the extent seen with the higher chlorinated PCBs (Fig 
11 and 12). All tri, tetra, and penta chlorinated PCB congeners, including non-ortho-PCB 126, 
and two hexachlorinated congeners (PCB 128, and 141) expressed a weaker contribution to the 
congener profile in human samples than would have been predicted from their presence in the 
total average Finnish diet (Fig 11 and 12).  Those congeners showing the highest 
bioaccumulation tendency included PCBs 180, 170, 194, 156, 153 and 138. 
Changes in PCDD/F and PCB profiles attributable to the deposition or other non-animal 
origin sources via the food-chain into humans raises the question of the applicability of the 
current TEF scheme in assessing the risk to human health of these contaminants in different 
matrices. The differences in accumulation efficiencies should be taken into account when 
assessing TEF by e.g. using matrix specific TEFs.    
The dominating congeners in adipose tissue samples of the Finnish general population 
were almost the same as those reported for the Swedish population with two exceptions (see 
CHAPTER 1, Fig. 5 and 6). In Finnish people, the contribution of 1,2,3,6,7,8-HxCDD exceeded 
the contribution of 2,3,7,8-TCDD in the WHOPCDD/F-TEq profile, while the reverse was true for 
the Swedes (Fig 13). In WHOPCB-TEq, the proportion of PCB 156 in the Finnish population was 
slightly higher than the contribution of PCB 126, while the reverse was true for Swedes as well 
as inhabitants of other countries (Fig 14). The predominance of the congener 2,3,4,7,8-PeCDF in 
WHOPCDD/F-TEq profile in the general population in Finland can be traced to the consumption of 
Baltic Sea fish, similar to Sweden. The relatively lower contribution of congeners 2,3,7,8-TCDD 
and 1,2,3,7,8-PeCDD might reflect the fact that these foods are relatively less contaminated with 
PCDD/Fs and PCBs in Finland, when compared to other European countries and the USA.
Fig 13. Adipose tissue or serum fat congener profile of (A) sum of PCDD/Fs and (B) WHOPCDD/F-TEqs in Sweden, Europe, USA, Far-East, and 
Finland. (Wingfors et al. 2000, Päpke 1998, Koppen et al. 2002, Arfi et al. 2001, Schecter et al. 2003, Kumar et al. 2001, Choi et al. 2002, Kim 
et al. 2005, this study). Congeners: 1D: 2,3,7,8-TCDD; 2D: 1,2,3,7,8-PeCDD; 3D: 1,2,3,4,7,8-HxCDD; 4D: 1,2,3,6,7,8-HxCDD; 5D: 
1,2,3,7,8,9-HxCDD; 6D: 1,2,3,4,6,7,8-HpCDD; 7D: OCDD; 1F: 2,3,7,8-TCDF; 2F: 1,2,3,7,8-PeCDF; 3F: 2,3,4,7,8-PeCDF; 4F: 1,2,3,4,7,8-
HxCDF; 5F: 1,2,3,6,7,8-HxCDF; 6F: 2,3,4,6,7,8-HxCDF; 7F: 1,2,3,7,8,9-HxCDF; 8F: 1,2,3,4,6,7,8-HpCDF; 9F: 1,2,3,4,7,8,9-HpCDF; 10F:
OCDF.
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Fig 14. Adipose tissue or serum fat congener profile of  (A) certain PCBs and (B) WHOPCB-TEqs in Uelen/Russia, Sweden, Europe, Far-East, 
and Finland (Wingfors et al. 2000, Wicklund Glynn et al. 2000, Wicklund Glynn et al. 2003, Sjödin et al. 2000, Grimvall et al. 1997, Covaci et 
al. 2002, Koppen et al. 2002, Costabeber and Emanuelli 2003, Sandanger et al. 2003, Kumar et al. 2001, Choi et al. 2002, this study).
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6. CONCLUSIONS 
 Based on the results of the present studies, the following conclusions can be drawn about 
the exposure and human PCDD/F and PCB body burden in Finland: 
1. Assessment of the average daily intake of PCDD/Fs and PCBs
• On average, PCDD/Fs and PCBs contributed equally to the total daily adult intake of these 
contaminants. The total average intake was below the EU SCF suggested tolerable daily 
intake (2 pg WHO-TEQ/kg bw). With respect to the WHO suggested TDIs, the average 
exposure of the Finnish population was well below the TDI on a provisional basis (4 pg 
WHO-TEQ/kg bw), but the suggested ultimate goal of TDI (1 pg WHO-TEQ/kg bw) was 
exceeded. 
• The average daily adult intake of WHOPCDD/F-TEq was very similar to that in other European 
countries, while WHOPCB-TEq intake was somewhat lower. 
• A significant part of PCDD/Fs and PCBs in the Finnish diet originated from fish and fish 
products.  
• A decline in the intake of PCDD/Fs during 1990s was detected, which is similar to that seen 
in other countries throughout the world. The main causes of the diminishing concentrations 
are likely to be (1) lowering concentrations in foodstuffs, but not in fish and (2) changes in 
population dietary habits.  
2. Assessment of the average body burden of PCDD/Fs and PCBs 
• Adipose tissue concentrations of PCDD/Fs and PCBs in Finnish people were comparable to 
the concentrations found in other countries. 
• There was a decrease in concentrations of PCDD/Fs and PCBs from coastal area to the 
inland area, and this was thought to be due to differences in fish consumption. 
• The body burdens of PCDD/Fs and PCBs in the general Finnish population did not follow 
the upward convex curve with increasing concentrations until 40 years of age to be expected 
on toxicokinetic basis at constant intake. This was concluded to be due to decreasing 
exposure of the general population to these contaminants. 
3. Assessment of the PCDD/Fs and PCBs concentrations in breast milk
• A decline in breast milk concentrations of PCDD/Fs and PCBs was detected between 1987 
and 1994 being annually 4% and 8%, respectively. This decrease continued also after taking 
into account the more recent breast milk concentrations from the years 1995 to 2000, and 
was similar to that found in other countries. 
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• Concentrations of the contaminants in breast milk samples in 2000 were somewhat lower 
than those in other European countries. 
• The concentrations in breast milk declined as one moved away from the capital area to a 
more inland (Kuopio) area at least till the mid 1990s. This gradient was concluded to be due 
to consumption of different fish species in these two locations. 
4. High exposure fishermen population 
• Professional fishermen were found to be a population highly exposed to PCDD/Fs and PCBs, 
with the concentrations of both compound groups being 2 to 4 times higher compared to non-
fishermen of the same age. 
• The source of this high exposure was concluded to be more frequent use of wild fish, 
especially Baltic fatty fish by professional fishermen. 
• PCDD/F congener profiles of many individual fishermen closely resembled the congener 
profile of the fish species that the fisherman mostly consumed as food. 
5. Congener occurrence and accumulation
• Dioxin congeners, especially higher chlorinated compounds, expressed more efficient 
accumulation potency from diet to human adipose tissue than furan congeners. The 
accumulation efficiency of the furan congener 2,3,4,7,8-PeCDF was not as high as one would 
expect it to be on the basis of reported half-life for that congener. 
• Lower chlorinated PCB congeners expressed lower bioaccumulation potencies than higher 
chlorinated congeners.
• When comparing the average Finnish adipose tissue congener pattern to the corresponding 
patterns in other countries, it was evident that the Finnish pattern most resembled the 
Swedish pattern. 
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ANNEX I  
Dietary advice on fish consumption dated April 28, 2004    
Fish is recommended food and consumption of fish should be increased. Fish contain healthy fatty acids, several 
vitamins and minerals and a lot of protein. Fish are a particularly good source of n-3 fatty acids and vitamin D. The 
useful fatty acids contained in fish have been shown to reduce the risk of cardiovascular diseases. 
The National Nutrition Council recommends that 
- fish should be eaten at least twice a week  
- different fish species should be varied in the diet.  
EXCEPTIONS TO DIETARY ADVICE ON FISH CONSUMPTION 
Despite the favourable nutritional qualities of fish, salmon and herring caught in the Baltic Sea, particularly in the 
Gulf of Bothnia and the Gulf of Finland, may subject consumers to higher than normal levels of dioxins and PCB 
compounds which are harmful to health. Also, higher than normal levels of methyl-mercury can be derived from 
predatory fish caught in inland waters, particularly pike, but also from pike caught in the sea. The older the fish, the 
more contaminants will have been accumulated in it. For these reasons, the following special recommendations 
have been issued to children, young people and people at fertile age. 
Large Baltic herring and wild-caught salmon 
Large herring, more than 17 cm in length (whole fish), can be eaten once or twice a month and as an alternative to 
large herring salmon caught in the Baltic Sea can be eaten once or twice a month.  
Pike and predatory fish from inland waters 
Pike caught in the sea or inland waters can be eaten once or twice a month. 
In addition to these recommendations  
- consumers who eat fish from inland waters on an almost daily basis should also reduce their consumption of the 
following predatory fish that accumulate mercury: large perches, pike perches and burbots 
- pregnant women and nursing mothers should not eat pike due to the mercury risk 
FISH CONTAMINANTS AND DIETARY ADVICE 
The purpose of the dietary advice is to ensure safe consumption of fish. The advice concerns dioxins, PCB 
compounds, mercury and cesium-137 contained in fish. The safety assessments are based on a portion size of 100 g 
of fish. If the portion eaten is smaller, fish can be eaten more often. Herring as well as salmon caught from the 
Baltic Sea and predatory fish from inland waters can be eaten from time to time. In summer, for example, they can 
be eaten in larger amounts, as long as the total annual consumption is balanced and restricted. 
Part (up to one third) of the dioxins and PCB compounds accumulated in fish can be removed by skinning the fish 
before preparing it as food. The exceptions to dietary advice do not apply to small herring, less than 17 cm long 
(whole fish). Filleted herring are usually large, more than 17 cm in length. 
The dioxin and PCB levels in fish from inland waters are normally low, and the mercury levels in other lake fish are 
lower than in pike. The mercury and cesium-137 levels in fish vary from one lake to the other.  
Farmed fish contain only low levels of dioxin and PCB compounds, thanks to the control of fish feed quality. 

